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Abstract
Biopharmaceutical process development is complex and based on a vast number of sub-
processes to be optimized. Nowadays, many approaches for process design are still expert-
and experience-oriented and follow a certain hierarchy. Upstream and downstream proc-
esses are still optimized separately, creating guratively spoken an 'Over the Wall' work-
ow. Consequently, the upstream conditions of highest product titers are selected for
subsequent purication strategies even though further parameters like the concentration
levels of critical impurities may pose a problem in downstream processes. Choosing an
integrated process development approach instead of a strict separation in the workow
may increase the overall process performance. Another challenge during industrial process
development is caused by the 'Time to Market' demand, resulting in insucient screening
and optimization.
This thesis deals with strategies to tackle both industrial issues by the development of
an integrated platform combining upstream and downstream processing features coupled
with the latest technologies in high-throughput screening (HTS) systems and mechanistic
modeling. To prevent an analytical bottleneck created by high-throughput (HT) technolo-
gies another main focus is the development of HTS compatible analytical tools, meeting
the quality attributes for creating mechanistic models.
The rst section of this thesis is concerned with the development and evaluation of so-
phisticated analytical technologies and their use in HTS and modeling applications. The
rst approach makes use of a protein fusion tag with special optical properties for quan-
titative real-time and in-line tracking of proteins in up- and downstream applications.
The Cherry-TagTM resembles the heme group of cytochrome c and can be detected in
the spectral VIS region. It was proven that destabilizing conditions result in a loss of the
tag's chromophore function, making the Cherry-TagTM an ideal tool in screening for pro-
tein solubility and stability. In HT upstream process development in 48-well format using
the BioLector R(m2p-Labs, Germany) the tag helped identifying conditions of non-native
protein formation as inclusion bodies in Escherichia coli SE1, producing glutathione-S-
transferase. During downstream processing the red-colored enzyme fusion was identied
to be the active species as it was eectively bound to an anity column, based on a bind-
ing mechanism which relies on the catalytic activity of the enzyme. The Cherry-TagTM
proved to be a reliable and exact analytical tool for real-time tracking of protein stability
and solubility in diverse elds of biopharmaceutical process development. Additionally,
the study revealed that the optimized conditions for soluble product formation in the
upstream apply for the product without the additional tag. Alternatively, an eective
enzymatic tag cleavage reaction was presented for nal removal of the colored fusion pro-
tein.
As a second approach for HTS compatible analytical tools, multi-variate data analysis of
protein spectra was employed. The method exploits dierences in protein mid-UV (200 -
300 nm) spectra, derived by properties of peptide bonds and amino acid residues. These
absorption dierences in spectra of distinct protein species enable generating empirical
models (partial least squares - projection to latent structures (PLS) regression) based
on calibration samples of known concentration and composition which can be used for
unknown samples in the calibrated region. The methodology was successfully used for
deconvolution of high-throughput multi-component isotherm data of model proteins at
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dierent pH levels and salt concentrations. The generated data were of modeling quality,
resulting in predictive semi-mechanistic models. Besides the accuracy of the analytical
method, its fast and non-invasive nature makes it an ideal tool for implementation into
the HTS workow of robotic workstations without the need of sampling.
The third proposed approach for HTS analytics deals with high-throughput capillary
gel electrophoresis (HT-CGE) which was used as the central analytics for establishing
a high-throughput platform for the production of virus-like particles (VLPs) in E. coli
Rosetta. The presented work on VLPs can be seen as the interface between the analytical
process development discussed above and the up- and downstream process development
strategies proposed below. As mentioned above, the HT upstream optimization was per-
formed in 48-well format in the BioLector Rsystem (m2p-Labs, Germany). An Escheri-
chia coli strain, regulated by a tac-promoter, was investigated for producing the murine
polyomavirus capsid protein (VP1). As a large number of cultivation conditions for the
intracellular product were screened including dierent cultivation temperatures, shaking
speeds, induction conditions and cultivation media, a fast and eective cell disruption
process needed to be developed. The released product was analyzed by HT-CGE which
was shown to be a highly HTS compatible analytical tool for characterizing the soluble
and insoluble protein fraction of all tested setups. Based on the results of the screen-
ing a well performing system was scaled up and the VP1 product was puried using
an anion-exchange chromatography membrane adsorbent, followed by a size exclusion
chromatography polishing procedure. Using HT-CGE also the downstream process was
well characterized, enabling even high-resolution fractionation procedures. Finally, the
puried VP1 proteins were successfully assembled into empty capsids and characterized
using transmission electron microscopy (TEM).
The topic of the second section of the thesis follows up downstream process intensi-
cation strategies by developing systematic methods for dierent chromatographic unit-
operations. A rst strategy is proposed for purifying salt-intolerant proteins using ion-
exchange (IEX) chromatography which might be a challenging task due to increased salt
levels during product elution. Product losses are not only based on insucient optimiza-
tion of purication setups but also product sensitivity to process conditions. Thus, the
methodology includes both stability investigations in HT, as well as a global optimiza-
tion approach for optimal operational conditions for product capturing under stabilized
conditions. The stability experiments cover short- and long-term pH stability, salt to-
lerance tests and additive screenings. With the boundary conditions for product stability
being set the crude feedstock is then analyzed by pH gradient chromatography for iden-
tifying the operational pH window for IEX chromatography (deterministic experimental
process development). Finally, the product's salt stability determines the mode of action
for product capturing, being salt elution mode for salt-tolerant protein species and pH
elution mode for salt-intolerant species respectively. The proposed systematic strategy
was successfully applied in a case study for capturing the salt-intolerant enzyme human
-Galactosidase A from Pichia pastoris. The study enabled an eective low salt capture
step under stable conditions by well-chosen prior screening experiments.
A second approach for downstream process intensication dealt with nding a similar
deterministic experimental approach for the setup of hydrophobic interaction chroma-
tography (HIC). The main focus was to correlate the protein binding behavior to the
protein solubility and the binding pH. Solubility screening and chromatographic column
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experiments were performed on a fully automated robotic workstation for proteins of a-
cidic, neutral, and alkaline isoelectric points to cover a broad spectrum of biomolecules. In
analogy to the strategy for ion-exchange chromatography discussed above, conditions of
instant protein precipitation during the solubility screening were identied and eliminated
from the miniaturized robotic chromatography column experiments. The screening results
showed a direct correlation between the dynamic binding capacity and the operational
pH as well as the overall solubility. Interestingly, process conditions of decreased product
solubility were found to be benecial for binding to the HIC column. As an inverse trend
of protein binding and the binding kinetics was observed, a re-orientation process was
assumed to be the determining factor for increasing the dynamic binding capacity in
HIC. Overall, the dynamic binding capacity could be increased up to 30% compared to
the standard purication procedure performed at neutral pH. Structural changes during
the binding process were nally excluded by performing a principal component analysis
(PCA) of protein spectra of feed and elution samples as another elegant analytical tool
based on multi-variate data analysis, as discussed above.
The third section of this work describes a straightforward methodology for mechanis-
tic chromatography modeling based on process UV data without any knowledge about
the feed composition or concentrations. Industrial chromatography steps are mainly con-
trolled based on process UV data, making this methodology highly relevant for diverse
applications in terms of feed variability and pooling decisions. With the 'Quality by De-
sign' guideline being close to be extended to in silico methods there is even more need for
such straight-forward modeling tools. For UV-based mechanistic modeling of a complex
E. coli feed stream presented here, the model equations including the transport dispersive
model as well as the binding terms were modied to allow modeling based on bounda-
ry conditions in UV absorbance units. The molar concentration based terms were thus
remodeled by including absorption coecients so standard parameter estimation pro-
cedures based on inverse modeling (tting the chromatogram to the measured data by
altering parameters) were applicable. An anion-exchange chromatography case study of a
target protein expressed in E. coli with diverse lumped impurity peaks demonstrated the
practical applicability of the method. The product concentration from the feed material
was estimated from solely UV-based chromatogram data and veried by HT-CGE.
In a nal setup the above-mentioned tools for high-throughput process development and
mechanistic modeling were merged into a project for integrated upstream and downstream
process development. As upstream processes are highly complex and global models for the
large variety of process conditions are hardly applicable, the upstream optimization was
based on HT cultivation screenings in micro-scale format. The cell lysate characterization
of the dierent cell lysates was performed in silico using the above-mentioned procedure
of mechanistic UV-based inverse modeling of chromatography data. The created models
were highly predictive and were used for optimizing IEX capture steps in silico. The
validation experiments of the proposed optimal setups showed that shallow and steep
gradients from the calibration runs could correctly predict setups which were unknown
to the model. The overall integrated up- and downstream performance was determined
by an in silico sampling of all possible elution pooling setups and subsequent Pareto
optimization (multi-objective optimization), based on product recovery (initial titer 
purication yield) and purity. The so determined Pareto fronts of the dierent lysates
resulted in a global set of optimal system points which need to be chosen according to the
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value of the product. In an E. coli case study this proposed integrated approach showed
large potential for concerted up- and downstream optimization, as was the main focus of
the presented thesis. As upstream conditions were found to have a strong impact on the
lysates' impurity proles the 'Over the Wall' workow of a strict separation of up- and
downstream process design should be questioned.
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Zusammenfassung
Die Prozessentwicklung in der biopharmazeutischen Industrie ist komplex und basiert auf
der Optimierung einer Vielzahl an Teilprozessschritten. Heutzutage beruht ein Groteil
der Ansatze zur Prozessentwicklung auf Meinungen von Experten oder Erfahrungsberich-
ten und folgt einer strengen Hierarchie. Prozessstrategien zur Fermentation und Produkt-
aufreinigung werden meist getrennt voneinander optimiert. Kultivierungsprozesse werden
dabei hauptsachlich auf das Erzielen hoher Produkttiter ausgelegt. Weitere wichtige Pa-
rameter, wie z.B. die Reduktion von fr die Aufreinigung kritischen Verunreinigungen,
werden meist vernachlassigt. Eine integrierte Betrachtung beider Arbeitsgebiete birgt
das Potential die Gesamtprozessleistung zu erhohen. Eine weitere Herausforderung bei
der Entwicklung industrieller Prozesse ist der 'Time to Market' Anspruch (ein Prozess
muss aus nanzieller Sicht schnellstmoglich marktfahig werden), sodass ausreichende Pro-
zessoptimierung und -charakterisierung stark eingeschrankt ist.
Diese Dissertation befasst sich mit Strategien, um die genannten Herausforderungen
der Industrie zu erfullen. Dies wird durch die Entwicklung einer integrierten Plattform
fur kombinierte Prozessentwicklung im Kultivierungs- und Aufarbeitungsbereich (Up-
und Downstream Processing) unter Verwendung moderner Technologie im Bereich der
Hochdurchsatz-Verfahren sowie mechanistischer Modelle realisiert. Um einem durch Hoch-
durchsatz-Experimente entstehenden analytischen Engpass entgegenzuwirken, liegt ein
weiterer Fokus der Arbeit in der Entwicklung von Hochdurchsatz kompatiblen Analy-
tikmethoden, welche gleichzeitig eine ausreichend hohe Datenqualitat fur den Einsatz fr
mechanistische Modelle bieten.
Der erste Abschnitt der Dissertation beschaftigt sich mit der Entwicklung und Un-
tersuchung solcher hoch entwickelter analytischer Verfahren und deren Anwendung fur
Hochdurchsatz-Experimente und Modellierung. Das erste Konzept beschaftigt sich mit
dem Einsatz eines Protein-Fusionstags mit besonderen optischen Eigenschaften fur den
quantitativen in-line Nachweis von Proteinen in Kultivierungs- und Aufarbeitungsan-
wendungen in Echtzeit. Der Cherry-TagTM ahnelt der Hamgruppe von Cytochrom C und
kann im VIS-Bereich detektiert werden. Es wurde gezeigt, dass Protein destabilisierende
Bedingungen zu einem Verlust der chromophoren Eigenschaften des Tags fuhren, so-
dass der Cherry-TagTM ein geeignetes Werkzeug zur Untersuchung von Proteinloslichkeit
und -stabilitat darstellt. Unter Verwendung des Tags in Hoch-durchsatz-Kultivierungs-
experimenten zur Prozessentwicklung im 48-Well Format im BioLector RSystem (m2p-
Labs, Deutschland) konnten Bedingungen fur Escherichia coli SE1 identiziert werden,
bei der die Bildung des Produktes Glutathione-S-Transferase (GST) in nicht nativer
Form von Einschlusskorperchen (Inclusion Bodies) erfolgte. In Aufreinigungsexperimen-
ten konnte das rot gefarbte Enzym als aktive Proteinspezies identiziert werden, da
GST eektiv an eine Anitatssaule gebunden werden konnte, deren Bindemechanismus
auf der katalytischen Aktivitat des Enzyms beruht. Der Cherry-TagTM erwies sich als
verlassliches und genaues Hilfsmittel fur analytische Anwendungen zur Echtzeit-Detektion
von Proteinstabilitat und -loslichkeit in verschiedenen Teilgebieten der biopharmazeuti-
schen Prozessentwicklung. Zusatztlich konnte gezeigt werden, dass die optimalen Prozess-
bedingungen der Kultivierung zur Erzeugung groer Mengen an loslichem Produkt direkt
ubertragbar sind fur das Produkt ohne Tag. Zustzlich wurde eine eektive enzymatische
Tag-Spaltreaktion vorgestellt, um den Fusionstag nal zu entfernen.
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Als zweites Konzept Hochdurchsatz kompatibler analytischer Methoden wurde multi-
variate Datenanalyse (MVDA) von Proteinspektren angewandt. Diese Methode nutzt Un-
terschiede im Spektrum des mittleren UV-Bereichs verschiedener Proteine, hervorgerufen
durch Eigenschaften der Peptidbindungen und Aminosaurereste. Diese Unterschiede in
den Absorptionsspektren verschiedener Proteine ermoglichen die Erstellung empirischer
Modelle (Projection to Latent Structures (PLS) Regression) basierend auf einer Kalibrie-
rung mit Proben bekannter Konzentration und Zusammensetzung, die fur unbekannte
Proben im kalibrierten Bereich genutzt werden konnen. Diese Methodik wurde erfolgreich
fur die Spektrenentfaltung von Hochdurchsatz-Multikomponenten-Isothermen Daten von
Modellproteinen bei verschiedenen pH-Werten und Salzkonzentrationen verwendet. Die
erzeugten Daten waren von ausreichender Qualitat fur Modellierungsanwendungen und
ermoglichten die Erstellung von pradiktiven semi-mechanistischen Chromatographie Mo-
dellen. Neben der Genauigkeit der analytischen Methode kann sie insbesondere durch
ihre schnelle und nicht invasive Durchfuhrbarkeit uberzeugen und eignet sich somit zum
Einsatz in Hochdurchsatz-Prozessen auf roboterbasierten Plattformen ohne zusatzliche
Probenentnahme.
Der dritte vorgeschlagene Ansatz einer Hochdurchsatz-Analytik beschaftigt sich mit Hoch-
durchsatz-Kapillargelelektrophorese (HT-CGE), die als zentrale Analytik fur die Entwick-
lung einer Hochdurchsatz basierten Plattform fur die Produktion virusahnlicher Parti-
kel (VLPs) in Echerichia coli Rosetta verwendet wurde. Die Arbeit uber VLPs kann als
Schnittstelle zwischen der bisher behandelten analytischen Methodenentwicklung und den
nachfolgenden Arbeiten uber Prozessentwicklung im Kultivierungs- und Aufarbeitungsbe-
reich betrachtet werden. Die Kultivierungsoptimierung im Hochdurchsatz erfolgte im 48-
Well Format im BioLector RMikrokultivierungssystem (m2p-Labs, Germany). Ein Esche-
richia coli Rosetta Stamm, reguliert durch einen Tac-Promotor, wurde hinsichtlich hoher
Ausbeuten des murinen Polyomavirus Kapsid Proteins (VP1) untersucht. Aufgrund einer
hohen Zahl an untersuchten Kultivierungsbedingungen (Temperatur, Schuttlerdrehzahl,
Induktionsbedingungen und Kulturmedien) musste eine schnelle und eektive Zellauf-
schlussmethode entwickelt werden. HT-CGE erwies sich als kompatible Analytik zur
Charakterisierung der loslichen und nicht loslichen Proteinfraktion aller untersuchter
Kultivierungsbedingungen. Anhand der Ergebnisse der Kultivierungsexperimente wurde
das optimale System auf einen groen Mastab skaliert und durch Anionenaustausch-
Chromatographie mit einem Membranadsorber und anschlieender Groenausschluss-
Chromatographie aufgereinigt. Auch der Aufreinigungsprozess konnte durch HT-CGE
genau charakterisiert werden und ermoglichte eine hochauosende Fraktionsanalytik. Als
letzter Prozessschritt wurden die VP1-Proteine erfolgreich zu leeren Kapsidhullen assem-
bliert und uber Transmissionselektronen-Mikroskopie (TEM) nachgewiesen.
Der zweite Abschnitt der Dissertation beschreibt Strategien zur Intensivierung von Auf-
arbeitungsprozessen durch Entwicklung systematischer Strategien fur verschiedene Chro-
matographiearten. Ein erster Ansatz behandelt die Aufreinigung salzintoleranter Prote-
ine durch Ionenaustauschchromatographie was aufgrund erhohter Salzkonzentration bei
der Produktelution eine Herausforderung sein kann. Da Produktverluste nicht nur auf
suboptimale Prozessfuhrung sondern ebenfalls auf Anfalligkeit des Proteins auf Prozess-
bedingungen zuruckzufuhren sind, beinhaltet die Methode Stabilitatsuntersuchungen im
Hochdurchsatz sowie eine globale Strategie zur Bestimmung optimaler Prozessbedingun-
gen zur Proteinaufreinigung unter stabilen Bedingungen. Die Stabilitatsuntersuchungen
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beinhalten Kurz- und Langzeitstudien bezuglich pH- und Salzeinussen, sowie Untersu-
chungen zum Einsatz stabilisierender Additive. Nach Festlegung der prozessrelevanten
Grenzen und Sicherstellung der Proteinstabilitat im untersuchten Bereich kann das ent-
sprechende Zelllysat mit pH-Gradienten-Chromatographie zur Feststellung des optimalen
pH Fensters zur Aufreinigung analysiert werden (deterministischer experimenteller An-
satz). Letztendlich entscheidet das Salzstabilitatsverhalten des Proteins, ob eine Aufreini-
gung durch traditionelle Elution im Salzgradienten oder durch pH Shift fur salzintolerante
Spezies erfolgen muss. Die vorgeschlagene Methodik wurde erfolgreich in einer Fallstu-
die fur das salzintolerante Enzym -Galactosidase A von Pichia pastoris angewandt. So
konnte durch sinnvoll gewahlte Vorexperimente ein eektiver Aufreinigungsschritt unter
produktschonenden Niedersalz-Bedingungen entwickelt werden.
Ein zweiter Ansatz zur Intensivierung von Aufarbeitungsprozessen beschaftige sich mit
der Entwicklung eines ahnlichen deterministisch experimentellen Ansatzes fur hydropho-
be Interaktionschromatographie (HIC). Das Hauptziel war die Korrelation des Protein-
bindeverhaltens mit der Proteinloslichkeit und dem pH Wert der Umgebung. Sowohl fur
die Loslichkeitsstudien als auch fur die Saulenchromatographie-Experimente wurde eine
voll automatisierte Roboterplattform verwendet. Es wurden Proteine mit saurem, neu-
tralem und basischem isoelektrischen Punkt verwendet um ein breites Spektrum an Bio-
molekulspezies abzudecken. In Anlehnung an die zuvor erlauterte Strategie fur Ionenaus-
tauschchromatographie wurden produktschadigende Bedingungen vorab in Loslichkeits-
studien von den Saulenexperimenten ausgeschlossen. Die Studie zeigte eine direkte Korre-
lation zwischen dynamischer Bindekapazitat und pH Wert der Umgebung sowie der Pro-
teinloslichkeit. Insbesondere Bedingungen verminderter Proteinloslichekeit erwiesen sich
als geeignet fur erhohtes Bindeverhalten bei HIC. Der festgestellte gegenlauge Trend von
Bindeverhalten und der Bindekinetik lie eine Umorientierung an der Adsorberoberache
wahrend der Beladung vermuten. Die maximale Bindekapazitat konnte im Vergleich zu
den Standardbedingungen bei neutralem pH um bis zu 30% gesteigert werden. Struktur-
veranderungen durch den Bindeprozess wurden durch eine Hauptkomponentenanalyse
(PCA) an Proteinspektren des Ausgangsmaterials und der Elutionsproben ausgeschlos-
sen. Hier erwies sich die multi-variate Datenanalyse (MVDA), wie zuvor im analytischen
Teil erwahnt, als geeignete analytische Methode.
Der dritte Abschnitt dieser Arbeit beschreibt eine elegante Methode fur mechanisti-
sche Modellierung von Chromatographie-Prozessen unter direkter Verwendung von UV-
Prozessdaten ohne genaue Kenntnis der Zusammensetzung und Konzentration des Aus-
gangsmaterials. Industrielle Chromatographieprozesse werden hauptsachlich uber UV-
Prozessdaten gesteuert, sodass die entwickelte Methode hohe Relevanz fur verschiedene
Anwendungen betreend Variabilitat des Ausgangsmaterials und Festlegung der Eluti-
onsgrenzen hat. Durch die moglicherweise zeitnahe Erweiterung der 'Quality by Design
(QbD)' Richtlinie um computergestutzten Methoden wird der Bedarf an unkomplizierten
Modellierungswerkzeugen weiter steigen. Zur UV-basierten mechanistischen Modellierung
des hier verwendeten komplexen E. coli Lysats wurden die Modellgleichungen des 'Trans-
port Dispersive Models' sowie der Adsorptionsgleichungen (Isothermen) modiziert, so-
dass die Randbedingungen ebenfalls in UV-Absorptionseinheiten verwendet werden konn-
ten. Die Terme, basierend auf molaren Konzentrationen, wurden durch eingefuhrte Ab-
sorptionskoezienten abgewandelt, sodass eine Standard-Parameter-bestimmung durch
die inverse Modellierungsmethode (Fitten des Chromatogramms an die Messdaten durch
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Veranderung der Parameter) erfolgen konnte. Eine Anionenaustausch-Fallstudie mit ei-
nem in E. coli exprimierten Zielprotein und verschiedenen uberlagerten Kontaminanten-
peaks bestatigte die praktische Anwendbarkeit der Methodik. Die Produktkonzentration
des Ausgangsmaterials konnte allein anhand UV-basierten Daten des Chromatogramms
geschatzt und durch Hochdurchsatz-Kapillargelelektrophorese bestatigt werden.
Der letzte Abschnitt der vorgelegten Dissertation beschreibt die Verknupfung der zu-
vor erlauterten Werkzeuge der Hochdurchsatz-Prozessentwicklung und der mechanisti-
schen Modellierung zur integrierten Optimierung von Kultivierungs- und Aufarbeitungs-
prozessen. Aufgrund der hohen Komplexitat und Vielfalt von Kultivierungsprozessen
sind globale Modelle fur die Vielfalt an Prozessparametern kaum anwendbar, sodass die
Kultivierungsoptimierung anhand von Hochdurchsatz-Experimenten durchgefuhrt wurde.
Die Charakterisierung der groen Vielfalt an Zelllysaten erfolgte in silico unter Anwen-
dung der zuvor erlauterten UV-basierten inversen mechanistischen Modellierungsmetho-
de fur Prozess-Chromatographiedaten. Die generierten Modelle erwiesen sich als hochst
pradiktiv und wurden zur in silico Optimierung des Ionenaustausch-Aufreinigungsschritts
verwendet. Die Validierungsexperimente der vorgeschlagenen Prozessablaufe zeigten, dass
sowohl ache als auch steile Elutionsgradienten anhand der Kalibrierungsexperimente kor-
rekt vorhergesagt werden konnten, obwohl die Aufreinigungsschritte dem System unbe-
kannt waren. Die globale Leistungsfhigkeit des integrierten Ansatzes fur Kultivierung und
Aufreinigung wurde durch in silico Fraktionierung unter Betrachtung aller moglicher Elu-
tionspools und anschlieender Pareto-Optimierung (mehrkriterielle Optimierung) durch-
gefuhrt. Die betrachteten Parameter waren hierbei die Gesamtproduktausbeute (Anfangs-
konzentration  Ausbeute in der Aufreinigung) und die Produktreinheit. Die so bestimm-
ten Pareto-Fronten der verschiedenen Zelllysate ergaben eine Auswahl an optimalen Sy-
stempunkten die anschlieend je nach Wert des Produktes gewahlt werden mussen. In
einer E. coli Fallstudie zeigte dieser integrierte Ansatz ein groes Potential fur gemein-
same Optimierungsprozesse unter Berucksichtigung von Kultivierung und Aufarbeitung,
was das Hauptziel der hier vorgestellten Dissertation war. Da gezeigt wurde, dass die
Kultivierungsbedingungen einen groen Einuss auf die Kontaminantenprole der Zell-
lysate haben, sollte die strikte Trennung von Kultivierungs- und Aufarbeitungsprozessen
zukunftig in Frage gestellt werden.
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1 Introduction
The biopharmaceutical industry has changed rapidly in the last couple of decades. The
variety of products was expanded from the production of small molecules to more complex
pharmaceuticals such as enzymes, antibodies, protein vaccines (e.g. virus-like particles),
as well as hormones and growth factors (Grgacic and Anderson [2006], Walsh [2005]).
Whereas larger molecules were initially extracted from natural sources like the human
blood stream or specic cell tissues, genetic engineering enabled the directed produc-
tion of complex pharmaceuticals in large quantities starting from the 1970s (Walsh and
Murphy [1999]). Nowadays, the biopharmaceutical industry is at another turning point
going from large quantity blockbuster production of therapeutic agents ('one drug ts all
approach') to a more personalized medicine (Jain [2009]).
All stages of process development for biopharmaceutics are shifted from straightforward
routines like antibody platform processes (Shukla et al. [2007]) to individual and tailored
productions. As a consequence of this new trend and the 'Time to Market' demands, fast,
reliable and predictive screening tools need to be developed in all stages of biopharma-
ceutical production. In that context the 'Quality by Design (QbD)' approach (Chhatre
et al. [2011], ICH [2011]) demands a deeper process understanding not only for existing
but also for new processes for gaining a more profound insight of the parameters' impact
on the overall process. Possible approaches exploit systematic exploration of the design
space based on Design of Experiments (DoE) and high-throughput process development
(HTPD) (Kelley et al. [2008]). This leads to a miniaturization of experimental setups, a
reduction in time and materials and allows for parallelization and automation of screen-
ing experiments e.g. on robotic workstations (Oelmeier et al. [2011], Wiendahl et al.
[2008]). However, the generation of large data sets poses major challenges on subsequent
analytical technologies creating a bottleneck in the process workow. New analytical
technologies still need to be of highest quality for producing accurate experimental re-
sults that can at best be used for predictive in silico models.
Such new technologies and tools can be implemented in all stages of biopharmaceutical
process development as in upstream processing - USP (strain construction/ screening and
cultivations), in downstream processing - DSP (cell disruption, clarication and puri-
cation), as well as in stability studies (crystallization, solubility screenings). The high
information content might even enable predictions of inuences of one certain unit op-
eration on the following process step. Today, e.g. USP and DSP are still optimized
separately, meaning that the cultivations of highest product titers are chosen for subse-
quent downstream process development. Concentration levels of critical impurities for
DSP (e.g. product variants), however, can be regulated up or down based on dierent
cultivation conditions (Gawlitzek et al. [1995]). Thus, a compromise between product
titer and depletion or reduction of certain impurities might lead to an overall superior
process performance. High-throughput screening (HTS) tools and sophisticated models
open up new opportunities for process design and even concerted process optimization
strategies.
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1.1 Upstream Process (USP) Development
The development of a successful biopharmaceutical upstream process is dependent on
a large number of variables. The expression host, the expression vector, the inserted
gene of interest as well as the cultivation conditions need to be scored and selected for
maximizing the overall product concentration.
1.1.1 Expression Hosts
The rst step in designing a process for new or existing biopharmaceuticals is selecting a
suited expression system. Not only the choice of host cells (e.g. bacteria, yeasts, insect
cells, mammalian cells, etc.) but also the expression vectors need to be screened and
evaluated. Currently, recombinant proteins are predominantly produced in Escherichia
coli - 40% of the recombinant protein market - and chinese hamster ovary cells (CHOs)
- 50% of the recombinant protein market (Demain and Vaishnav [2009]).
Bacteria (e.g. Escherichia coli from the family of Enterobacteriacae) as hosts have the
advantage of short cultivation times and cost-eective media compared to e.g. mam-
malian cells like CHOs which are often used for antibody production. Protein expression
in bacterial cells can be easily controlled as there exists a large variety of commercially
available cloning vectors. The protein of interest may make up to 50% of the total soluble
protein (TSP) in E. coli (de Marco et al. [2005]). However, this overproduction often
leads to a bottleneck in protein biosynthesis leading to misfolded or incomplete product
species without the desired biological activity. Additionally, bacteria are not capable
of many post-translational modications, e.g. glycosylations, disulde bond formations,
amidations and others. These incapabilities introduce another source of non-active prod-
uct species and in many cases formation of insoluble product agglomerates called inclu-
sion bodies (IBs) (Demain and Vaishnav [2009]). For small protein species IBs can be
transformed into the active form of the product, however, this process is rather complex
starting with unfolding and dierent sequential refolding procedures (Berg et al. [2012],
Vallejo and Rinas [2004]). For larger proteins such a process becomes more and more
complex and expensive additives like folding enhancers (e.g. the major E. coli chaperonin
GroEL - Vallejo and Rinas [2004]) need to be included into the reaction mixtures. An-
other drawback (especially in E. coli) is the high content of endotoxins which can trigger
strong immune responses in humans and mammals in general (Voedisch et al. [2005]).
Yeast cells, being eucaryotic microorganisms, present a number of advantages. As for
bacterial cells, cultivations of yeasts are easy to handle due to their low shear sensitivity
and cultivation media are inexpensive compared to those for mammalian cells. In addi-
tion, yeast cell lines enable product secretion and some posttranslational modications
such as disulde bond formations and glycosylation patterns (Wink [2011]). Those gly-
cosylation patterns can, however, vary strongly from those produced by mammalian cells
and hyperglycosylation was reported (Demain and Vaishnav [2009]). Cultivation dura-
tions, being in a range of several days, are much longer than those for bacteria, being not
longer than 24 h in most setups.
In contrast to bacteria and yeasts, mammalian cell cultures as CHOs enable the produc-
tion of recombinant proteins with identical activity and structure as proteins produced
in the human body with almost all human translational modications (Voedisch et al.
[2005]). However, mammalian cell cultivations are very complex and cost intensive and
16
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Figure 1: Schematic illustration of the StabyExpressTM dot - antidote technology, introduced by Delphi
Genetics, Belgium (Stieber et al. [2008]). The toxin (red triangle) is constitutively produced as an element
in the bacterial genome. A: Cell including an intact plasmid producing the antidote and the product.
B: Cell without or lost plasmid, unable to produce the antidote leading to cell death.
suer from poor recombinant protein secretion. Also, processes using mammalian cells
as hosts carry the risk of contamination by viruses (Demain and Vaishnav [2009]). The
lack of a cell wall makes mammalian cells very shear-sensitive leading to challenges in
process control (Chmiel [2011]).
Besides bacteria, yeasts and mammalian cells, many other expression systems, i.a. insect
cell lines, lamentous funghi, plant cell lines etc. exist (Demain and Vaishnav [2009]) but
will not be discussed here.
1.1.2 E. coli Expression System
The following chapters will focus on E. coli as an expression host, being the central cell
system of this PhD thesis. When a suited cell system is selected being capable of all
needed requirements for producing the protein of interest, there are dierent possibilities
of protein expression and process optimization in E. coli. Nowadays, a large variety of
restriction enzymes, vectors, bacterial host systems and even straight-to-use cloning kits
exist. Besides phages, cosmids and articial chromosomes the most frequently used vec-
tors are bacterial plasmids allowing insertion of up to 10 kb cDNA being sucient for
most recombinantly expressed proteins in the biopharmaceutical sector (Wink [2011]).
Such vectors can then be transformed into the cells (e.g. by electroporation and chemical
treatment - Shrivastava [2013]) as additional genetic elements being replicated indepen-
dently from the host genome. Some plasmids can also be integrated into the bacterial
genome. In general, plasmids are equipped with several basic elements (Wink [2011]):
 Origin of replication (ori) for increasing the copy numbers inside the transformed
cells (e.g. derived from dierent plasmids like pBR322-ori or pUC-ori)
 Marker sequence as a selection marker (e.g. antibiotics resistance like ampicillin
AmpR/ kanamycin KanR or dot - antidote systems like ccdA/ ccdB system, etc.)
 Regulated promoter (RNA polymerase binding site including operator response
elements for regulation) for transcription (e.g. lac, tac, trp etc. - de Boer et al.
[1983])
 Multiple cloning site (MCS)/ Polylinker with dierent recognition sites for restric-
tion enzymes to include the gene sequence of the product
17
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Promoter Origin & References Expression Characteristics
araBAD arabinose metabolic operon Inducible by arabinose
(Guzman et al. [1995]) Glucose/ Fucose repressed
lac lac-operon Inducible by IPTG
(de Boer et al. [1983]) Basal expression
pL/pR Bacteriophage  Temperature regulated
(Elvin et al. [1990])
SP6 SP6 bacteriophage Constitutive with SP6-RNA-Polymerase
(Kang and Wu [1987])
T7 Bacteriophage T7 Constitutive with T7-RNA-Polymerase
(Kang and Wu [1987])
(Tabor and Richardson [1984])
T7-lac Bacteriophage T7 and lac-operon Inducible by IPTG
(Tabor and Richardson [1984]) T7-RNA-Polymerase controlled by lac
(de Boer et al. [1983]) Almost no basal expression
tac Hybrid of lac and trp Inducible by IPTG
(de Boer et al. [1983])
trp tryptophan-operon Repressible by tryptophan
(de Boer et al. [1983])
Table 1: Overview of frequently used bacterial promoters including origin, references and expression
characteristics
The marker sequence helps selecting successfully transformed cells from the wild type
species. Orthogonal antibiotic strategies, meaning that two dierent antibiotic resistance
genes are included into the host genome and into the plasmid, help overcoming these
shortcomings. Employed cell types can be selected from contaminating species by an
antibiotic resistance integrated into the bacterial genome. The second antibiotic resis-
tance is included in the plasmid so that transformed cells can be distinguished from the
wild type species (Wink [2011]). A non antibiotic based alternative was introduced by
e.g. Delphi Genetics (Belgium), being based on a dot - anti-dote (ccdA/ ccdB) system
illustrated in Fig. 1 (Stieber et al. [2008]). The ccdB-gen is encoding for a bacterial toxin
and is integrated into the bacterial genome. The genetic code of the antidote (ccdA) is
included into the plasmid sequence leading to cell death when the plasmid is lost. Con-
sequently, the system cannot only be used as a selection marker but also for enhancing
plasmid stability inside the transformed cells.
The choice of the promoter system is one of the most central aspects when searching for a
suited vector system. The employed systems should be strictly controlled without any un-
desired basal activity and expression rates should be high. A selection of frequently used
bacterial promoters including origin and expression characteristics are given in Table 2
showing dierent possibilities for induction, repression and overall regulation. For exam-
ple the T7 promoter derived from the bacteriophage T7 is transcribed very strongly by a
special T7 RNA Polymerase but not by the host RNA Polymerase (Kang and Wu [1987],
Tabor and Richardson [1984]) and is a very commonly used system for overproduction
of recombinant proteins. Cell growth and the production phase can thus be decoupled
18
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Figure 2: Overview over dierent applications of the Cherry-TagTM technology. A: Upstream ap-
plications for nding conditions of soluble protein expression and scale-up validation B: Downstream
applications for product tracking C: Stability studies for increasing product solubility and for identifying
conditions of instant product denaturation
by putting the gene encoding for the T7 RNA polymerase under the control of a second
promoter e.g. lac (de Boer et al. [1983], Tabor and Richardson [1984]). The rst growth
phase can then be used for biomass accumulation as the gene for the T7 RNA polymerase
is repressed by the lac repressor followed by the recombinant protein production phase
after addition of IPTG which inactivates the lac repressor (Fig. 3). In straight-to-use
cloning kits such sophisticated promoter fusions are realized by integrating the T7 RNA
polymerase gene into the host genome under control of the lac promoter whereas the pro-
tein of interest is cloned into a bacterial plasmid and controlled by the T7 promoter as
shown in Fig. 3. As a result the host strain can be used for all combinations of products
and only the plasmid needs to be changed.
Very strong promoters like T7 can, however, result in a metabolic burden which might
decrease cell growth and might yield in inclusion body formation (Huber et al. [2009]).
A reasonable induction strategy is therefore one of the central tasks to tackle (section
1.1.4). For some products choosing a weaker promoter like tac is another option.
Conveniently, straight-to-use cloning kits are available including suitable cell lines for
transformation and bacterial vectors as described above. Many of these employed plas-
mids include additional genetic elements encoding for fusion proteins which are appended
to the product sequence. Such tags are mostly solubility/ stability enhancers (e.g. Cherry-
TagTM - Azhar and Somashekhar [2014], Padmanabha Das et al. [2009], Halo-TagR-
Ohana et al. [2009]), visibility markers (e.g. Cherry-TagTM - Padmanabha Das et al.
[2009], GFP-Tag - Cabantous et al. [2005]) and anity sequences for simplifying the
purication process (e.g. His-Tag - Ramos et al. [2004], GST-Tag - Lipin et al. [2008],
Halo-TagR- Ohana et al. [2009]). An overview over dierent applications of the Cherry-
TagTM technology is shown in Fig. 2. In upstream applications it helps nding suitable
conditions for soluble protein expression and scale-up validation (Fig. 2A), in downstream
applications the product can be tracked throughout the purication process (Fig. 2B).
For stability studies (Fig. 2C), the Cherry-TagTM helps increasing the product solubility
and can be used for identifying conditions of instant product denaturation.
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Figure 3: Schematic illustration of the T7-lac system of the pStaby plasmid by Delphi Genetics,
Belgium. The lac repressor (red) is constitutively produced as an element in the bacterial genome and
additionally on the plasmid. A: The lac repressor hinders the production of the T7 RNA polymerase
until induction with IPTG (orange). As a result the T7 promoter (green) is not transcribed and the
recombinant protein (blue) is not expressed. B: Addition of the inducer (IPTG) results in a removal of
the lac repressor and the T7 RNA polymerase (green) is expressed. As a consequence the T7 promoter
is transcribed and the protein of interest (blue) is produced.
1.1.3 Codon Usage
However, even with a suited E. coli strain and a stable plasmid of high copy number
the product expression level might be low. One of the main reasons for such behavior is
the codon (base triplett) usage of bacterial cells. Dierent codons encode for the same
amino acid and expression hosts have distinct codon usage (Baneyx [2004]). Some genetic
elements from e.g. human-derived genes include base tripletts that are translated by a
low copy number of transfer RNAs (tRNAs) during protein biosynthesis (rare codons) as
shown in Table 2 (Makrides [1996]). This results in a biochemical bottleneck which may
induce low expression, premature translational termination and changes in the amino
acid sequence (Baneyx [2004]). A possible solution is to replace such rare elements by
codons commonly used in E. coli in a codon optimization. This results in a modied
messenger RNA (mRNA) which is not eecting the amino acid sequence and can improve
protein expression in E. coli as was shown for short-chain dehydrogenase/reductase genes
(SDRs) (Burgess-Brown et al. [2008]) and a recombinant malaria candidate vaccine (Zhou
et al. [2004]). A coexpression of rare tRNAs is another alternative for eliminating these
shortcomings in protein expression (Makrides [1996]).
1.1.4 Process Management
High yields of expressed protein in E. coli are not only inuenced by the expression system
itself but by the cultivation strategy used. The following section will focus on process
management in batch cultivation mode. Other modes of operation (e.g. fed-batch and
continuous cultivations) will be excluded.
1.1.4.1 Media & Additives
Choosing suitable media combinations and additives can strongly enhance protein solubil-
ity, stability and activity. Not only a medium type (e.g. minimal, complex, dened media)
needs to be chosen but those media types also need to be evaluated among each other.
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Amino acids Rare Codons
Arginine AGA, AGG, CGA, CGG
Cysteine UGU, UGC
Glycine GGA, GGG
Isoleucine AUA
Leucine CUA, CUC
Proline CCC, CCU, CCA
Serine UCA, AGU, UCG, UCC
Threonine ACA
Table 2: Rare codons in E. coli (Makrides [1996])
Losen et al. [2004] used two dierent rich complex media and enhanced the benzoylfor-
mate decarboxylase productivity in E. coli about factor 10 when comparing LB and TB
media. Changing the pH level of the employed media can also enhance protein production
as was shown by Kopetzki et al. [1989] for -Glucosidase under lowered initial cultivation
pH. Also, dierent levels of trace elements and additives aected productivity. Huber
et al. [2011] showed that the production of a uorescent protein was enhanced by intro-
ducing a phosphate limitation . In the study of Gill et al. [2000] addition of DTT before
induction yielded in enhanced productivity of GFP-chloramphenicol-acetyltransferase.
Each cell type in combination with dierent expression vectors and products have dier-
ent requirements concerning media compositions and can dier majorly in product titers
as well as impurity proles. Consequently, screening for such compositions is a crucial
factor for resulting in a successful upstream process.
1.1.4.2 Process Conditions
Besides the media composition, the process conditions need to be set carefully for en-
hancing the productivity of cells. As an example, the cultivation temperature inuences
cell growth, metabolic pathways and protein folding kinetics. Dierent studies indicated
that a reduction in temperature is benecial for some proteins for soluble and correctly
folded product species. These ndings were shown by e.g. Schein and Noteborn [1988]
for human interferon-2, human interferon-, and the interferon-induced murine protein
Mx and Shirano and Shibata [1990] for rice lipoxygenase L-2 in E. coli.
As a second factor the oxygen transfer rate was identied as a central factor for soluble
protein formation. Dikshit et al. [1990] found an increase in Vitreoscilla globin production
in E. coli under oxygen limitations. Similar results were obtained by Losen et al. [2004]
when expressing benzoylformate decarboxylase from Pseudomonas putida in E. coli. In-
creased product concentrations were investigated for oxygen limited cultures, whereas
the overall cell density followed an inverse trend. Overall, introducing stress factors can
help for enhancing product formation. Nevertheless, a minimum oxygen supply must be
guaranteed to prevent cell death and product degradation.
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1.1.4.3 Growth State
The growth state of the cell often determines whether or in which form a protein is
produced. The typical bacterial growth curve in batch cultivation mode can be divided
into four dierent phases (Barton [2005]):
 Lag-phase in which bacteria adapt to a new environment and the growth rate is
very slow
 Exponential or log-phase in which bacteria have the highest reproduction rate
 Stationary phase in which the number of new cells produced equals the number of
dying cells due to limitations
 Death phase in which a limitation or toxic environment leads to cell death
When the sequence of the protein of interest is coupled with an inducible promoter the
bacterial growth and production phase can be decoupled. It is important to screen for
induction conditions e.g. the induction time (dependent on cell density) and the inducer
concentration for enhancing the productivity of cells. Whereas in traditional setups the
induction time is set to OD600 nm = 0.7 - 0.8 AU being the early exponential phase (Wink
[2011]), newer studies indicate that an induction at higher cell densities can be highly
benecial. Induction in the early growth phase can result in a metabolic burden which
hinders cell growth and might lead to bottlenecks during protein biosynthesis (Huber
et al. [2009]). Wrongly folded proteins as inclusion bodies might be the consequence as
discussed earlier. Ou et al. [2003] reported the enhancement of soluble expression of RNA
binding protein in E. coli when performing the induction in the early stationary phase.
Similar results were obtained by Galloway et al. [2003] for human proteins.
In a study by Huber et al. [2009] an extended DoE approach of dierent induction times
and inducer concentrations was performed using a robotic platform for producing high
concentrations of the uorescent protein EcFbFP. An induction during the early log-
phase was found benecial for productivity and the inducer concentration showed dierent
trends depending on the induction time. Low inducer concentrations were benecial for
early induced cells, whereas the inducer concentration was negligible for late induced
cells.
1.2 Miniaturized USP Systems
The previously presented literature review of dierent possibilities in process management
implies the need for screening tools allowing for investigating large numbers of process
parameters. Industrial cultivations in fully instrumented bioreactors have the highest
process information available but cannot be used for high-throughput experimentation.
A large variety of miniaturized high-throughput cultivation systems were described in
literature, mostly lacking of accessible process information (Betts and Baganz [2006]). A
compromise between basic process control and HTS capabilities oer small-scale stirred
vessels in milliliter-scale run in parallel, imitating industrial scale fermenters (Akkoc et al.
[2011], Lamping et al. [2003], Puskeiler et al. [2005], Wollerton et al. [2006]). Altenbach-
Rehm et al. [1999] introduced a HTS compatible system of small-scale bubble column
reactors. Improvements have also been made for standard shake ask cultures where
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Figure 4: Illustration of the ambr R15 cell culture system by Startorius Stedim Biotech, Germany
integrated into a robotic workstation (illustration taken from: www.sartorius.us - Poster Publication No:
SBI1536-e150301 by Tait et al.).
oxygen and carbodioxide rates can e.g. be monitored using the Respiration Activity
Monitoring System (RAMOS R-Technology) and pH values can be determined by optical
measurements using uorescent dyes (Anderlei et al. [2004], Scheidle et al. [2007]). In
terms of high-throughput, micro-scale cultivations in microtiter plates are optimal for
exploring the experimental design space as shown by Duetz [2007]. However such a sim-
plication often results in a pronounced reduction in accessible process information and
control and can produce results that are not transferable for scale-up.
An ideal HTS tool for upstream process development must combine both, a high amount
of process information and control, as well as low material consumption and low culture
volume. An example for such a sophisticated technology is the Advanced Microscale
Bioreactor (ambrR) by Sartorius Stedim Biotech, Germany (Fig. 4). It mimics lab-scale
fermenters using 24 or 48 parallel bioreactors of 10 - 15 mL, operated on fully automated
robotic workstations (www.sartorius.us - Poster Publication No: SBI1536-e150301 by
Tait et. al). Each block of 12 bioreactors can be set to a separate temperature and
shaking speed and for each reactor the oxygen uptake as well as the pH can be monitored
continuously using optical sensors (Ratclie et al. [2012]). An additional impeller at the
reactor bottom enables good oxygen uptake and mixing. The combination with a pipet-
ting robot enables fed-batch cultures and sampling for determination of cell densities and
product levels. This new technology was successfully applied for optimizing monoclonal
antibody processes in CHO cells (Hsu and Aulakh [2012], Rameez et al. [2011]) and for
scale-down experiments of haematopoetic stem cell suspension cultures (Ratclie et al.
[2012]).
The BioLector Rsystem by m2p-Labs (Germany), as was used in this PhD thesis, is an-
other elegant alternative for HT upstream screenings. The cultivation experiments are
carried out in sub-milliliter scale in continuously shaken 48-well plates equipped with
an optical bottom. Cell growth can be detected quasi-continuously via scattered light
signals without the need of sampling as necessary in shake ask experiments and the
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Figure 5: Schematic overview over the BioLector Rsystem by m2p-Labs, Germany. A:
BioLector Rmeasurement principle based on scattered light determinations with a dened angle of the
excitation light beam of the optical ber according to Kensy et al. [2009a]. The optical ber is xed to
the shaken parts making measurements possible throughout the process without pausing the system. B:
Photograph of an inoculated 48-well FlowerPlate R(left) and a schematic drawing of the optical bottom
with additional optodes for pH and oxygen level measurements (right).
ambr Rtechnology (Kensy et al. [2009b], Kottmeier et al. [2009]) as illustrated in Fig. 5A.
Dierent additional lters enable the determination of dierent colorimetric products
such as GFP or labeled proteins. So called Flower Plates were developed, designed with
an optimal geometry to counteract inhomogeneous mixing and low oxygen uptake in mi-
crotiter plates (Funke et al. [2009]). Optionally, FlowerPlates Rwith additional optodes
xed to the well bottom of the plate are accessible for pH and oxygen uptake measure-
ments (Wenk et al. [2012]) as shown in Fig. 5B. Changes in the chemical environment in
the cultivation well result in a change in uorescence of the dyes, as was discussed earlier
for shake ask cultures.
Further improvements of the BioLector Rsystem was realized by fusion with a fully auto-
mated robotic station called RoboLector R(Kensy et al. [2012]). By using this technology,
fully automated screenings for media, additives and induction proles can be realized (Hu-
ber et al. [2009]). Nowadays, even a microuidic version of the BioLector Rexists allowing
for feeding strategies and pH adjustment (Funke et al. [2010]). The BioLector Rsystem
has been employed for dierent studies, e.g. for identifying C. glutamicum succinate pro-
duction strains (Kinast et al. [2012]), optimizing the secretory production of a cutinase
in C. glutamicum (Rohe et al. [2012]) and optimizing the production of the recombinant
parathyroid hormone (rPTH) fragment 1-34 in Hansenula polymorpha (Mueller et al.
[2013]). As a straightforward scale-up strategy based on constant oxygen uptake rate (the
sulte oxidation method) exists (Hermann et al. [2003], Kensy et al. [2009a]), optimiza-
tion results are directly transferable for production scale making these HTS technologies
compatible with the bioprocess development workow.
1.3 Downstream Process (DSP) Development
In E. coli recombinant proteins are mostly expressed intracellularly demanding for a cell
disruption strategy after cell harvest. In contrast to extracellular proteins as produced in
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Figure 6: Schematic overview of dierent chromatographic purication modes: A: Anity chromatog-
raphy with a receptor binding the product selectively. Elution is performed by a shift in chemical
environment or competitive ligand. B: Ion-exchange chromatography with a ligand binding oppositely
charged proteins. Proteins are eluted by increasing the salt concentration or changing the buer pH.
C: Hydrophobic interaction chromatography with a hydrophobic ligand binding hydrophobic surface
patches of proteins. Proteins are bound at high salt conditions and are eluted by decreasing the salt
concentration. D: Size exclusion chromatography with chromatography media of a certain pore size dis-
tribution. Proteins of dierent size have dierent access to these pores and thus have diering residence
times inside the chromatography column.
many cell systems like the methylotrophic yeast P. pastoris (Wink [2011]) the crude feed
stock from disrupted cells is much more complex. It contains high amounts of impurities
like cytosolic proteins, nucleic acids, substances from the cultivation process, as well as
many other macromolecules like sugars and fatty acids. Such a composition represents
a challenge for the purication process in order to meet the requirements stated by the
authorities like the Food and Drug Administration (FDA - http://www.fda.gov/) in the
USA or the European Medicines Agency (EMA - http://www.ema.europa.eu). New tech-
nologies in protein purication in terms of strategies, materials and additional statistical
and in silico methods resulted in major advancements in the biopharmaceutical industry
for designing new or improving existing drug substances and meeting the given regulatory
standards. Typical protein purication procedures include selective precipitation/ crys-
tallization of the product or contaminants, extractions using aqueous two-phase systems
(ATPS), ltration technologies (e.g. ultra-/ dialtration), and predominantly chromato-
graphic procedures (Ahuja [2000]).
Chromatography exploits dierent interactions of molecule species (proteins, nucleic acids
etc.) in the mobile phase with a certain type of stationary phase resulting in distinct
residence times or binding behavior (Janson [2011]). A schematic overview of dierent
chromatographic purication modes used in this thesis is shown in Fig. 6. Anity chro-
matography (Fig. 6A) is based on a specic interaction between the protein of interest and
a ligand (e.g. Protein A resins for monoclonal antibodies, glutathione resins for proteins
with GST-tag etc.) (Carta and Jungbauer [2010]). In theory, only the desired protein
species is bound to the ligand whereas all impurities can be found in the ow-through
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fraction. Nevertheless, especially for low column loading some product-resemblant con-
taminants and product binding species (backpack proteins) can result in certain levels of
impurities in the elution fraction. The elution can be performed by weakening the binding
anity after changing the chemical environment (e.g. pH shift) or by introducing a species
that has a higher anity than the protein of interest. Ion-exchange chromatography
(Fig. 6B) exploits the electrostatic binding between charged ligands (positive for anion-
exchange/ negative for cation-exchange) and charged protein patches (Roos [1999], Walsh
[2002]). Under low salt conditions proteins of identical charge as the ligand are washed
through, whereas oppositely charged molecules are bound. The elution is then performed
by increasing the salt concentration or changing the buer pH and proteins elute accord-
ing to their binding strength. Hydrophobic interacton chromatography (Fig. 6C) employs
hydrophobic ligands that bind hydrophobic surface patches of proteins (Walsh [2002]).
For the binding procedure a high salt condition is used which enhances hydrophobic in-
teractions and highly hydrophilic proteins are washed through the column. The elution
procedure follows a decreasing salt concentration whereas weakly hydrophobic protein
species elute rst. For size exclusion chromatography (Fig. 6D) no special ligands are
used but porous media of a certain distribution of pores (Carta and Jungbauer [2010]).
Dependent on the protein size these pores are mostly accessible or inaccessible yielding in
dierent residence times within the chromatography column and thus a dierent elution
time based on size. Small molecules like salts have access to all pores and elute as the
nal species. Additionally, mixed mode interaction chromatography resins are available
e.g. combining both hydrophobic and electrostatic interactions (Zhao et al. [2009]) which
were successfully employed for e.g. an alternative antibody capturing process (Pezzini
et al. [2011]).
1.4 Protein Purication Process
The protein purication process after cell disruption of dierent biopharmaceuticals can
be divided into four process steps (Ahuja [2000]):
 Solid-liquid separation/ Clarication
 Product isolation/ Capturing
 Product purication/ Intermediate purication
 Product polishing
Whereas solid-liquid separation using precipitation, centrifugation and ltration steps
are rather straightforward for most cell extracts, it will not be discussed here. However,
subsequent unit operations can be challenging. During product isolation (Capturing) the
main focus is to reduce the sample volume by removing large quantities of water. Also
critical impurities such as proteases are removed for product stabilization and isolation
(Wen et al. [2015]). Predominantly used unit operations include anity or ion-exchange
chromatography, precipitation steps and also extractions using ATPS.
The main objective of the subsequent product purication (intermediate purication)
step is the removal of impurities with similar physico-chemical properties as the product.
At this stage orthogonal downstream strategies (unit operations exploiting dierent pro-
tein specic properties than the capturing step) must be considered (Wen et al. [2015]).
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Typical unit operations include ion-exchange chromatography (IEX), hydrophobic inter-
action chromatography (HIC) or selective precipitation.
In a nal step (Product polishing) product-related contaminants such as charge variants
or aggregates and additional trace contaminants are removed (Janson [2011]). Addition-
ally, the product is transferred into a stabilizing environment using unit operations for
buer exchange. Polishing procedures include ultra- and dialtration procedures, as well
as further chromatographic procedures such as size exclusion chromatography (Wen et al.
[2015]).
The selection and combination of the above-mentioned separation technologies in com-
bination with dierent modes of operation demands tools for process understanding,
optimization and exploring the experimental design space. Especially with the 'Time
to Market' demands the need for a basic understanding of the parameters' inuence
on the process performance is of major importance. Three fundamentally distinct ap-
proaches can be used for designing purication processes for proteins (Guiochon and
Beaver [2011], Nfor et al. [2009]): expert-based approaches (heuristics and platform pro-
cesses), experimental approaches (high-throughput process development and statistical
design of experiments) and model-based approaches.
1.4.1 Heuristic Approaches & Platform Processes
Heuristic or knowledge-based approaches make use of expert knowledge and conservative
rules of thumb. Collections of such rational design strategies were captured in databases
in so called expert systems including facts about main impurities encountered (Leser and
Asenjo [1992], Lienqueo and Asenjo [2000]). Whereas such rules may help for nding suit-
able starting points still the design space for nding an overall optimum is rather limited
resulting in suboptimal process conditions (Nfor et al. [2009]). Additionally, some ideas
suer from being based on outdated laboratory equipment and questionable scientic
theories (Guiochon and Beaver [2011]).
Platform processes, in contrast, are sophisticated downstream strategies which are known
as highly eective processes for a certain type of molecule and might be used as a tem-
plate for additional resemblant products (Guiochon and Beaver [2011]). Such platforms
are known to result in more eective starting points than employing heuristics for new
products of a similar type. A very well-known example is the monoclonal antibody
(mAB) platform process being based on a Protein A anity chromatography capture
step (selective binding of the mAB FC region) and two additional purication steps for
removal of residual host cell proteins (HCPs), DNA and product-related impurities such
as aggregates (Shukla and Thoemmes [2010]).
1.4.2 Experimental Approaches
Designing processes for new products and expression paths is rather dicult and heuristic
approaches and platform processes are based on knowledge derived from past studies and
similar existing processes. In cases of no founded knowledge about a certain bioprocess
or protein a straightforward solution can be experimental approaches, based on a large
number of screening experiments for exploring the design space. High-throughput process
development becomes the method of choice for investigating large sets of parameters in
downstream processing (Kelley et al. [2008]). Often such miniaturized technologies are
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coupled with statistical design of experiments (DoE), optimal experimental design (OED)
or genetic algorithms (GA) for gaining a more profound process understanding and for
reducing the number of relevant experiments (Nfor et al. [2009]).
High-throughput systems for downstream processing unit operations are widely employed
in biotechnological research, as well as in biopharmaceutical companies. A large variety
of HTS strategies exist for almost all unit operations employed during protein release and
purication which are reviewed in the following chapter.
1.4.2.1 HT Cell Lysis
Cell disruption methods in terms of chemical treatment are straightforward for HTS
applications. Cell lysis can be achieved by alkaline pH, chaotropes like guanidinium
hydrochloride or urea, detergents, solvents etc. (Harrison [1991]) in standard 96-well
plates. Analogously, temperature treatment, osmotic shocks, freeze drying and enzymatic
strategies are easy to use methodologies. Cell disruption by mechanical treatment can be
realized using beating beads in combination with agitation, as was used for the analysis
of bacteria from digesta and fecal samples (Yu and Morrison [2004]) and salivera bacteria
(Lazarevic et al. [2013]) using the NucleoSpin Rbead system (Machery-Nagel, Germany).
Nowadays, also more sophisticated sonication devices were adapted for HTS applications,
e.g. a 24-well HTS sonication device (Hohnadel et al. [2014]) which was successfully
employed for 15 dierent microbial cell types (Staphylococcus, Pseudomonas, Salmonella,
Aspergillus, Candida etc.) including gram negative and gram positive bacteria. Poudineh
et al. [2014] introduced three-dimensional, sharp-tipped electrodes for cell disruption by
electric elds in parallel microchannels shown for the extraction of biomarkers from E.
coli cells.
1.4.2.2 HT Solubility Screenings
HTS technologies are also widely applied for screenings on colloidal stability of proteins
and investigating protein phase behavior. Wiendahl et al. [2009] developed a fast 96-
well method for the determination of protein solubility lines on a robotic liquid handling
station for lysozyme and dierent insulin variants. The experimental setup includes sys-
tem preparation (pipetting steps), equilibration and several consecutive steps of optical
analysis and liquid evaporation until crossing the solubility line. The Rock Imager by For-
mulatrix (USA) is an automated imaging system which cannot only distinguish between
the soluble and insoluble state but can also identify e.g. aggregates, crystals, gelation
states etc. This technology was proven to be highly useful for investigating protein phase
phenomena as was shown for an antibody (Rakel et al. [2014]) and lysozyme, glucose
oxidase as well as glucose isomerase (Baumgartner et al. [2015]).
1.4.2.3 HT Inclusion Body Refolding
As discussed earlier the formation of inclusion bodies is a major problem during upstream
processing. Nevertheless, for some proteins eective unfolding and refolding procedures
exist making such processes highly feasible. High-throughput technologies can be used in
screening for the large number of variables for inclusion body refolding processes. Berg
et al. [2012] optimized an HTS refolding process for lysozyme on a fully automated robotic
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Figure 7: Schematic illustration of the RoboColumn Rsystem by Atoll (Germany) according to Wien-
dahl et al. [2008]. A cross-section of the RoboColumn Ris shown on the left, droplet collection in 96-well
UV plates and spectral evaluation in the middle and a laboratory photograph during breakthrough
experiments on the right.
workstation by varying solute pH and applying dierent additives like sodium chloride,
ammonium sulfate, dithiothreitol and glutathione. Vincentelle et al. [2004] developed a
similar process for dierent proteins expressed in E. coli considering additional additives
like folding enhancers (chaperones), glycerol, polyethylene glycol, co-factors and redox
components. Commercially available HTPD refolding kits include the Pro-MatrixTM
system (Thermo Scientic, USA) and the QuickFoldTM system (Athena Enzyme Systems,
USA) (Bhambure et al. [2011]).
1.4.2.4 HT Aqueous Two-phase Systems
HTPD in screening for aqueous two-phase systems (ATPS) was introduced by Bensch
et al. [2007] with a fast methodology for spectrophotometric determination of binodal
curve and conodes using dyes. The method was successfully applied on bovine serum
albumine (BSA) as a model protein as well as on a complex mixture of a monoclonal
antibody and host cell proteins using a PEG4000 - phosphate system (Oelmeier et al.
[2011]).
1.4.2.5 HT Chromatography
For liquid chromatography a large variety of HTS equipment exists allowing for static
as well as dynamic binding experiments. Batch chromatography in lter plates can be
used for optimizing binding and elution conditions, determination of isotherm data as
well as kinetic studies. Such systems have been applied for the angiotensin-II-generating
enzyme from a raw extract from renal tissue using strong cation- and anion-exchange
resins (Thiemann et al. [2004]), -amylase from B. subtilis and scFv--Lactamase fusion
protein from E. coli (Rege et al. [2005]), as well as for mABs and Fc fusion proteins
testing dierent IEX and HIC resins (Coman et al. [2008]). The MediaScout RResiQuot
system (Atoll, Germany) was introduced by Herrmann et al. [2006] for generating equal
amounts of adsorber volumes (adsorber plaques) using a special vacuum device. An al-
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ternative for batch chromatography to all before mentioned strategies oer PreDictorTM
lter plates prepacked with a dened adsorber type and volume by GE Healthcare Life
Sciences (USA). PhyNexus Inc. (USA) introduced a system of pipetting tips, prepacked
with a certain type and volume of adsorber. Binding, washing and elution studies can
than be easily performed by aspirating and dispensing the respective liquids. Such adsor-
ber tips were used for fast anity isolation of Fab-fragments (Wassaf et al. [2006]) and as
a pre-processing step for oligosaccharide mapping of glycoproteins (Prater et al. [2007]).
All those described strategies lack in mimicking real dynamic binding processes in chro-
matography columns. To eliminate these shortcomings special small-scale columns for
robotic workstations (RoboColumn Rby Atoll, Germany) were developed (Wiendahl et al.
[2008]). The column inlet of RoboColumns Ris of conical shape for the direction of the
pipetting needle of the liquid handling system (LHS) and an O-ring assures tight seal-
ing as shown in Fig. 7 left. The ow of liquids is solely based on pumped liquids by
the LHS and is stopped as soon as the pipetting needle leaves the column. The out-
let of the column is not connected to a tubing and the leaving droplets are collected
in 96-well UV plates for analysis in a spectrophotometer (Fig. 7 middle/right). The
RoboColumn Rsystem thus describes a quasi-continuous setup which was proven to be
highly eective for scale-down models for multi-stage monoclonal antibody processes
(Treier et al. [2012]) as well as for dierent model proteins like BSA and lipolase for break-
through and elution screenings (Wiendahl et al. [2008]). Further approaches for scale-
down models employ small-scale chromatography columns for liquid chromatography sys-
tems, e.g. MediaScout RMiniColumns R(Atoll, Germany) (Bhambure et al. [2011]).
In general, miniaturized systems result in a reduction in time and materials and allows for
parallelization and automation of the workow for screening a large number of process pa-
rameters. A summary of dierent commercially available tools for HTPD in fermentation
and cell culture science, precipitation and refolding processes as well as chromatography
was reviewed by Bhambure et al. [2011].
1.4.3 Model-based Approaches
Besides all other approaches for protein purication process development discussed above,
modeling and simulations can help reducing the number of experiments during the op-
timization process by in silico predictions (Nfor et al. [2009]). Especially in the eld of
chromatography various accurate and predictive models exist. Generally two types of
models must be distinguished, being of empirical or mechanistic nature.
1.4.3.1 Empirical Models
Empirical models are based on process output data and calibration relies on empirical
model tting to respective process data. Such models are only valid within the calibrated
range and are less robust towards changes in media composition and variations in the
design space (Osberghaus et al. [2012]). After cross validations and evaluating the model
with external test sets, data predictions in terms of extra- and intrapolations from the
model can follow. Examples of empirical models are multi-variate data analysis (MVDA)
approaches e.g. used for predictions of protein concentrations based on evaluating protein
spectra as shown for in-line quantication and real-time pooling decisions for model
proteins (Brestrich et al. [2015]), antibodies and serum proteins (Brestrich et al. [2014]).
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Figure 8: Transport and adsorption phenomena as a basis of mechanistic modeling. Transport on the
column level (left) includes convection and dispersion in axial direction. Transport on the particle level
(right) includes lm and pore diusion as well as adsorption phenomena according to Michel et al. [2005].
1.4.3.2 Mechanistic Models
Mechanistic models, in contrast, exploit knowledge about physico-chemical parameters
for accurate predictive models (Osberghaus et al. [2012]). Model calibration results in a
set of parameters which rely on fundamental understanding of the biochemical process
(e.g. protein parameters for size and charge). Examples are molecular dynamics (MD)
approaches, where the 3D structure of the protein is investigated and the interactions
in a certain environment is assessed as used by Lang et al. [2015] in all-atom molecular
dynamics simulations on -lactalbumin, -lactalbumin, phospholipase A2 and ribonucle-
ase A on a cation-exchanger. Starting from such sophisticated models on the molecular
level, certain properties can be correlated to a predicted behavior of the protein as e.g.
the overall activity or binding behavior as used for quantitative structure-activity rela-
tionship (QSAR) and quantitative structure-property relationship (QSPR) approaches as
shown by Ladiwala et al. [2005].
Similar to empirical modeling, model validation experiments determine whether the mech-
anistic model is truly predictive or if a recalibration using dierent and broader data
ranges are needed. In some scenarios the employed model is not suited for the given
setup, making need of a reevaluation of the chosen model.
Liquid chromatography can be modeled by an equation of the convection diusion reac-
tion (CDR) type describing transport phenomena inside the column. Such models include
equations of continuity (mass balances etc.) and the reaction term which follows in terms
of protein binding processes mostly an isotherm equation. Dierent models were sug-
gested being suited depending on the application. For chromatography processes of slow
mass transfer kinetics the general rate model is commonly used as it includes axial dis-
persion, as well as resistances in external and internal mass transport (Piatkowski et al.
[2002]). In this thesis, the transport-dispersive model was used (Michel et al. [2005])
describing transport phenomena inside the chromatography column in the interstitial
volume of the mobile phase and the mass transfer into the pore volume (Eqs. (1) and
(2)). As a simplication compared to the general rate model the lm and pore diu-
sion eects are lumped in an eective mass transfer coecient keff;i. Eq. (1) models
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the change of the concentration ci(x; t) of component i in the inter-particle phase of a
column with length L. Term 1 in Eq. (1) describes the convective transport inuenced
by the inter-particle velocity of the uid u. The middle term describes hydrodynamic
dispersion in axial direction inuenced by the dispersion coecient Dax. The right term
describes the transition of molecules from the inter-particle phase into the particle pores
ci  cp;i. The last term is inuenced by the bed porosity "b, the adsorbent particle radius
rp, and a lumped eective mass transfer coecient keff;i. Eq. (2) models the mass inside
the pores and includes the protein pore concentration in the liquid phase cp;i and the
protein concentration bound to the stationary phase qi. A major inuencing factor is the
particle porosity "p. The transport and adsorption phenomena on the column (left) and
pore level (right) are illustrated in Fig. 8.
@ci
@t
=  u@ci
@x
+Dax
@2ci
@x2
  1  "b
"b
keff;i
3
rp
(ci   cp;i) (1)
@cp;i
@t
= keff;i
3
rp"p
(ci   cp;i)  1  "p
"p
@qi
@t
(2)
A review on dierent isotherms for dening the binding mechanism is given by Foo and
Hameed [2010] including common adsorption models such as Langmuir, Freundlich and
BET.
In this thesis the semi-mechanistic steric mass-action (SMA) isotherm (Brooks and Cramer
[1992]) was applied for modeling ion-exchange chromatography binding behavior includ-
ing the inuence of varying salt concentrations (Fig. 9). Eects of counter-ions on the
retention behavior of proteins are taken into account, as well as the proteins' charac-
teristic charge i. The model also includes dierent adsorbent properties, such as the
total ionic capacity . The steric shielding factor i describes eects caused by proteins
covering binding sites without electrostatic interactions. The kinetic form of the SMA
isotherm is shown in Eq. (3) for k proteins, with qi and cp;i being the concentration of the
protein i adsorbed and in solution inside the pore, respectively. cp;salt describes the eec-
tive pore salt concentration. The constants of adsorption and desorption are described
by kads;i and kdes;i and qsalt (Eq. (4)) equals the number of salt ions still attached to the
adsorbent surface.
@qi
@t
= kads;i
 
 
kX
j=1
(j + j)qj
!i
cp;i   kdes;icip;saltqi (3)
qsalt =  
kX
j=1
jqj (4)
With the governing equations being dened the model generation step follows in which the
calibration data is tted to the respective model. Here, the inverse method was used by
solving a non-linear optimization problem and minimizing the error between measured
data points and the employed chromatography model (Soetaert and Petzoldt [2010]).
The inverse method was successfully employed for small molecules (Forssen et al. [2006]),
model proteins (Osberghaus et al. [2012]), antibodies (Degerman et al. [2006], Karlsson
et al. [2004]), as well as industrial process applications (Close et al. [2014], Mollerup et al.
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Figure 9: Schematic illustration of the mechanism of the steric mass-action model according to Brooks
and Cramer [1992]. Besides adsorption and desorption processes the model includes factors like the steric
shielding of binding sites (yellow cations) and the characteristic charge of the protein.
[2007]). Huuk et al. [2014] used the inverse method for modeling a multi-step optimization
by comparing a consecutive anion- and cation-exchange step in dierent orders for model
proteins.
1.5 Integrated USP - DSP Approach
As shown in diverse case studies, modern tools such as high-throughput process develop-
ment and in silico methods can be used to improve process understanding, development
timelines, and ultimately the product quality. Nevertheless, such technology is mostly
used for separate optimization of upstream and downstream processes. In other words,
cultivation conditions yielding in maximal product titer are selected for downstream pro-
cessing independently of investigating the impurity feed composition. This might result
in an overall suboptimal process as impurity levels are highly inuenced by the cultivation
conditions (Gawlitzek et al. [1995]).
The level of dissolved oxygen strongly inuences HCP levels in terms of stress-response
proteins and enzymes for alternative metabolic pathways (e.g. for carbon metabolism
and electron transport) (Marino et al. [2000], Starck et al. [2004], Ye et al. [2000]). Tem-
perature changes were found to induce the formation of heat or cold shock proteins,
temperature-adapted metabolic enzymes, and proteins involved in transport mechanisms
(Budde et al. [2006], Smoot et al. [2001], Wang et al. [2007], Weiner III et al. [2003], Woo
et al. [2009]). Moreover, the chemical environment and media, in which the cultivation
takes place (e.g. exposure to dierent pH levels) result in an up- or downward regulation
of certain gene areas (Lee et al. [2008], Stancik et al. [2002]). In general, alternative path-
ways and transport mechanisms are used to either metabolize or eliminate the respective
chemicals from the cells (Guina et al. [2003], Kirkpatrick et al. [2001], Pedersen et al.
[1978]). Additionally, the state of the cell in the cell cycle as well as the induction process
change the proteome of cells drastically (Grunenfelder et al. [2001]). Especially induc-
tion leads to an overburden in the host cell mechanism (Durrschmid et al. [2008]). As a
consequence of such dierences in impurity proles, conditions of reduced initial product
titer might result in an overall superior biopharmaceutical process. It is therefore not
only important to develop tools for fast USP and DSP development but there is also the
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need for feed stock characterization tools using modern technologies such as HTPD and
in silico methods.
Another prerequisite for HTPD data of high quality for modeling is the development of
a sophisticated analytics which might in terms of e.g. analytical high-performance liquid
chromatography (HPLC) and product-specic immunoassays (Maiser et al. [2012], Van
Lierop et al. [2002]) not be compatible with the HTS workow and suers from its inva-
sive nature.
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2 Research Proposal
This research work is part of the project 'ERA Net Euro Trans Bio - 6: Development of
an integrated strategy for a high-throughput process development platform on a micro-
scale format - FORECAST'. The overall project structure (Bn = process development
for biologics) covers three sub sections as shown in Fig. 10. The S3 package includes
strain construction and clone screening, as well as lab-scale validation experiments. The
main focus are besides product titers also downstream relevant aspects such as colloidal
and conformational stability of proteins, feed compositions for downstream applications
and including genetic elements for analytical purposes. The P3 package mostly focuses
on the integrated upstream-downstream process development platform. It includes feed
stock characterization technologies, purication strategies, product performance tests, as
well as back coupling to the upstream process development. The nal section C3 covers
chromatographic procedures including in silico methods, crystallization and precipita-
tion screenings as well as working with highly concentrated protein solutions and protein
engineering technologies e.g. by fusion tags.
The development of a biopharmaceutical process is very complex and the nal outcome
depends on the results of a large number of subprocesses. Each step from choosing the
expression host/ system, cloning, clone screening as well as up- and downstream process
development poses major challenges. Although each process step can decide on the suc-
cess of a bioprocess industry is mostly still based on heuristics (expert/ experience-based)
and sequential optimization of the separate process steps. In most research facilities the
upstream conditions resulting in highest product titers are chosen for downstream process
development meaning that the purication site must work with the presented lysates and
cannot inuence concentration levels of critical impurities. Thus, the major challenge in
industry is the fact that the overall success of a process depends on the decisions made
during each individual stage which are driven by contradictory goals and motivations.
Besides problems caused by the strict process development hierarchy also the 'Time to
Market' demands restrict exploring the design space in a sucient way, resulting in sub-
optimal process conditions.
To eliminate these shortcomings and to propose feasible concepts for industrial process
development the main focus of this thesis was to develop an integrated platform combining
up- and downstream processing features (P3) and to loosen the barrier set up between
up- and downstream processing. By using the latest technologies in high-throughput
process development and employing sophisticated models even concerted process opti-
mization strategies can be realized. Synchronously there is need for fast, straightforward,
exact and at best non-invasive analytical technologies to prevent an analytical bottleneck
created by high-throughput technologies. Such analytics need to be of high standard to
produce data of modeling quality to meet the demands of the proposed strategy.
The upstream part focuses on process development based on high-throughput technology.
The BioLector Rfrom m2p-Labs (Germany) enables 48-well cultivations in a sub-milliliter
scale and allows for exploring the design space in terms of cultivation conditions and
parameters with low demands on sample volume and process control. The large number
of cell lysates then need to be scored in terms of product titers, as well as on impurity
proles. Therefore high-throughput compatible analytical technologies need to be devel-
oped including the Cherry-TagTM technology by Delphi Genetics (Belgium) as a visual
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Figure 10: Overview over the Bn ERA Net Euro Trans Bio - 6 project structure. The project is
subdivided into the upstream section S3, the downstream part C3 and the platform development P3.
protein marker. Scale up experiments shall validate the results obtained in micro-scale.
The focus of the downstream part is to develop straightforward tools for designing ef-
cient purication steps in dierent chromatography modes. Such technologies include
systematic strategies (deterministic approach), as well as HTS technologies (experimen-
tal approach) and modeling for parameter estimation and in silico process optimization.
The integrated approach must then be capable of bringing together these technologies
for concerted up- and downstream process development. In that context especially tools
for lysate characterization and scoring as well as HTS compatible analytical tools need
to be developed.
The overall objective of the presented thesis is to create and to link dierent powerful
bioprocess development tools in up- and downstream processing using the latest technol-
ogy in high-throughput process development and in silico tools. The ultimate goal is to
meet both, the 'Quality by Design (QbD)' and 'Time to Market' demands and also to
increase the overall process eciency.
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1. Integrated Development of Up- and Downstream Processes Supported
by the Cherry-TagTM for Real-time Tracking of Stability and Solubility
of Proteins
P. Baumann, N. Bluthardt, S. Renner, H. Burghardt, A. Osberghaus, J. Hubbuch
J. Biotechnol. (2015), doi:10.1016/j.jbiotec.2015.02.024
This article presents a protein tag as a quantitative real-time and in-line product
tracking tool which allows for a distinction between insoluble/ non-native proteins
and soluble/ native species shown in a Glutathione-S-Transferase (GST) case study.
In upstream processing conditions of inclusion body formation were identied and
in downstream applications it was shown that the colored GST fusion protein was
catalytically active and could be bound eectively to a GST anity column.
2. Deconvolution of High-throughput Multi-component Isotherms Using
Multi-variate Data Analysis of Protein Spectra
P. Baumannz, T. Huukz, T. Hahn, A. Osberghaus, J. Hubbuch (z: Contributed
equally)
Eng. Life Sci., accepted manuscript
This case study explores the usability of UV spectra and multi-variate statistics
to prevent an analytical bottleneck in high-throughput batch chromatography, in-
corporating multiple protein species. The presented approach enables integration
of the analytical setup in the batch chromatographic workow, using a standard
UV/VIS spectrophotometer. The quality of the analytical data was sucient to
t steric mass-action isotherms at various pH values and ionic strengths and get a
mechanistic insight into the competitive binding behavior.
3. Establishment of a High-throughput Platform for the Production of
Virus-like Particles in Escherichia coli
C. Ladd Eoz, P. Baumannz, P. Vormittag, C. Weigel, A. Middelberg and J. Hub-
buch (z: Contributed equally)
Biotechnol. Bioeng., submitted manuscript
This study describes the development of an HTS platform for the production and
characterization of virus-like particles (VLPs) produced in Escherichia coli. The
upstream optimization was based on high-throughput cultivations in 48-well for-
mat followed by HTS cell disruption. Capillary gel electrophoresis served as a
HTS-compatible analytical tool for scoring the large number of lysates. After a
successful scale-up culture and product purication, the assembled VLP product
was characterized by transmission electron microscopy (TEM).
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4. Systematic Purication of Salt-intolerant Proteins in Ion-exchange Chro-
matography: The Example of Human -Galactosidase A
P. Baumann, A. Osberghaus, J. Hubbuch
Eng. Life Sci. (2015), doi:10.1002/elsc.201400210
This paper describes a systematic strategy for purifying salt-intolerant proteins
using ion-exchange chromatography. The strategy considers product stability as
well as operational conditions and purication steps can be designed by well-chosen
prior screening experiments. The eciency was shown in a case study on capturing
human -Galactosidase A. The applied strategy allowed for a quick establishment
of a dedicated IEX capture step at low salt concentrations under stable conditions
by well-chosen prior screening experiments.
5. Inuence of Binding pH and Protein Solubility on the Dynamic Binding
Capacity in Hydrophobic Interaction Chromatography
P. Baumannz, K. Baumgartnerz, J. Hubbuch (z: Contributed equally)
J. Chrom. A (2015), doi:10.1016/j.chroma.2015.04.001
This article discusses the inuence of the binding pH on the dynamic binding ca-
pacity in hydrophobic interaction chromatography for proteins of acidic, neutral
and alkaline isoelectric point. Binding close to the solubility limit increased the
binding capacity, whereas an inverse correlation was found for binding kinetics and
protein binding. The latter might indicate protein rearrangement on the adsorber
surface during the binding process. Despite increased protein binding the protein's
integrity after elution was ensured.
6. UV Absorption-based Inverse Modeling of Protein Chromatography
T. Hahn, P. Baumann, T. Huuk, V. Heuveline, J. Hubbuch
Eng. Life Sci. (2015), doi:10.1002/elsc.201400247
This study explores the feasibility of modeling ion-exchange chromatography with-
out knowledge of feed composition in terms of molar or mass concentration. This is
especially valuable in early-stage process development when no information is avail-
able on the impurities. It was shown that all model parameters can be determined
uniquely from single-component elution curves. Here, the concentration of Cherry-
tagged glutathione-S-transferase within a crude feedstock could be determined from
chromatograms at a particular wavelength.
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7. High-throughput Micro-scale Cultivations and Chromatography Model-
ing: Powerful Tools for Integrated Process Development
P. Baumann, T. Hahn, J. Hubbuch
Biotechnol. Bioeng. (2015), doi:10.1002/bit.25630
This paper presents a combined up- and downstream optimization approach based
on high-throughput micro-scale cultivation experiments and chromatography mod-
eling. The methodology is presented in a case study for the enzyme Glutathione-
S-Transferase from Escherichia coli SE1. It was shown that the overall optimized
system must not necessarily be the one with highest product titers, but the one
resulting in an overall superior process performance in up- and downstream.
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Abstract
Product analytics is the bottleneck of most processes in bioprocess engineering, as it
is rather time-consuming. Real-time and in-line product tracing without sample pre-
treatment is only possible for few products. The Cherry-TagTM (Delphi Genetics, Bel-
gium) which can be fused to any target protein allows for straightforward product an-
alytics by VIS absorption measurements. When the fused protein becomes unstable
or insoluble, the chromophore function of the group is lost, which makes this technol-
ogy an ideal screening tool for solubility and stability in up- and downstream process
development. The Cherry-TagTM technology will be presented for the tagged enzyme
Glutathione-S-Transferase (GST) from E. coli in a combined up- and downstream pro-
cess development study. High-throughput cultivations were carried out in a 48-well for-
mat in a BioLector Rsystem (m2p-Labs, Germany). The best cultivation setup of highest
product titer was scaled up to a 2.5 L shake ask culture, followed by a selective anity
chromatography product capturing step. In upstream applications the tag was capable
of identifying conditions where insoluble and non-native inclusion bodies were formed.
In downstream applications the red-colored product was found to be bound eectively to
a GST anity column. Thus, it was identied to be a native and active protein, as the
binding mechanism relies on catalytic activity of the enzyme. The Cherry-TagTM was
found to be a reliable and quantitative tool for real-time tracking of stable and soluble
proteins in up- and downstream processing applications. Denaturation and aggregation
of the product can be detected in-line at any stage of the process. Critical stages can be
identied and subsequently changed or replaced.
Keywords: Cherry-TagTM, BioLector R, Micro-cultivation, Product Analytics, Na-
tive Protein
1 Introduction
Product analytics is a major bottleneck during process development in bioprocess en-
gineering. Most methods are rather time- and material-consuming and cannot be im-
plemented in-line and in real-time. Many analytic procedures include additional sample
preparation steps (i.e. chemical treatment and denaturation), leading to analytical re-
sults which can dier from the untreated sample. Common o-line methods for protein
analytics are gel electrophoresis (GX) and capillary gel electrophoresis (GX II) [1, 2]. By
means of both approaches, protein samples are separated according to their molecular
weight in a denatured and linear state [3, 4]. GX is rather qualitative and is mostly used
for fast and qualitative analytics of cell cultivation harvests and cell lysates [5, 6]. In con-
trast to this, GX II allows for the sequential and quantitative analysis of approximately
400 samples within 2 h of processing time. Sample preparation is rather complex and
time-consuming. However, this technology produces highly accurate and reproducible
analytical results. It was shown that GX and GX II identify almost identical product
and contaminant patterns [1, 7].
The most complex and accurate way of protein analysis is mass spectrometry. In anal-
ogy to GX and GX II, protein analysis is performed o-line and in a denatured state.
The analyte is ionized and subsequently accelerated in a static or dynamic magnetic or
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electrical eld [8]. Separation is performed according to the mass to charge ratio which
is characteristic of a certain type of molecule. Products of higher molecular weights (e.g.
proteins) require mild ionization techniques to prevent fragmentation, such as electro-
spray ionization (ESI-MS) [9], matrix-assisted laser desorption ionization (MALDI-MS)
[10, 11], and desorption/ ionization on silicone (DIOS) [12]. MS protein analytics can
also be coupled with enzymatic digestion prior to ionization, leading to smaller molecule
fragments. The detected peptide pattern can be characterized and identied by an auto-
mated peptide mapping software [13]. MS systems are rather expensive and require vast
expertise for data post-processing. They are mostly applied for protein identication and
proteome analysis studies [14, 15, 16].
A possible o-line alternative to GX, GX II, and MS for analyzing protein samples in
a native state is analytical chromatography [17, 18, 19]. Major disadvantages are sam-
ple pre-treatment (e.g. buer exchanges) as well as buer- and time-consuming column
wash, equilibration, binding, and elution steps for each applied sample. Improvements
have been achieved by introducing a parallel interlaced chromatography method [20].
Still, the time per sample could not be reduced to below 2 min.
O-line analysis including selective protein determination combined with analysis in a
native state, can be realized by customized assays. Those methods are widely applied for
enzymes, hormones, and growth factors: For the granulocyte colony-stimulating factor
(G-CSF), the NFS-60 proliferation assay is used [21, 22]. For enzymes, a selective me-
tabolization of a substrate or the accumulation of a product is evaluated [23, 24]. Other
products with specic binding sequences can be analyzed by e.g. antibody-based ana-
lytical methods like sandwich ELISA or Western Blotting [25, 15, 26]. However, such
technologies are not available for all proteins and assay development and optimization
are rather complex.
Selective and real-time product tracking without sample pre-treatment so far has been
mostly limited to proteins with special optical properties, which are exceptions rather
than the rule. Examples are uorescent proteins like GFP, YFP, mBanana, tdTomato,
mCherry [27], and proteins with chromophore groups like cytochrome c [28]. Most other
proteins, however, are hard to distinguish spectrometrically. Few setups were reported
for on-line analytics by multi-variate data analysis of protein spectra [29, 30]. However,
quantitative protein analysis requires calibration experiments and a secondary analysis
for the determination of single protein titers.
An elegant way to make the advantages of uorescent proteins and chromophores acces-
sible for all proteins is the use of protein tags with special optical properties. Examples
are uorescent GFP- and Halo-Tags R[31, 32, 33]. Quantitative analysis for uorophores,
however, is limited to a constant chemical environment. Wild-type GFP is quenched
under acidic conditions and several GFP mutants like enhanced GFP (EGFP) show a re-
duction in uorescence of approximately 50% starting from pH 5.5 [34]. Also uorescence
is inuenced by dierent ions (e.g. chloride) and is subject to photo bleaching [35, 36].
Moreover, GFP- and Halo-TagRboth do not allow for a distinction between the native and
soluble or denatured state of the fused protein. This said, a GFP-tag alteration exists,
the split GFP-tag system, which can distinguish between soluble and insoluble proteins
for upstream applications [33]. A fragment of GFP is fused to the product and is not
presented, if the protein is in a misfolded state. After product expression, the second
part of GFP is added to the sample and only natively folded proteins show uorescence.
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However, this system is not suited for real-time product tracking of native protein, as the
GFP assembly needs to be performed post-processively and is still based on uorescence
measurements.
The presented Cherry-TagTM technology must not be confused with the uorescent pro-
tein mCherry that is e.g. used for high-resolution two-color uorescence microscopy and
exists as a split mCherry-tag system as discussed for GFP [37, 38]. The newly developed
Cherry-TagTM (Delphi Genetics, Belgium) can be determined by VIS absorption mea-
surements and is not based on uorescence [39, 40]. Protein instability and denaturation
result in a loss of the chromophore group. Thus, the technology can be used for quanti-
tative online and real-time analysis of proteins without sample pre-treatment and allows
conclusions to be drawn with respect to the protein's physiological state in all stages of
bioprocess engineering. Though the potential of the Cherry-TagTM in terms of increas-
ing thermo-stability and solubility of proteins was shown for proteins like enterokinase,
staphylokinase, and the granulocyte colony-stimulating factor [41, 42], the tag has never
been used in quantitative studies and its optical properties have never been applied in
up- and downstream process development studies.
Here, the potential of the Cherry-TagTM technology is tested and evaluated for the en-
zyme glutathione-S-transferase (GST) in up- and downstream applications. The up-
stream optimization is based on 48-well high-throughput cultivations on micro-scale level
in a BioLector Rsystem (m2p-Labs, Germany) [43, 44, 45]. Dierent cultivation condi-
tions, such as the induction setup, shaking speeds, and temperatures, are investigated.
The best cultivation setup is picked by the simple VIS absorption analytics of the cleared
cell lysates. The cleared lysate of a scaled-up cultivation is subsequently puried by GST
anity chromatography. In all applications the above-mentioned GX II will be applied
for validation purposes.
2 Materials & Methods
2.1 Materials
2.1.1 Disposables & Reaction Vessels
The Glutathione-S-Transferase (GST) nucleic acid sequence was cloned into the CherryTM
Express T7, as well as into the StabyCodon RT7 (T7 promoter without adding Cherry-
TagTM) protein expression kit (Delphi Genetics, Belgium). Cells were stored as cryo-
cultures in a CryobankTM strain maintenance kit for microorganisms (Mast Diagnostica,
Germany). Micro-scale cultivations were carried out in 48-well FlowerPlatesRcovered
with adhesive sterile sealing foil (m2p-Labs, Germany). Lab-scale cultivations were per-
formed in 1 L baed asks (Schott, Germany) and 2.5 L baed TUNAIRTM shake
asks (Sigma Aldrich, Germany). Centrifugations for cell harvest and after cell dis-
ruption were carried out in 15, 50, and 225 mL centrifugal tubes (Falcon, Germany).
Absorption measurements were carried out in 96-well at-bottom UV-Star Rhalf-area
micro-plates (Greiner Bio-One, Germany) and 70 L UV-Cuvettes micro (Brand GMBH
+ CO KG, Germany). For gel electrophoresis (GX), Novex RNuPAGER4 - 12% Bis-
Tris (1.0 mm, 12 well) protein gels were purchased from Life Technologies, Sweden.
Capillary gel electrophoresis (GX II) was performed in an HT Protein Express & Pico
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LabChip R(Perkin Elmer, USA). Sample preparation for GX II was conducted in skirted
96-well twin.tecRPCR plates (Eppendorf, Germany). For anity chromatography runs,
5 mL GSTrapTM 4B columns and 50 mL super loops for sample application were pur-
chased from GE Healthcare, Sweden. Fractionations were carried out in 2 mL 96-well
square deep-well plates (VWR, Germany). Filtrations were performed using polyether-
sulfone 0.2 m syringe sterile lters (VWR, Germany).
2.1.2 Chemicals & Buers
Cultivations were carried out in TB (Terric Broth) medium, consisting of 12 g/L wheat
peptone for microbiology (Fluka, Germany), 24 g/L bacteriological yeast extract (Am-
resco, USA), 5 g/L glycerol bidistilled 99.5%, 17 mM potassium dihydrogen phosphate,
and 7 mM di-potassium hydrogen phosphate (VWR, Germany). For induction of the T7
promoter isopropyl--D-thiogalactopyranosid (IPTG) from a 0.25 M and for repression,
glucose from a 20% (w/w) stock solution (VWR, Germany) was applied. Chemicals for
scale-up by determination of the oxygen transfer rate were applied as follows: 12 mM
di-sodium hydrogen phosphate (VWR, Germany), 500 mM sodium sulte BioUltra an-
hydrous as substrate, 2  10 7 M cobalt(II) sulfate heptahydrate ReagentPlus as reaction
catalyst, and Bromothymol Blue as indicator (Sigma Aldrich, Germany). The initial pH
value was adjusted to pH 8 by titration with sulfuric acid (Sigma Aldrich, Germany).
The lysis buer for cell disruption was composed of 50 mM Tris-HCl (VWR, Germany)
and 1X SigmaFASTTM Protease Inhibitor (Sigma Aldrich, Germany) adjusted to pH 8
with hydrochloric acid (Merck, Germany). For reduction of the nucleic acid content,
1 L/10 mL lysate of benzonase purity level II ( 90%) for biotechnology (Merck, Ger-
many) and 10 mM magnesium chloride anhydrous (Sigma Life Sciences, Germany) from
a 1 M stock solution were applied. Cell disruption under denaturing conditions was real-
ized using trichloroacetic acid BioChemica (AppliChem, Germany) and acetone for liquid
chromatography (Merck, Germany).
For gel electrophoresis (GX), 20X Bolt RMES SDS running buer, NuPAGER4X LDS
sample buer, and the Mark 12TM unstained standard (Life Technologies, Sweden) were
used. Dithiothreitol (DTT) was purchased from Sigma-Aldrich, Germany, and prepared
as a 1 M stock solution. Staining of the gel protein bands was realized with 'blue silver'
staining solution, consisting of 10% (v/v) phosphoric acid of 85% purity (Roth, Germany),
100 g/L ammonium sulfate BioChemica (AppliChem, Germany), 1.2 g/L Coomassie Bril-
liant Blue G-250 (Merck, Germany), and 20% (v/v) Methanol (Sigma Aldrich, Germany).
For the capillary gel electrophoresis (GX II) experiments, an HT protein express reagent
kit (Perkin Elmer, USA) was purchased. Lysozyme served as an internal standard of
known concentration (Hampton research, USA).
For the enzymatic tag removal reaction, a recombinant bovine enterokinase (43 kDa cat-
alytic fragment from P. pastoris) from BioIngenium (Spain) was used. The reaction
buer consisted of 50 mM Tris-HCl (VWR, Germany), 1 mM calcium chloride, and 0.1%
of Tween-20 (Sigma-Aldrich, Germany).
The binding buer for the 5 mL GSTrapTM 4B anity column consisted of 50 mM Tris-
HCl pH 8. Elution was performed in 50 mM Tris-HCl pH 8 with 10 mM of reduced
98% purity L-glutathione (Sigma-Aldrich, Germany). For column regeneration, a 50 mM
Tris-HCl pH 8 CIP buer was applied, including 3 M guanidine hydrochloride for molec-
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ular biology (Sigma-Aldrich, Germany). The pH adjustment of all buers was realized
by titration using sodium hydroxide (Merck, Germany).
2.1.3 Instrumentation & Software
Micro-scale cultivations were carried out in a BioLector RMB micro-fermentation system
using the BioLection RHMI & analysis software (m2p-Labs, Germany). Lab-scale fermen-
tations were realized in a MaxQTM 6000 incubator (Thermo scientic, USA). For time
documentation of the indicator's change of color during scale-up, a Spotlight Webcam Pro
(Trust, Netherlands) coupled with the ContaCam Software (Contaware, USA) was used.
Solid-liquid separation for cell harvest and removal of cell debris was performed with a
5810 R centrifuge (Eppendorf, Germany). For cell disruption, a Digital Sonier R 450
(Branson Ultrasonic Corporation, USA) was used. Absorption measurements were con-
ducted in an Innite M200 Reader controlled with I-control 1.9 (Tecan, Germany). The
enzymatic tag removal reaction and the sample denaturation for the GX system was re-
alized in a MUR 13 thermo-shaker with additional lid heating (HLC BioTech, Germany).
The GX was performed in an Xcell SureLockTM Novex RMiniCell gel chamber operated
with a PowerEase R 500 power supply (Life Technologies, Sweden). The gels were scanned
in a Bio-5000 Gel Scanner (Serva Electrophoresis GmbH, Germany). Capillary gel elec-
trophoresis (GX II) was carried out in a Caliper LabChip RGX II (Perkin Elmer, USA).
For data processing and analysis, the LabChip RGX 3.1 software (PerkinElmer) was used.
The GST anity chromatography purication runs were carried out using an AKTATM
purier system (GE Healthcare Life Sciences, Sweden). The system was equipped with a
pump P-900, mixer M-925, UV detector UV-900, motor valve INV-907, pH and conductiv-
ity monitoring pH/C-900, and a fraction collector Frac-950 unit. The FPLC system was
controlled using Unicorn 5.2 (GE Healthcare Life Sciences, Sweden). For pH determina-
tion during pH adjustment of all buers, an HI-3220 pH meter (Hanna Instruments, USA)
was used. Data processing and creation of gures were performed in Matlab R R2011a
(MathWorks, USA).
2.2 Experimental Setup
2.2.1 Establishment of the Cherry-TagTM Analytics
Establishment of the Cherry-TagTM analytics was performed using lysates from 250 mL
cultivations. Two 1 L baed asks were lled with 250 mL sterile TB medium each.
12.5 mL of TB medium were removed from one ask (negative control) and replaced by
20% (w/v) sterile ltered glucose solution, resulting in a nal glucose concentration of
1% (w/v). Addition of glucose results in an inhibition of the lac-operon (cAMP positive
control). Both shake asks (positive and negative control) were inoculated with an E.
coli SE1 Cherry-GST cryo-culture from the CryobankTM strain maintenance kit and cul-
tivated for 20 h in the Max Q 6000 incubator at 170 rpm and 37 C. For cell harvest,
180 mL of cell broth were transferred to 225 mL centrifugal tubes and centrifuged at
4000 rpm and 5 C for 30 min in the 5810 R centrifuge. The supernatant was discarded
and the cell pellets were frozen for 24 h at -20 C as pre-treatment by physical cell dam-
age. Each thawed cell pellet was resuspended in 20 mL lysis buer and sonied in the
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Branson Digital Sonier R 450 using a 1/2" extension cylindrical sonication probe. Soni-
cation was performed at 70% maximal power output and a total treatment time of 150 s
(10  15 s pulse on and 30 s pulse o for liquid cooling on ice). After the last sonication
cycle, 0.1 L/mL of benzonase and 10 mM MgCl2 were added for reduction of the nucleic
acid content. The lysates were transferred to 50 mL centrifugal tubes and centrifuged
twice at 12000 rpm and 10 C for 60 min.
Lysate spectra were monitored to verify the Cherry-TagTM-specic wavelength. Spectra
of the positive and negative control lysates were determined from 300 to 700 nm in 1 nm
steps in an Innite M200 Reader. The spectra were scaled to an equal lysate protein
concentration by using a 300 nm scaling factor. The Cherry-TagTM-specic wavelength
was then determined from the dierence spectrum of the Cherry-GST and negative glu-
cose control sample. Puried Cherry-GST samples in a concentration of 2.2, 4.4, 6.6, 8.8,
and 11 mg/mL, respectively, served as a reference and to investigate samples of higher
protein concentrations. The puried Cherry-GST samples were produced as described in
the 'Purication of Cherry-GST' section.
The Cherry-GST extinction coecient was determined to calculate product concentra-
tions directly from VIS absorption measurements. The Cherry-GST lysate was diluted to
a nal absorption at the Cherry-TagTM-specic wavelength of approximately 1.2 AU. 100,
75, 50, 25, and 0% dilution steps of the lysate using 50 mM Tris-HCl pH 8 were measured
as triplicates in 96-well at-bottom UV-Star Rmicro-plates in the spectrophotometer. For
determination of the corresponding concentrations, the samples were also measured in the
LabChip RGX II device as quadruplicates using the HT Protein Express LabChip Rkit.
The sample and chip preparation procedures were performed as described in the manufac-
turer's protocol for the HT Protein Express Assay [46]. The samples were analyzed using
the HT Protein Express 200 assay and the LabChip RGX 3.1 software. The resulting
electropherograms were aligned to the size of Cherry-GST (approx. 39 kDa). Quanti-
cation of the proteins in each sample was realized by using peak-baseline integration and
scaling to an external lysozyme protein standard of 1 mg/mL.
2.2.2 HTE Upstream Screening
Cultures for the upstream screening were prepared in 250 mL standard TB medium as
described in the product analytics section. After 17 h (end of the exponential growth),
the cells were diluted in sterile TB medium to a starting OD600 nm of 0.1 AU. 1 mL of this
inoculum culture was then transferred to each well of the FlowerPlateRwhich was sealed
with an adhesive gas-permeable sterile membrane for micro-scale cultivations. Thus, an
equally treated pre-culture was ensured for all upstream experiments.
The cultivation setups of the HTE upstream screening were performed as quadruplicates,
leading to a total of 12 dierent cultivation conditions per 48-well FlowerPlateR. Four
dierent induction times (OD600 nm of 1, 2, 4, and 8) and three dierent inducer concen-
trations (IPTG concentrations of 0.1, 0.5, and 1 mM) were investigated. The induction
times were calculated based on scattered light values in the BioLector Rsystem using pre-
viously determined OD600 nm/ scattered light correlation functions. For 600 rpm, a linear
correlation slope of 17.26 SU/AU was used. For 800 and 1200 rpm, slightly higher lin-
ear correlation slopes of 18.69 and 19.8 SU/AU were applied. When the scattered light
signals exceeded the threshold value of the pre-dened induction time, the fermentation
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process was interrupted for the addition of IPTG. The experiments were performed at
three dierent temperatures (27, 32, and 37 C) and three dierent shaking speeds in the
BioLector Rsystem (600, 800, and 1200 rpm). Including the quadruplicates of three non-
induced 600 rpm cultivations, a total of 48  9 + 12 = 444 fermentations (111 cultivation
conditions) were investigated as a full factorial experimental design. The fermentation
was stopped after 20 h. 1 mL fermentation broth of each well was transferred to a 2 mL
96-well square deep-well plate and centrifuged at 4000 rpm and 10 C for 30 min. The
supernatants were discarded and the cell pellets were frozen at -20 C for physical pre-
treatment until cell disruption.
For Cherry-GST quantication from the pellets of the HTE upstream screening, a stan-
dardized cell disruption was developed. The frozen cell pellets from 1 mL cultivations
were resuspended in 1.25 mL lysis buer. 4 pellets were pooled in a 15 mL centrifugal
tube, leading to 5 mL suspension. The sonication process was performed in the Branson
Digital Sonier R 450 using a 1/8" tapered micro-tip sonication probe. For a standardiza-
tion of the cell disruption process, the immersion depth of the probe was kept constant
at 0.5 cm above the centrifugal tube bottom for all cell disruptions. The sonication was
performed at 30% maximal power output and a total treatment time of 90 s (6  15 s
pulse on and 30 s pulse o for cooling on ice). Following the cell disruption, 0.1 L/mL
of benzonase and 10 mM MgCl2 were added for nucleic acid reduction. The lysates were
centrifuged at 12000 rpm and 10 C for 60 min. Disruption of 12 identical cell samples
resulted in a relative standard deviation below 5%. As a result, this method was found
suitable for quantitative comparison of the dierent conditions of the HTE upstream
screening.
2.2.3 Detection of Inclusion Bodies
As a proof, that proteins with Cherry-TagTM lose their color, as soon as they become
unstable or are in a denatured state a methodology for detection of inclusion bodies was
used. Cultivations with inclusion body formation are to show no red color, but to reveal
product bands in an SDS PAGE after total protein extraction under denaturing condi-
tions.
Protein extraction under denaturing conditions was used to extract all soluble and in-
soluble proteins from cell pellets. A cell pellet from a 1 mL cultivation broth was resus-
pended in 1 mL of ultrapure water and 50 L of 100% (w/v) cold trichloroacetic acid
(TCA) were added. After mixing for 20 s, the solution was stored on ice for 10 min
and centrifuged (12000 rpm, 4 C for 10 min). The supernatant was discarded and the
pellet was washed twice with 500 L of cold, ultrapure acetone to remove residual TCA.
After each washing step, another centrifugation cycle followed. The nal pellet was left
for two hours under a hood at room temperature for removal of residual acetone. The
OD600nm value of the original 1 mL cell suspension sample served as a scaling factor for
redissolution. The dried pellet from the denatured total protein extraction process was
dissolved in OD600nm  200 L of 1X NuPAGE RLDS sample buer and 12.5 mM DTT for
gel electrophoresis. Redissolution was performed for at least 1 h in an overhead shaker.
The dissolved samples were denatured at 100 C and 300 rpm for 15 min on a plate
shaker with lid heating. The further GX procedure was performed as described in the
Novex RNuPAGER4 - 12% Bis-Tris Protein Gel manual [47]. The gels were stained with
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'blue silver' staining solution and analyzed in a Bio-5000 gel scanner.
2.2.4 Scale-up Culture
The scale-up from the 1 mL BioLector Rculture of highest product titers to the 800 mL
shake ask was based on a constant oxygen transfer rate. OTR and kLa values were de-
termined by the sulte oxidation method [48]. 800 mL of the initial solution (as described
in the materials section) were transferred to a 2.5 L baed TUNAIRTM shake ask and
the initial pH value was set to pH 8. The solution was agitated in the Max Q 6000 incu-
bator. The exact time of the change of color was determined using a Spotlight Webcam
Pro coupled with the ContaCam Software. The kLa value can be calculated as follows:
kLa =
cNa2SO3  k1
  t  k1  cO2   cNa2SO3
(1)
with cNa2SO3 being the sulte initial concentration, k1 the rst-order reaction constant,
 the stoichiometric coecient of oxygen, t the time until the indicator's change of color,
and cO2 the oxygen solubility. The determined shaking speed was then used for the
scale-up cultivation. The adapted cultivation and the cell disruption were performed as
described in the product analytics section.
2.2.5 Purication of Cherry-GST
The purication of Cherry-GST was performed using GST anity chromatography on a
5 mL GSTrapTM 4B anity column. 10 mL of lysate from the scale-up experiment were
mixed with 30 mL of 50 mM Tris-HCl pH 8 binding buer. For removal of aggregates
and particulates from the thawing process, the mixture was centrifuged at 12000 rpm,
20 C for 15 min and ltered using a sterile 0.2 m PES syringe lter. 40 mL of sample
were injected into the anity column. For sample loading and the washing step, a ow of
1 mL/min was applied. For elution and regeneration, the ow was increased to 5 mL/min.
The GSTrapTM 4B anity column was equilibrated with 2 CV (10 mL) of binding buer
until 8 CV (40 mL) ushed sample injection, followed by 2 CV (10 mL) of additional
binding buer wash. The product elution was performed in a 100% step to the elution
buer which included 10 mM of reduced L-glutathione. Fractions of 2 mL were taken
throughout the purication process. The fractions and the applied sample were then
analyzed by Cherry-TagTM-specic absorption measurements and compared to capillary
gel electrophoresis analysis.
2.2.6 Production of Untagged GST
To investigate whether the productivity trends derived from the HTE upstream screen-
ing for Cherry-GST are identical for GST alone, two experimental extremes (low and
high natively produced product titers) were investigated for an E. coli SE1 GST strain
constructed in a StabyCodon T7 protein expression kit. The scale up cultures were pro-
duced as described above. As the Cherry-TagTM was not present in these experiments, the
amount of natively produced GST was determined by binding to a 5 mL GSTrapTM 4B
anity column, as described above.
As an alternative for producing untagged GST, an enzymatic tag removal reaction was
49
300 400 500 600 700
0.2
0.4
0.6
0.8
1
Wavelength [nm]
Ab
so
rp
tio
n
 
[A
U]
 
 
Difference spectrum
Cherry-GST 2.2 mg/mL
Cherry-GST 4.4 mg/mL
Cherry-GST 6.6 mg/mL
Cherry-GST 8.8 mg/mL
Cherry-GST 11 mg/mL
19 20 21 22 23
2000
4000
6000
8000
Aligned time [s]
Fl
uo
re
sc
en
ce
 
 
standard
25 % lysate
50 % lysate
75 % lysate
100 % lysate
A B
48 kDa
68 kDa
16 kDa
29 kDa
Lower Marker
20 kDa
System peak
Figure 1: Development of a Cherry-TagTM analytics - A: Lysate spectra for the determination of a
specic detection wavelength. Puried Cherry-GST samples in a concentration range of 2.2 to 11 mg/mL
are compared to a dierence spectrum of a lysate with and without Cherry-GST. B: Fluorescence signal
of four dilution steps of a Cherry-GST lysate determined by capillary gel electrophoresis and a virtual
gel of the applied lysate. The 29 and 48 kDa standards are illustrated by blue circles.
investigated using a recombinant bovine enterokinase. Puried Cherry-GST was stored
in enterokinase reaction buer. The cleavage reaction was performed in 200L batches
using a 2 mL 96-well square deep-well plate at 37 C on a MUR 13 thermo-shaker with
5 L enterokinase per 1 mg of fusion protein. The reaction was stopped after 10, 20, 30,
and 40 min for investigating the reaction kinetics. All samples were then analyzed in the
GX II as duplicates, as described above.
3 Results & Discussion
3.1 Establishment of the Cherry-TagTM Analytics
Lysate spectra were taken to determine a specic wavelength for the quantication of
Cherry-GST. The blanked and 300 nm scaled spectra of a Cherry-GST (positive con-
trol) and a glucose-repressed lysate (negative control) were used to calculate a dierence
spectrum (Fig. 1A - pentagrams). The spectrum shows one major maximum at 414 nm
and one minor maximum at 536 nm with a shoulder at 562 nm. The rst maximum
agrees with the Cherry-TagTM-specic wavelength from the Cherry Express kit manual
of 413 nm [39, 40]. The second wavelength has not yet been reported and shows a lower
sensitivity.
The Cherry-GST extinction coecient was determined to nd a linear correlation between
414 nm/ 536 nm absorption measurements and the product concentration in solution.
The Cherry-GST concentrations of four lysate dilutions (25, 50, 75, 100% lysate) were
measured in the capillary gel electrophoresis system as quadruplicates. The denatured
samples were stained with a uorescent dye. Small molecules have a higher mobility in
the highly viscous capillary gel matrix and are detected at an earlier aligned time. Fig. 1B
shows the mean uorescence signal plotted versus the aligned time for the lysate dilution
quadruplicates and for the system internal 29 kDa (20.1 s) and 48 kDa (22.3 s) protein
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Shaking speed/Temperature 27 C 32 C 37 C
600 rpm 18.7  1.3 SU/h 19.9  0.7 SU/h 22.9  1.1 SU/h
800 rpm 29.9  0.3 SU/h 34.2  0.5 SU/h 39.7  0.4 SU/h
1200 rpm 37.0  0.5 SU/h 59.4  2.0 SU/h 65.4  2.8 SU/h
Table 1: Maximal growth rates of E. coli SE1 at cultivation temperatures of 27, 32, and 37 C and
rotational shaking speeds of 600, 800, and 1200 rpm in the exponential growth phase in SU/h.
standards of known concentration that were injected after each 12 assayed samples for
internal calibration. The Cherry-GST product peak was correlated to a molecular weight
of 39 kDa at an aligned time of 21.3 s. As GST has a molecular weight of approximately
27 kDa and the Cherry-TagTM alone of 11 kDa, this determined size agrees well with
the size of the protein fusion. The concentrations were calculated by peak-baseline in-
tegration and compared to the external lysozyme standard of 1 mg/mL to compensate
lot-to-lot variations of GX II chips and chemicals. As expected, the uorescence signals
intensify with increasing lysate concentration. In Fig. 1B a virtual gel of the measured
sample (calculated from the integrated uorescence signals) is shown on the right. The
lysate dilutions were also measured at 414 nm in a spectrophotometer as triplicates.
Comparison of Cherry-GST concentrations with the absorption signal at 414 nm leads
to a linear correlation up to an absorption of 1.2 AU with a coecient of determination
(R2) of 99.4%. The slope of this linear correlation of 2.213 mg/(mLAU414 nm) was used
as the extinction coecient of Cherry-GST at 414 nm. The GX II measurements only
served for method validation and can be neglected in future work with Cherry-TagTM
proteins. For the 536 nm extinction coecient, spectra of puried Cherry-GST samples
(see purication of Cherry-GST section) with concentrations of 2.2 to 11 mg/mL were
compared (Fig. 1A). As expected for Cherry-GST concentrations above 3 mg/mL, the
414 nm signal was outside of the linear measurement range. The 536 nm signal showed
a 10 times lower sensitivity. The slope of the linear correlation was determined to be
24.290 mg/(mLAU536 nm) and a coecient of determination (R2) of 99.8% was obtained.
Hence, the 536 nm signal can be a useful alternative for the determination of more con-
centrated Cherry-TagTM solutions.
3.2 HTE Upstream Screening
On each 48-well FlowerPlate Rused for cultivation screening, four dierent induction times
at cell densities of OD600 nm 1, 2, 4, and 8 AU and three inducer concentrations of 0.1,
0.5, and 1 mM IPTG were investigated as quadruplicates. Coupled with three cultivation
temperatures of 27, 32, and 37 C and three shaking speeds of 600, 800, and 1200 rpm, 108
dierent cultivation setups resulted. Only cells cultivated at a shaking speed of 600 rpm
qualitatively showed colored pellets (Fig. 2B).
Quantitative evaluation of all setups was realized with the standardized cell disruption
method by sonication and lysate absorption measurements at 414 nm. The spectral data
were converted to concentrations via the extinction coecient. The product titers of all
cultivation setups were determined within less than 5 min in a standard plate reader.
Analyzing that amount of samples in a GX II, including system preparation, would take
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Figure 2: BioLector Rgrowth curves and determined product titers after cell disruption of E. coli SE1
producing Cherry-GST under dierent cultivation conditions: Temperatures of 27, 32, and 37 C and
three dierent shaking speeds of 600, 800, and 1200 rpm coupled with dierent induction times (OD 1,
2, 4, and 8) and inducer concentrations (0.1, 0.5, and 1 mM IPTG) are shown. A: Product titers of
soluble Cherry-GST [mg/mL] under the above-mentioned cultivation conditions. B: Photographs of the
centrifuged cell pellets cultivated at 600 rpm shaking speed. C: BioLector Rgrowth curves under the
above-mentioned cultivation conditions. The scattered light signal is plotted versus the time starting
from inoculation. The black triangles indicate the respective induction times.
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approximately 3 - 4 h.
The titers of soluble and native Cherry-GST of all cultivation setups are illustrated in
3D bar plots (Fig. 2A). For 600 rpm experiments, the non-induced samples are shown as
well. The best product titers were achieved for cultivations at 600 rpm shaking frequency,
yielding a maximum of 1.34 mg/mL Cherry-GST for the not-induced setup at 600 rpm
and 37 C. Shaking frequencies higher than 600 rpm resulted in maximum product con-
centrations of 0.49 mg/mL (at 800 rpm, 32 C, induction at OD600 nm of 8). The increased
oxygen transfer rates at higher shaking speed (15.0 mmol/L/h at 600 rpm, 24.5 mmol/L/h
at 800 rpm, and 65.0 mmol/L/h at 1200 rpm as known from the FlowerPlate Rproduct
sheet by m2p-labs) were found to decrease native Cherry-GST production.
For the 600 rpm setups at 37 and 32 C, a late or not-induced cultivation led to highest
product titers. Early induced cells at OD600 nm of 1 yielded only 0.09 to 0.27 mg/mL
native Cherry-GST, whereas late or not-induced setups resulted in titers of 0.77 to
1.34 mg/mL. The T7 promoter seems to be too strongly induced to produce Cherry-GST
in a native state, resulting in inclusion bodies for early induced cells. This assumption
was investigated by a total protein extraction under denaturing conditions, as discussed
in the experimental section. For the 600 rpm setups at 27 C, an almost constant prod-
uct level was determined in a range of 0.32 to 0.53 mg/mL. The variation of the IPTG
concentration, showed no pronounced inuence on the bacterial growth and product for-
mation in all investigated setups. The T7 promoter in E. coli SE1 is bound very strongly
by the T7 RNA polymerase and results in a switch-on or -o mechanism which was
concentration-independent in the investigated setups.
The growth curves of all experiments are illustrated in Fig. 2C. The slope of the expo-
nential growth phase determines the maximal growth rates and, thus, the proliferation
frequency and activity (Table 1). The slopes decrease with a reduction of shaking speed
and also with decreasing temperatures. The highest growth rates of 65.4  2.8 SU/h
were determined at 37 C and 1200 rpm shaking speed of the BioLector Rand the lowest
growth rates of 18.7  1.3 SU/h were observed at 27 C and 600 rpm shaking speed. The
shaking speed was found to be the more inuencing parameter on bacterial growth. For
all 600 rpm experiments, the slopes for all temperatures were found to be in a similar
range of 18.7  1.3 SU/h and 22.9  1.1 SU/h. Those comparably low proliferation rates
had been expected, as E. coli is an aerobic and mesophilic microorganism and exhibits
decreased growth under oxygen-limited conditions and temperatures other than 37 C.
Growth under conditions other than the optimum were benecial for slow and correctly
folded proteins, however. The lower stationary phase plateaus of the early induced cells
imply a strong change in metabolism due to product formation. This again indicates
formation of inclusion bodies which were not detectable in the 414 nm signals.
3.3 Detection of Inclusion Bodies
The HTE upstream screening resulted in low product titers for early induced cells. As
proteins with Cherry-TagTM are said to lose color in a denatured and insoluble state,
those ndings suggested the formation of inclusion bodies. A protein extraction under
denaturing conditions was applied, where all soluble and insoluble proteins were extracted
and unfolded. The stained gel from a gel electrophoresis run under dierent cultivation
conditions is illustrated in Fig. 3. Lane 1 shows the protein standard with markers
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Figure 3: SDS-PAGE of the denaturing protein extraction for determination of the total protein content
and identication of inclusion bodies of dierent cultivation setups at 600 rpm and 37 C. Lane 1: Protein
standard of molecular weight in a range from 3.5 to 116.3 kDa. Lanes 2 + 3: Induction at OD600 nm 1
with 1 mM IPTG. Lanes 4 + 5: Induction at OD600 nm 8 with 1 mM IPTG. Lanes 6 + 7: Not induced.
of known molecular weight in a range of 3.5 to 116.3 kDa. Lanes 2 and 3 are total
protein extracts from an early induced (OD600 nm of 1) BioLector
Rcultivation at 37 C
and 600 rpm. Lanes 4 and 5 show extracts of a not induced sample under the same
cultivation conditions and lanes 6 and 7 of a glucose-repressed sample. All samples
exhibit an identical contaminant pattern with protein bands over the entire molecular
weight range. As expected, the Cherry-GST band at 39 kDa is missing in lanes 6 and 7
due to the inhibition of the lac-operon (cAMP positive control). Note that the close band
at 37 kDa represents a contaminant and, hence, is present in all investigated samples.
Lanes 2 to 5 show an intense product band at 39 kDa. As gel electrophoresis is a
qualitative analytical method, product titers cannot be specied. However, the induced
sample shows an at least equal amount of Cherry-GST than the not induced sample. The
lysate measurements of those samples (compare Fig. 2A - 37 C, 600 rpm), by contrast,
showed 10 times higher absorption values for not induced cells. Hence, the intense product
band for the induced cultivation can be correlated to misfolded inclusion bodies. The E.
coli SE1 T7 promoter was proven to be too strong for the native production of Cherry-
GST under induced conditions. The assertion of uncolored protein in the unfolded state
was veried for upstream applications.
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3.4 Scale-up Culture
The optimized 1 mL BioLector Rculture at 600 rpm shaking frequency and 37 C was
scaled up by keeping the oxygen transfer rate constant. From the FlowerPlateRproduct
sheet by m2p-labs, it was known that for 1 mL lling volume at 600 rpm, a kLa value
of 88.9 h 1 was determined by the sulte oxidation method [48]. The incubator shaking
speed of equivalent oxygen uptake for the 2.5 L baed TUNAIRTM shake ask with
800 mL lling volume was found to be 180 rpm with a kLa value of 87.1 h
 1.
In analogy to the BioLector Rsetup, cell harvest was performed after 20 h, followed by
the cell disruption as described in the experimental section. Capillary gel electrophoresis
runs of the lysate resulted in a Cherry-GST concentration of 12.96 mg/mL. Note that
the concentration is in 20 mL lysis buer from 180 mL cell broth (concentration factor
9). The 600 rpm and 37 C setup in the BioLector Rresulted in a Cherry-GST concen-
tration of 1.34 mg/mL in 5 mL lysis buer from 4 mL cell broth (concentration factor
0.8). To compare the product titers of those two scales, the determined concentrations
were divided by the concentration factors, resulting in 1.68 mg/mL in micro-scale and
1.44 mg/mL in the scaled-up cultivation. Although the oxygen transfer rate was kept
constant, a deviation in productivity of 0.24 mg/mL was observed. Garcia Ochoa et al.
proposed that apart from physical and biochemical system properties also geometrical
parameters of the bioreactor, such as the size and design, inuence the scale up process
[49].
3.5 Purication of Cherry-GST
Capturing of GST using an anity resin (GSTrapTM 4B) is based on the catalytic ac-
tivity of the enzyme. Only soluble and enzymatically active GSTs bind to the chosen
resin, as was outlined in [50, 51]. The chromatogram of the purication process is shown
in Fig. 4A. The 280 nm signal (solid line) is the non-specic protein signal of aromatic
amino acids. The 414 nm and 536 nm signals (dash-dotted and dotted lines) were used
as the Cherry-TagTM-specic signals. The glutathione concentration is represented by
the dashed line.
After sample injection, the 414 nm signal increases to approximately 300 mAU and it
continues to increase with time up to 720 mAU after 40 mL of injection. The rst sharp
increase of the 414 nm signal can be correlated to colored media components from the
cultivation procedure. In contrast to this, the steady increase with time indicates the
advanced loading of the anity column. After the column wash at 50 mL, the product is
eluted by shifting the glutathione concentration to 10 mM. The 280 nm and the 414 nm
signals increase above the linear range of the UV measurement cell. The 536 nm signal
can still be recorded with a maximum of 1080 mAU. The less sensitive 536 nm signal
was proven to be useful to evaluate high product titers of dierent purication runs.
This ensures measurement signals in the linear range even for product elution, which is
a prerequisite for e.g. modeling.
Fractionation times for the 2 mL samples are marked by downward triangles. Those frac-
tions were 10 times diluted and analyzed in the Caliper GX II capillary gel electrophoresis
system (reference analytics). Fig. 4A shows virtual gels of the applied sample (left of the
dashed line) and all fractions of the anity chromatography run, calculated from the
integrated uorescence signals. The 39 kDa Cherry-GST band intensies with sample
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Sample Purity [%] Concentration
[mg/mL]
Sample 43.65  0.42 3.24  0.10
FT2 mL 51.30  0.71 0.04  0.01
FT4 mL 25.21  1.92 0.30  0.03
FT6 mL 13.46  0.53 0.66  0.05
FT8 mL 13.70  0.19 0.78  0.06
FT10 mL 14.30  0.23 0.76  0.06
FT12 mL 14.34  0.44 0.76  0.08
FT14 mL 15.01  0.10 0.81  0.06
FT16 mL 15.56  0.27 0.82  0.04
FT18 mL 16.09  0.90 0.85  0.09
FT20 mL 16.11  0.08 0.86  0.03
FT22 mL 16.39  0.02 0.88  0.05
FT24 mL 16.57  0.21 0.91  0.07
FT26 mL 17.15  0.01 0.88  0.00
FT28 mL 18.38  0.13 0.89  0.02
FT30 mL 18.02  0.36 0.96  0.01
FT32 mL 19.08  0.95 0.96  0.05
FT34 mL 20.05  0.68 1.06  0.14
FT36 mL 21.56  0.01 0.98  0.03
FT38 mL 20.91  1.45 1.06  0.05
FT40 mL 24.44  3.69 0.74  0.49
W2 mL 24.63  0.69 1.04  0.10
W4 mL 38.00  0.08 0.35  0.00
W6 mL 100.00  0.00 0.04  0.00
W8 mL 100.00  0.00 0.02  0.00
W10 mL - 0.00  0.00
E2 mL 100.00  0.00 0.03  0.01
E4 mL 89.86  0.11 11.89  0.24
E6 mL 90.10  0.12 20.14  0.00
E8 mL 89.62  0.18 7.70  0.16
E10 mL 88.98  0.35 3.08  0.15
Table 2: GX II fraction analysis of the GST anity chromatography procedure: Purity and concentra-
tion of all ow-through (FT), wash (W) and elution (E) fractions are compared to the performance of
the applied sample.
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loading, while the contaminant levels remain constant. Fluorescence signals of the GX II
for selected ow-through (FT) and elution (E) fractions are illustrated in Fig. 4B + C.
The system internal 29 kDa (20.1 s) and 48 kDa (22.3 s) protein standards are indicated
as circles. The Cherry-GST product peak was correlated to a molecular weight of 39 kDa
(21.3 s). In Fig. 4B the sample and three ow-through fractions after 6, 24, and 40 mL
are compared. The contaminant peaks for all illustrated samples are identical, while the
product uorescence peak (21.3 s) of the ow-through fractions is far below the Cherry-
GST signal of the applied sample. Still, a minor increase of the product peak can be
observed over the sample loading volume from 6 to 40 mL agreeing well with the ndings
derived in 414 and 536 nm real-time measurements on the AKTATM purier as discussed
above. Fig. 4C shows the uorescence signals of all elution fractions. There is only one
major peak corresponding to Cherry-GST (21.3 s) with a concentration ranging from 3.08
to 20.14 mg/mL (Table 2).
Cherry-GST concentrations and purities of the sample and all fractions are listed in Ta-
ble 2. The concentration of the applied sample was determined to be 3.24  0.10 mg/mL.
In the ow-through fractions the product concentration increased from 0.30  0.03
mg/mL (9.3% of the applied sample) to 1.06  0.05 mg/mL (32.7% of the applied sam-
ple). The yield of the purication was determined to be 71.1% and the product was three
times concentrated to 10.7 mg/mL in the elution pool E4 mL to E10 mL. As over 90% of
Cherry-GST were binding after sample application, Cherry-GST was proven to be in a
catalytically active state.
Comparison of the 536 nm signal from the integrated AKTATM purier system to the
concentrations from GX II resulted in a linear correlation of 11.521 mg/(mL2AU536 nm)
with an R2 of 99.1%. Hence, concentrations can be determined directly from online
measured signals, also for downstream applications making sampling obsolete. Another
major advantage of using the Cherry-TagTM in DSP applications is the possibility of mak-
ing decisions in real-time, e.g. making product fractionation decisions without needing
post-processive analytics and having to repeat the experiment.
3.6 Production of Untagged GST
To prove that the productivity trends derived from the HTE upstream screening for the
tagged product hold for GST alone for the E. coli SE1 GST strain, two experimental
extremes of low and high natively produced product titers (induction at OD600 nm of 1
and 8 using 0.5 mM IPTG) were investigated at 37 C and 180 rpm as scale-up cultures.
The titer of natively produced GST was determined by binding to a 5 mL GSTrapTM 4B
anity column and evaluation of the eluate fractions. The chromatography runs of the
two investigated cell lysates are shown in Fig. 5A. The red curves represent the UV
signals of the early induced cultures (OD600 nm of 1) and the blue curves indicate the late
induced cultures (OD600 nm of 8). The 300 nm signal serves as a less sensitive protein
signal in addition to the standard 280 nm signal. The ow-through fraction of 40 mL
is similar for both lysates with both UV signals within the measurement noise. After
the wash, however, dierences were observed for the elution peaks. The early induced
cell lysate shows a much smaller 300 nm peak with an integrated area of 1230 mAU*mL
compared to the late induced cell lysate with an integrated peak area of 21026 mAU*mL.
GX II analysis of the collected elution fractions indicated a total yield of 30.0 mg GST
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for OD600 nm of 1 induced cells and 511.2 mg GST for OD600 nm of 8 induced cells. The
trends of a benet of a late induction, as seen for Cherry-GST (approximately 7 times
increase in productivity compared to early induction), were thus conrmed for GST
alone, leading to an over 17-fold increase in productivity for late induced cells. Whereas
relative trends were conserved, absolute values diered due to the inuence of the fused
tag. Nevertheless, the results from the HTE upstream screening using the Cherry-TagTM
were directly transferable to a production process for the protein of interest alone.
When using the Cherry-TagTM as an in-production assay, a nal removal of the tag
after production is mandatory. The enzyme enterokinase recognizes the Asp-Asp-Asp-
Asp-Lys linker sequence situated between the protein of interest and the Cherry-TagTM
and cleaves at the Lys-residue [41]. Fig. 5B shows uorescence signals for the applied
Cherry-GST sample (red curve) and the reaction mixture after 10, 20, 30, and 40 min
of reaction time determined in the GX II (green curves). The 43 kDa enterokinase is
represented by the uorescence peak at 22 s and the enzyme-related impurities are found
at 20.0 s and 20.3 s. The peak at 19.5 s indicates untagged GST, whereas Cherry-GST
is detected at 21.3 s. The Cherry-GST concentration decreases over time, yielding 14.0%
residual substrate after 10 min and 3.9% after 20 min reaction time, as can be seen by
the decreasing uorescence peak at 21.3 s in Fig. 5B. This indicates an ecient catalytic
process within the rst 20 to 30 min after starting the enzyme reaction. The GST peak
at 19.5 s, in contrast, maximizes steadily, whereas the highest increase is detected again
within the rst 20 to 30 min of catalytic time. It was shown that the tag was eectively
cleaved using enterokinase making the Cherry-TagTM a valuable tool for in-production
analytics. Also when co-expressing enterokinase with the tagged protein of interest, an
economic autocatalysis can be realized, as was shown by Azhar et al. [41].
4 Conclusions
The Cherry-TagTM was found to be a fast and reliable tool for product tracking in diverse
elds of bioprocess engineering by simple VIS absorption measurements. The presented
technology revealed various advantages when compared to traditional analytical tech-
nologies used for proteins.
One major aspect is that no sample pre-treatment is required and the protein can be
investigated in the natively folded state. The absence of such pre-processing steps as
needed for GX, GX II, and MS leads to a reduction in time and material costs. Never-
theless, those analytical tools are accurate and perform well, as was shown for GX II as
the reference analytical method in the presented study for Cherry-GST. However, the to-
tal time per sample to be analyzed is much higher for GX II. Preparation of the analytical
microuidics chip as well as sample pre-treatment can easily take up to 2 h. Addition-
ally, approximately 40 s per analyzed sample follow, adding up to another 64 min for
analyzing a set of 96 samples. In contrast, analyzing such a number of samples using the
Cherry-TagTM analytics takes approximately 1 min in total with a standard 96 well plate
reader. Thus, the proposed technology can be implemented easily into HTS systems like
robotic workstations.
The possibility to perform in-line and real-time protein analysis, as was shown in the
anity purication setup, even makes sampling obsolete and enables continuous process
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control. Such setups are hardly implementable for most other analytical tools, namely,
GX, GX II, MS, analytical chromatography, and customized assays. In those setups, frac-
tionated samples have to be analyzed post-processively using e.g. auto-sampling units to
perform systematic analysis.
Finally, the Cherry-TagTM was even capable of distinguishing between insoluble - unstable
and soluble - active products, as shown in up- and downstream applications. Although
strongly diering chemical environments were encountered in up- and downstream ex-
periments, the optical properties of the Cherry-TagTM were not altered in contrast to
uorescent proteins, as was discussed previously. The Cherry-TagTM analytics was ap-
plied for the evaluation of the HTE induction screening in the BioLector Rsystem. It
was shown that only the lowest shaking frequency of 600 rpm investigated resulted in
soluble and native Cherry-GST. Early induced cells were found to result in inclusion
body formation, leading to uncolored cell pellets. This agrees with the assumptions that
only native and soluble proteins show red color. The best upstream setup for soluble
Cherry-GST was scaled up successfully. Cherry-GST was puried from the lysate in an
anity chromatography step binding over 90% of the product after injection. As only
catalytically active enzymes are retained in GST anity chromatography columns, the
colored proteins were in a native and soluble state. It was possible to calculate product
concentrations directly from online 536 nm data in the AKTATM purier system.
The established Cherry-TagTM analytics resulted in two possible wavelengths for the
quantitative detection of tagged proteins. 414 nm signals can be used in a concentration
range of approximately 0 to 3 mg/mL, whereas 536 nm measurements can be applied
even up to 30 mg/mL in a standardized cuvette of 10 mm path length.
This technology has a big potential for simplifying product analytics during bioprocess
engineering. One possible application is for pre-production HTS process development
by fast and straightforward plate reader analytics on automated robotic workstations.
In upstream processing it can be used as a fast tool for clone screening experiments to
nd suitable promoters for product expression and for the prevention of inclusion bodies.
In the study presented the optimized upstream conditions were veried for the product
alone, allowing for a scale up of the cultivation process for the untagged protein based on
the screenings including the tag. Additionally, the technology is useful for in-production
analytics, as was shown in the GST anity chromatography experiments. The tag is a
powerful instrument for real-time determination of protein instabilities during dierent
unit operations. Buer compositions and unit operations can be changed to make those
processes more ecient with less product losses. Electrostatic and hydrophobic protein
interaction in downstream processing can, however, strongly dier for the tagged and the
pure product species due to the nature of the tag. Despite those obvious drawbacks for
DSP, this fact can be used for protein engineering by shifting the elution conditions of
proteins that are dicult to separate.
The Cherry-TagTM product sheet indicates its additional potential for stabilizing pro-
teins compared to the untagged species. This might be useful for highly concentrated
protein solutions which might be examined in a next step. However, it also remains to
be investigated how the tag inuences the biological activity of the fused protein.
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Deconvolution of High-throughput Multi-component Isotherms
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Abstract
Gaining a more profound understanding of biopharmaceutical downstream processes is a
key demand of the 'Quality by Design (QbD)' guideline. One of the most dominant
approaches to gain process understanding is the extensive use of experimental high-
throughput formats, such as batch chromatography on robotic liquid handling stations.
Using these high-throughput experimental formats, the generation of numerous samples
poses an enormous problem to subsequent analytical techniques.
Here, a high-throughput case study for batch chromatographic multi-component isotherms
is presented. To debottleneck the subsequent analytics, a non-invasive technique using
UV spectra and multi-variate statistics was adapted to a batch chromatographic format.
Using this approach, it was possible to integrate the entire analytical setup into the
robotic workow.
As a case study, batch isotherms for SP Sepharose FF and the model proteins cytochrome
c and lysozyme at various pH values and ionic strengths were recorded. A successful
examination of the quality of the analytical procedure as compared to classical single
wavelength photometry was carried out. To address the growing demand for a more pro-
found process understanding, the experimental data were tted to the steric mass-action
isotherm, getting a more detailed insight into the competitive binding behavior at various
pH values and ionic strengths.
Keywords: Ion-exchange Chromatography, Multi-component Batch Isotherms, Steric
Mass-action Isotherm, High-throughput Process Development, Multi-variate Data Anal-
ysis
1 Introduction
Nowadays, biopharmaceutical downstream process (DSP) development is mainly based on
chromatographic separation techniques. Chromatography, as many other techniques for
biopharmaceuticals, is inuenced by numerous operational parameters that aect process
performance. The growing need for a deeper mechanistic understanding of the techni-
cal process on a molecular level and the impact of the process on the product quality,
demanded by the 'Quality by Design (QbD)' approach, pose a great challenge to biophar-
maceutical DSP [1, 2]. The requested process understanding can be generated by several
approaches. One very obvious approach is the systematic experimental evaluation of the
impact of dierent operational parameters on the downstream process performance.
A possibility to support the exploration of the design space, as basis for many statistical
DoE approaches, is the use of high-throughput techniques [3]. These approaches enable
miniaturization of the experimental systems and parallelization and automation of the
experimental workow allowing for full factorial experimental designs [4, 5, 6]. Therefore,
high-throughput techniques enable a reduction of time and material consumption. In the
context of chromatographic process development, there are several experimental systems
adapted to robotic high-throughput experiments.
Batch chromatography can be implemented very easily on a liquid handling station us-
ing a dened adsorbent volume provided in a 96-well plate. The batch chromatographic
systems can be used for resin screening [3], batch bind-elute studies or the measurement
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of adsorption isotherms [3, 7, 8, 9] and kinetic data [10].
One major disadvantage of these experimental high-throughput formats is that the above-
mentioned experimental bottleneck is not prevented but often only shifted to subsequent
analytics. In the simplest case, when only single protein data have to be recorded, a
photometric measurement within the robotic workow is possible. This simple analytical
approach is restricted to the quantication of a single protein species or several protein
species with dierent exclusive absorption maxima beside 280 nm [11]. The major ad-
vantage of photometric assays is the high sample throughput, which can easily cope with
the amount of samples generated in robotic high-throughput experiments and the non-
invasive nature of the technique.
In pharmaceutical high-throughput process development, a simple photometric measure-
ment will be unable to dierentiate between several protein species. In this case, more
sophisticated analytics have to be performed. Such advanced analytics might be e.g., ana-
lytical high-performance liquid chromatography (HPLC) and product-specic immunoas-
says [12, 13]. The time requirement of these immunoassays is still high in comparison to
that of the chromatographic experiments. HPLC assays are predominant in the charac-
terization of the size and charge heterogeneity of a target protein. One major drawback
of processing high-throughput experimental samples with HPLC assays is the low sample
throughput of HPLC techniques. Despite the mentioned drawbacks, HPLC and other
analytical techniques such as immunoassays bear the major disadvantage of an invasive
nature.
An ideal analytical technique in the context of high-throughput experimental workows
would be a photometric assay that can be carried out in standard UV/VIS plate readers
typically installed on robotic workstations. This assay has to be protein species-specic
and quantitative. Such an assay, based on the measurement of UV spectra and sub-
sequent multi-variate statistics, was introduced by Hansen et al. in 2011 [14]. When
using protein mid-UV (200 - 300 nm) spectra, the absorption of dierent protein species
is strongly inuenced by properties of peptide bonds and amino acid residues. A par-
tial least squares - projection to latent structures (PLS) regression enables subsequent
quantitative evaluation of mixtures of dierent protein species. Here, we present a case
study on the high-throughput generation of multi-component isotherm data. We combine
a high-throughput method for the collection of multi-component isotherms in an auto-
mated batch format with a non-invasive protein-specic quantication method based on
the measurement of mid-UV spectra. The collected data are subsequently tted using the
steric mass-action isotherm including competitive protein binding introduced by Brooks
and Cramer [15].
2 Materials & Methods
2.1 Materials
2.1.1 Disposables & Reaction Vessels
As a strong cation-exchange adsorbent, sulfopropyl (SP) sepharose fast ow (FF) provided
by GE Healthcare Life Sciences, Sweden, was used. Binding experiments were carried out
in 2 mL 96-well square deep well plates (VWR, Germany). Absorption and protein spectra
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measurements were carried out in 96-well at bottom UV-Star Rmicroplates (Greiner Bio-
One, Germany). Buers were ltered using 0.2 m cellulose acetate lters supplied by
Sartorius, Germany.
2.1.2 Chemicals & Buers
Binding experiments at pH 5 were carried out in 20 mM acetate buer consisting of acetic
acid (Merck, Germany) and sodium acetate (Sigma-Aldrich, USA). For experiments at
pH 7, a 20 mM phosphate buer consisting of di-sodium hydrogen phosphate and sodium
di-hydrogen phosphate (Sigma-Aldrich, USA) was used. The ionic strength of the applied
buers was adjusted to 42, 65, 90, 115, and 150 mM using sodium chloride (AppliChem,
Germany). The model proteins lysozyme from chicken egg white and cytochrome c
from equine heart were purchased from Sigma-Aldrich, USA. Calibrations for the multi-
variate data analysis model of the two-component system were carried out using a 2.4
mg/mL protein solution. For binding experiments, a 10 mg/mL stock solution with 70%
cytochrome c and 30% lysozyme was used.
2.1.3 Instrumentation & Software
For pH adjustment of all buers, a HI-3220 pH meter (Hanna Instruments, USA) was
used. The instrument was calibrated using high-precision standards from Hanna Instru-
ments (USA). For generation of equal amounts of adsorbent per well, a MediaScout RResi-
Quot System (Atoll, Germany) was applied. For pressure adjustment, a vacuum pump
with pressure regulation was used. For the batch isotherms, a Freedom EVO R200 liq-
uid handling station (Tecan, Germany) was used, operated with Freedom EVOwareR2.1.
The system is equipped with eight xed tips, a plate-moving arm and an orbital shaker
(Tecan, Germany). A Rotanta 46RSC centrifuge (Hettich, Germany) and an Innite
M200 UV plate spectrophotometer (Tecan, Germany) are integrated in the system. The
spectrometer was controlled by i-control 1.9 (Tecan, Germany). Data processing and
creation of gures was performed in Matlab RR2011a (MathWorks, USA).
2.2 Experimental Setup
2.2.1 Model Calibration & Validation
The multi-variate data analysis calibration [14] was based on a four-level D-optimal onion
design generated with MODDE (Umetrics, Sweden) with additional data points added
at low concentration levels. The model included 7 mixing ratios (1:0; 2.5:1; 2:1; 1:1; 1:2;
1:2.5; 0:1) and 15 concentration levels (concentration levels correspond to the protein
concentration of cytochrome c and lysozyme in total) from 0 to 1.2 g/L (each 5 concen-
trations in a range of 0 to 0.1, 0.1 to 0.5, and 0.5 to 1.2 g/L). E.g. a mixing ratio of
2:1 means that the mixture contains 2/3 of cytochrome c and 1/3 of lysozyme. For the
example of a total concentration level of 1.2 mg/mL at a mixing ratio of 2:1, the solution
contains 0.8 mg/mL cytochrome c and 0.4 mg/mL lysozyme. In total, 32 samples were
used for model calibration.
8 samples were added as a test set for model validation. The cytochrome c and lysozyme
stock solutions were pipetted in the desired mixing ratios and diluted with the respective
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buers on the liquid handling station. All 40 samples were prepared as 1.8 mL solu-
tions in 96 deep-well plates to avoid small pipetted volumes. 300 L of each sample were
transferred to 96-well at bottom UV-Star Rmicroplates. Sample absorption spectra were
measured in a range of 240 - 300 nm in 2 nm steps. The spectral data of the 32 sam-
ples mentioned above were used for model calibration in Matlab RR2011a, using the PLS
toolbox (Eigenvector Research, USA). 5 samples out of 32 were used as an internal cross
validation. The regression model was then validated on the external test set of additional
8 samples and used for the concentration determination of unknown samples.
2.2.2 Generation of Equal Adsorbent Volumes
Generation of equal 20.8 L adsorbent amounts was achieved using the MediaScout RResi-
Quot system (Atoll, Germany) described by Herrmann et al. [16]. The system was
equipped with a pressure-controlled vacuum pump and the working pressure was set to
800 mbar. To remove the adsorbent storage solution, the adsorbent plaques were washed
twice with deionized water and the applied binding buer of the respective experiment.
The equilibrated plaques were transferred into a 2 mL 96-well square deep well plate and
suspended in 100 L binding buer. The plate was then stored until use on the liquid
handling station. The outer wells were not used for isotherm experiments due to the
largest variance in adsorbent volume on the plate [17].
2.2.3 Isotherm Experiments
Isotherms covering 10 dierent starting concentrations cin were generated on the liquid
handling station. As only the inner 60 wells were used for the experiments, 6 isotherms
could be created per sample plate. Each adsorbent plate was used for one pH level in-
cluding 5 dierent salt level isotherms (42, 65, 90, 115, and 150 mM) and one isotherm
as duplicate for investigating the repeatability of isotherm data.
The investigated pH levels were pH 5 and 7. 10 mg/mL stock solutions of 70% cytochrome
c and 30% lysozyme in the respective buers were applied. The starting concentrations
cin of the isotherm experiments were set to 2, 2.5, 3, 3.5, 4, 4.5, 5, 6, 7, and 8 mg/mL with
a nal volume of 800 l per well (including 100 L adsorbent storage buer from plaque
generation). The adsorbent plate was closed with a lid by the robotic plate-moving arm
and placed in the orbital shaker for 2 h. Kinetic studies for lysozyme [18] and a mon-
oclonal antibody [4] have shown that an incubation time of 20 to 40 min is sucient
for reaching the binding equilibrium on SP Sepharose FF. Afterwards, the plate was cen-
trifuged for 10 min at 1000 rpm in the Rotanta 46RSC centrifuge. 300 L of the resulting
supernatant was transferred to a 96-well at bottom UV-Star Rmicroplate. As for model
calibration, sample absorption spectra were measured in a range of 240 - 300 nm in 2 nm
steps. The spectral data were processed using the previously calibrated regression model.
Lysozyme and cytochrome c concentrations could be determined selectively. The valid-
ity of cytochrome c levels was additionally assured by comparison to 527 nm absorption
measurements.
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Figure 1: Comparison of isotherm data for determination of the experimental robustness and model
performance. Duplicates of the isotherm experiments performed at 90 mM ionic strength for pH 5 and
pH 7. The duplicates are indicated as diamonds and crosses, respectively. The results for cytochrome c
are shown in red (left) and for lysozyme in blue (right).
2.2.4 Isotherm Fitting
The purpose of isotherm tting is to validate, whether the observed measurements follow
the theoretical framework for protein adsorption in ion-exchange chromatography. The
adsorption model applied is the semi-mechanistic steric mass-action isotherm (SMA) in-
troduced by Brooks and Cramer [15]. It incorporates eects of counter-ions on the reten-
tion behavior of proteins and includes characteristic charges of proteins i. Additionally,
steric shielding eects of proteins are considered as a parameter i, representing sterically
hindered binding sites without electrostatic interactions. As a nal factor, the total ionic
capacity  of the applied adsorbent represents the total number of electrostatic binding
sites. The isothermal form of the SMA isotherm for a mixture of two proteins is shown
in Eq. (1) and Eq. (2), with qi and ceq;i being the concentration of the protein i adsorbed
and in solution, respectively. The eective pore salt concentration is described by csalt.
keq;i is the equilibrium constant of adsorption and desorption.
q1 = keq;1

  (1 + 1)q1   (2 + 2)q2
csalt
1
ceq;1 (1)
q2 = keq;2

  (2 + 2)q2   (1 + 1)q1
csalt
2
ceq;2 (2)
The SMA model allows for tting isotherm data, including concurring binding behavior
and varying salt concentrations. The tting procedure was carried out in Matlab RR2011a
using the least squares data tting function lsqcurvet (trust-region-reective algorithm).
The estimated parameters include the equilibrium constant keq;i, the characteristic charge
i, and the steric shielding i.
3 Results & Discussion
3.1 Model Generation & Experimental Performance
Partial least squares regression (PLS) is used to reduce data sets and nding signicant
variance for correlating several input variables (e.g. wavelengths) with output variables
3 PUBLICATIONS & MANUSCRIPTS
70
(e.g. concentrations). Input variables of similar information content are pooled as so-
called latent variables (LVs) leading to a data reduction. The rst LV carries the highest
information content, whereas each additional LV added leads to less and less improvement
of the model. At a certain number of LVs, further addition of LVs then leads to incorpo-
ration of measurement noise into the system which needs to be avoided. For generation
of the MVDA model, the optimal number of latent variables was found to be 5, yield-
ing normally distributed residues for the cross validation of all 32 samples. This setup
was found identical for both pH 5 and pH 7. The generated MVDA models were then
applied to the external test set consisting of 8 samples. The maximal relative deviation
in concentration was determined as 3.9% for pH 5 and 5.3% for pH 7. Hence, the model
performed well for a set of samples that were not used for the calibration experiments.
Besides testing the performance of the MVDA model, also the repeatability of the exper-
imental data was investigated. The duplicates of the isotherms in the presence of 90 mM
ionic strength at pH 5 and pH 7 are shown in Fig. 1 for cytochrome c (left) and lysozyme
(right). The protein bound to the adsorbent is plotted versus the residual protein in
free solution for equilibrium conditions. The trends of the duplicates (cross/ diamond)
agree well for both investigated pH values and proteins. Also, the absolute values of the
duplicates are in good accordance considering the experimental diculties when working
with low adsorbent and liquid volumes. Consequently, both the obtained MVDA model
and the experimental data were of high quality and were used in the presented study.
3.2 Multi-component Isotherms
To prove the applicability of the MVDA model for real isotherm data in a mixture of
proteins, the concentrations of cytochrome c derived from the MVDA are compared to
the values of a selective 527 nm analytical wavelength (see Fig. 2). The data points from
the MVDA model plotted over the selective 527 nm wavelength measurements are shown
in a parity plot. It has to be noted that the MVDA model was calibrated in the UV
range (240 - 300 nm) whereas the selective wavelength for cytochrome c is at a much
higher wavelength in the VIS region. For pH 5 (Fig. 2A) as well as for pH 7 (Fig. 2B),
the isotherm data agree well with coecients of determination of the data points for all
investigated ionic strengths (ISs) of 99.74% for pH 5 and 99.34% for pH 7. Thus, the
MVDA model was applicable to this large data set for straightforward HTS applications.
The isotherm data for both lysozyme and cytochrome c are shown in Fig. 3 as 2D (left)
and 3D (right) scatter plots. The experimental data are illustrated as markers and the
tted SMA model is shown as curves and planes. For all data sets, the binding of proteins
decreases with increasing ionic strength (from 42 mM to 150 mM IS). For cytochrome c
(red), both pH conditions (pH 5 - Fig. 3A and pH 7 - Fig. 3B) show a similar trend for
all ionic strengths: The isotherm data increase for low starting concentrations cin and
decrease for higher values of cin. However, the overall binding of cytochrome c at pH 5
(Fig. 3A) is slightly increased when compared to pH 7 (Fig. 3B). E.g., in the setups of
42 mM IS, the maximum binding capacity qcytc was determined to be 63.98 mg/mL for
pH 5 and 50.13 mg/mL for pH 7. Again, for lysozyme (blue), both pH conditions behave
similarly for all ISs. In contrast to cytochrome c, the isotherm data increase consistently
with the starting concentrations cin. The overall binding behavior of lysozyme at pH 5
(Fig. 3A) is slightly decreased when compared to pH 7 (Fig. 3B). The maximum binding
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Figure 2: Comparison of cytochrome c isotherm data points at pH 5 (A) and pH 7 (B) derived from the
MVDAmodel and the selective 527 nm wavelength as a secondary analytics for validation. The agreement
of the dierent data point is shown in parity plots for the equilibrium concentration of cytochrome in
solution and bound to the adsorbent.
capacity qlys at 42 mM IS was determined to be 67.48 mg/mL for pH 5 and 74.77 mg/mL
for pH 7. Although the initial amount of lysozyme in the mixture was much lower (30%)
compared to cytochrome c (70%), the maxima of qlys exceed those of qcytc.
The experimental results encountered follow the expected trends. As observed for all
investigated setups, an increase in ionic strength causes a weakening of the electrostatic
binding in ion-exchange chromatography. Cytochrome c showed a strong increase in
protein binding for low starting concentrations cin, starting to decrease with higher values
of cin. This indicates a displacement of cytochrome c by lysozyme when the binding
process approaches the maximal binding capacity of the adsorbent. This assumption was
conrmed by the trends encountered for lysozyme. Here, a continuous increase in protein
binding was observed towards a maximum for the highest starting concentrations cin. This
displacement under all investigated conditions agrees with the isoelectric points of the two
proteins being 10 to 10.5 for cytochrome c and 11.4 for lysozyme (compare data sheet
Sigma-Aldrich) yielding a higher net charge for lysozyme and thus a stronger binding
to the cation-exchange resin. This also explains the enhancement of the displacement
reaction for pH 7 compared to pH 5 due to cytochrome c being closer to its nominal pI.
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Figure 3: Isotherm data derived from the MVDA model-based equilibrium concentrations for both
cytochrome c (red) and lysozyme (blue) and the corresponding SMA isotherm tting curves. The exper-
imental results at pH 5 (A) and pH 7 (B) are illustrated for all investigated ionic strengths in a range
of 42 mM to 150 mM. The experimental data points are highlighted as markers and the SMA isotherm
tting curves are illustrated as solid lines for 2D plots and as planes for 3D plots.
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Figure 4: Predicted SMA model for dierent concentrations and mixing ratios of cytochrome c and
lysozyme at pH 5 (A) and pH 7 (B). Lysozyme is shown in blue (42 mM IS) and pink (150 mM IS),
cytochrome c is illustrated in red (42 mM IS) and yellow (150 mM).
3.3 SMA Data Fitting
For SMA data tting, the total ionic capacity  for the adsorbent plaques was estimated
rst. A packed 1 mL of SP Sepharose FF has a total ionic capacity of 800 mM [19]. The
calculation of the equivalent  for the adsorbent plaques being 0.504 mM followed the
description by Hermann et al. using the packed-bed porosity factor [16]. The data tting
was performed in Matlab RR2011a using qi and ceq;i being the concentration of the protein
i adsorbed and in solution inside the pore as input variables according to Eqs. (1) - (2).
The corresponding SMA tting functions are illustrated in Fig. 2 by solid lines plotted
combined with the respective MVDA data points. The ts were found to be of good
agreement as the experimental isotherm points are matched well and the competitive
binding trends were conserved.
The resulting SMA parameter sets for both proteins under the investigated conditions
are listed in Table 1. The lysozyme equilibrium constants keq;i are much higher (ranging
from 0.454 to 0.632) compared to cytochrome c (0.010 to 0.040) for both pH 5 and pH 7.
Comparable values and trends were reported by Gallant et al. for both proteins at pH 6
(keq;lys = 0.124, keq;cytc = 0.006) [20]. As shown in Table 1, the characteristic charge i
of cytochrome c was determined to be 20% higher than for lysozyme at pH 5 whereas for
pH 7, the same trend is shown inversely. i values given by Gallant et al. at pH 6 (lys
= 5.95, cytc = 6.15) as the center point between pH 5 and pH 7 indicated an identical
charge characteristic for both proteins agreeing well with this inversion of i from pH 5
to pH 7 shown in this study. Also, the absolute values for i match well. The steric
shielding parameters i shown in Table 1 are similar for all proteins under all conditions
ranging from 36.877 to 51.871. Those values are in accordance with Gallant et al. for
cytochrome c (53.4) and Osberghaus et al. for lysozyme (29.7 - 36.8) and cytochrome c
(28.7 - 40.8) [19].
The overall model quality depends on the identiability of isotherm parameters from
the chosen experiments. To determine the range of the design space used for model
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calibration, the total concentration of occupied binding sites in equilibrium bound is
calculated by:
bound =  
X
i
(i + i)qi (3)
Pairs (qcytc, qlys) can be taken from the experimental data in [mg/mL] and divided by
the respective molecular weights. MWcytc = 12.38 kDa and MWlys = 14.30 kDa were
taken from the Sigma Aldrich data sheet and the SMA parameters for pH 5 and pH 7 are
given in Table 1. For the lowest salt concentration and highest initial concentration at
pH 5, bound adds up to 432.5 mM (166.7 mM cytochrome c, 265.8 mM lysozyme) and for
pH 7 to 371.5 mM (69.7 mM cytochrome c, 301.8 mM lysozyme). For the lowest initial
concentration, we obtain bound;pH5 = 338.7 mM and bound;pH7 = 302.7 mM. Comparing
these values to the total ionic capacity  of 504 mM, the loading is in a range of 60% to
86%.
This could be an explanation for the deviation of the equilibrium constants from literature
values. As the linear range of the isotherms is not covered by the experiments, the 95%
condence intervals for keq are the largest (keq;cytc;pH5 94%, keq;cytc;pH7 233%, keq;lys;pH5
68%, keq;lys;pH7 187%). However, it should be be noted that Gallant et al. were investi-
gating cytochrome c and lysozyme at pH 6 and not at pH 5 and 7. Absolute values were
thus not comparable but relative trends were conserved. The condence intervals for the
steric shielding parameter were the smallest (cytc;pH5 13%, cytc;pH7 34%, lys;pH5 11%,
lys;pH7 28%) as they can be read from the concentration in the saturated state. For the
characteristic charge we determined slightly larger intervals (cytc;pH5 20%, cytc;pH7 42%,
lys;pH5 21%, lys;pH7 41%). As the parameters are still correlated, additional experiments
could be done to minimize the uncertainty, e.g. following [21]. Nevertheless, it can be
concluded that the SMA model is able to reproduce the observed binding behavior.
Finally, the tted SMA model was plotted for dierent protein concentration levels cin
of both proteins for pH 5 (Fig. 4A) and pH 7 (Fig. 4B). Lysozyme is shown in blue
(42 mM IS) and pink (150 mM IS), cytochrome c is illustrated in red (42 mM IS) and
yellow (150 mM IS). Data points along the x- and y-axes (0 mg/mL of lysozyme or
cytochrome c) are the single component isotherms showing a linear slope for low con-
centrations and resulting in a maximum (qmax) at the adsorbent saturation. The model
predicts an almost constant maximal binding capacity at pH 5 and pH 7 at both ISs
for lysozyme whereas the binding of cytochrome c is enhanced at pH 5 especially for
150 mM IS compared to pH 7. Furthermore the model in Fig. 4 predicts that already
2 mg/mL of lysozyme present in the mixture suppresses the binding of cytochrome c
on the adsorbent for both pH setups. These ndings agree with the experimental data
which indicated a diminished binding of cytochrome c (Fig. 3) though being the species
of excess concentration in the mixture (70% cytochrome c/ 30% lysozyme).
3.4 SMA Parameters vs. Experimental Data
The equilibrium constant keq;i as a factor describing the binding anity of proteins un-
der given conditions being over 10-fold higher for lysozyme compared to cytochrome c
(compare Table 1) is in accordance with the isotherms given in Fig. 3. The displacement
of cytochrome c by lysozyme at higher starting concentrations cin was discussed above.
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Protein pH keq;i i i
Cytochrome c 5 0.010 9.955 45.775
Cytochrome c 7 0.040 4.827 36.877
Lysozyme 5 0.632 7.945 48.278
Lysozyme 7 0.454 5.834 51.871
Table 1: SMA parameters of cytochrome c and lysozyme at pH 5 and pH 7 determined by least squares
tting of the MVDA isotherm data.
Surprisingly, the corresponding characteristic charge i is not the crucial factor driving
this phenomenon. E.g., for pH 5, lys of 7.945 is lower than cytc of 9.955 but still the
equilibrium is strongly shifted towards lysozyme. However, the above-discussed eects of
increased displacement of cytochrome c at pH 7 (towards the pI of both proteins) agree
with the change in characteristic charge from pH 5 to pH 7 which decreases strongly for
cytochrome c from 9.955 to 4.827 whereas lysozyme is much less aected. In summary,
the equilibrium constant was found to be a factor for indicating displacement phenom-
ena whereas the characteristic charge shows the extent. The shielding factors i being
similar for both proteins were expected as lysozyme and cytochrome c are similar in size.
Lysozyme as the slightly larger molecule (MWlys = 14.30 kDa, MWcytc = 12.38 kDa)
resulted in marginally higher i values.
4 Conclusions
It was demonstrated that multi-variate data analysis (MVDA) of protein spectra is a
straightforward method of determining accurate concentration levels for protein mixtures
for HTS applications such as batch isotherms. The data points were of high quality and
were thus usable for modeling purposes. Based on the MVDA data, accurate SMA ts
were found that coincide with literature values.
Analyzing the presented amount of samples using a standard analytical method, such
as analytical chromatography takes approximately 5 min per sample or above. Using
the presented MVDA method, in contrast, 10 - 15 s per sample are sucient. The time
requirement per sample is one of the key aspects in the concept of QbD, as the bottleneck
of HTS and exploring the design space is shifted to the analytics. Besides this, the major
advantage over traditional analytical tools, its non-invasive nature, is very convenient in
the context of performing experiments on robotic workstations, making sampling obsolete.
The proposed methodology can be used for any multi-component mixtures that do show
dierences in single-component absorption spectra. Brestrich et al. used the methodology
for a distinction between antibody monomers, aggregates and lower molecular weight
species though being spectrometrically similar [22]. Such species can be distinguished
due to an increase or decrease of exposed amino acid residues and by included scattering
eects for larger aggregates. The analytical technology based on MVDA of protein spectra
might become a standard tool for robotic workstations and in-line analytics [23]. The
technique of model calibration might be extended to more complex protein compositions
and proteins which are not available as pure components.
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Abstract
The production of safe vaccines against untreatable or new diseases has pushed the re-
search in the eld of virus-like particles (VLPs). Currently, a large number of commercial
VLP-based human vaccines and vaccine candidates are available or under development.
A promising VLP production route is the controlled in vitro assembly of virus proteins
into capsids with antigen epitopes on their surface. A rapid and economic production
host for industrial processes is Escherichia coli.
In the study reported here a high-throughput (HTS) platform for the production and
characterization of VLPs in bacterial cell systems was established. High-throughput
cultivations were carried out in 48-well format in the BioLector Rsystem (m2p-Labs, Ger-
many) using an Escherichia coli strain with a tac promoter producing the murine poly-
omavirus capsid protein (VP1). The screening covered dierent cultivation temperatures
and shaking speeds, as well as varying induction conditions and additives. An eective
cell disruption process was established using a HTS sonication device. Capillary gel elec-
trophoresis served as an HTS-compatible analytical tool for scoring the large number
of lysates under the cultivation conditions investigated. The most ecient system was
selected based on an evaluation of soluble and insoluble product concentrations as well as
on the percentage of product in the total soluble protein fraction. The optimized system
was scaled up to cultivation 2.5 L shaker ask scale and puried using an anion-exchange
chromatography membrane adsorber, followed by a size exclusion chromatography polish-
ing procedure. Puried VP1 capsomeres were assembled under dened buer conditions
into empty capsids and characterized using transmission electron microscopy (TEM).
The presented HTS platform allowed for a fast development of an ecient production
process of VLPs in E. coli. Under optimized cultivation conditions, the VP1 product
totaled up to 43% of the total soluble protein fraction, yielding 1.63 mg VP1 per mL
of applied cultivation medium. The developed production process strongly promotes the
murine polyoma-VLP platform, moving towards an industrially feasible technology for
new chimeric vaccines.
Keywords: Virus-like Particles, Escherichia coli, High-throughput Screening, Micro-
scale Cultivation, BioLector R
1 Introduction
Virus-like particles (VLPs) represent novel molecular means for the containment of in-
fectious diseases and the immunotherapeutic treatment of cancer, Alzheimer's disease,
and autoimmune diseases ([1, 2, 3, 4]. A steadily increasing number of VLP-based vac-
cines is currently undergoing clinical phase studies and several recombinant VLPs have
been licensed for prophylactic vaccination against cervical cancer (Gardasil R, Cervarix R),
hepatitis B (Recombivax R, Engerix R), and hepatitis E (Hecolin R) [5, 6]. Protein-based
VLPs are produced by recombinant expression of virus proteins in yeast, insect, or bacte-
ria cells [7]. For the production of homogeneous particles, currently licensed VLP-based
vaccines are assembled in vitro under dened and controllable buer conditions. Separate
disassembly process steps are needed for in vivo assembled VLPs. A promising approach
to the rapid and scalable production of VLPs is the expression of virus proteins in Es-
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cherichia coli. E. coli is the recombinant system of choice for multiple biopharmaceutical
products, such as human insulin [8], human growth hormones [9], antibody fragments
([10], or hepatitis vaccines [11], providing high product titers and total soluble protein
values of up to 50% [12].
In recent years, several microbial VLP production systems were developed and tailored
to epitope presentations in vaccine formulations, such as the bacteriophage Q system
[4, 13], the human hepatitis B core protein [14, 15, 16], the woodchuck hepadnavirus
core protein (WHcAg) [17] or the papaya mosaic virus (PapMV) system [18]. Another
well-characterized VLP-based nanocarrier is the murine polyoma virus protein VP1 that
is capable of spontaneously self-assembling into capsids and lacking the risk of human
pre-existing carrier-specic immunity. E. coli -derived VP1 builds pentamer structures
that allow processing small protein complexes instead of whole particles and, thus, do
not require any additional disassembly steps. Chimeric murine polyoma-VLPs were used
in the past for the presentation of inuenza antigen epitopes (H190, M2e) [19, 20, 21],
group A streptococcus epitopes (J8i) [22, 23], tumor cell epitopes [24, 25], and packaging
of small molecules and DNA [26, 27]. However, the current state-of-the-art platform for
E. coli -derived VP1 is limited by the expression and processing of glutathion-S-transferase
(GST)-VP1 fusion tag complexes [28]. These protein tags are widely used for enhancing
the solubility of proteins, increasing product titers, and facilitating lab-scale purica-
tion by using anity chromatography for capturing the product of interest with a high
selectivity [29, 30, 19]. Major drawbacks of protein tags are due to multimerization ef-
fects, slow and high-priced anity chromatography media, and the demand for additional
downstream procedures for the removal of the fusion tags [28, 31]. Boosting the produc-
tivity of the murine polyoma-VLP platform requires an optimization, acceleration, and
simplication of both upstream and downstream processing.
An optimization of protein expression in E. coli often is time-intensive when performing
shaker ask cultivations. Rapid process development can be performed in silico using
molecular dynamics simulations of the product of interest [32] or by high-throughput
experimentation with multiple recently developed tools for miniaturized automated cul-
tivations [33, 34, 35]. However, miniaturization may result in a reduction of accessible
process information, leading to diculties in process control and scale-up [33]. To over-
come these shortcomings, more sophisticated systems were developed, e.g. the Advanced
Micro-scale Bioreactors (ambr R) technology (Sartorius Stedim Biotech, Germany) mim-
icking lab-scale fermenters on a robotic workstation [36] and the BioLector Rsystem (m2p-
Labs, Germany) used in this study [37, 38]. For the BioLector Rsystem, special 48-well
cultivation plates with ower-shaped wells exist for improving mixing and oxygen uptake
into the medium [39]. Successful scale-up from the micro-scale to lab-scale can be imple-
mented to gain a large pool of cell broth for subsequent downstream process development
[40, 41].
In this paper, we present a high-throughput approach to the design of the upstream pro-
cess of murine polyoma-VLPs. In addition, we suggest an alternative membrane-based
downstream process enabling the rapid large-scale production of future chimeric murine
polyoma-VLP-based vaccine candidates.
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2 Materials & Methods
2.1 Materials
2.1.1 Disposables
Microbial cells were stored in a CryobankTM strain maintenance kit for microorganisms
(Mast Diagnostica, Germany). Cell transformation was carried out in 1 mm polycarbon-
ate electroporation cuvettes (Biozym Scientic GmbH, Germany). Micro-scale cultiva-
tion experiments were performed in 48-well FlowerPlatesRcovered with adhesive sterile
sealing foil (m2p-Labs, Germany). All pre-cultures were cultivated in 250 mL baed
asks (Schott, Germany). For scale-up, 2.5 L baed TUNAIRTM shake asks (Sigma
Aldrich, Germany) were used. Cell lysis and centrifugation procedures were carried out
in 300 L polypropylene 96-well plates with a conical bottom (VWR, Germany). Ster-
ile ltration of cell lysates prior to chromatography runs was conducted with 0.45 m
and 0.1 m cellulose acetate lters (Sartorius AG, Germany). 3 mL Slide-A-LyzerTM
G2 dialysis cassettes with 10 K MWCO cellulose membranes (Life Technologies, USA)
were used for the in vitro VLP assembly. For gel electrophoresis (GX) experiments,
Novex RNuPAGER4 - 12% Bis-Tris (1.0 mm, 12 wells) protein gels were purchased from
Life Technologies, Sweden. Capillary gel electrophoresis (GX II) was carried out in an HT
Protein Express & Pico LabChip R(Perkin Elmer, USA). GX II sample preparation was
conducted in skirted 96-well twin.tecRPCR plates (Eppendorf, Germany). For western
blotting, XCellTM blot sponge pads, lter papers, and a nitrocellulose transfer membrane
were purchased from Life Technologies, USA.
2.1.2 Chemicals & Buers
For the electroporation experiments, super optimal broth (SOB) medium composed of
20 g/L wheat peptone for microbiology (Fluka, Germany), 5 g/L bacteriological yeast
extract (Amresco, USA), 10 mM sodium chloride, 2.5 mM potassium chloride (VWR,
Germany), and super optimal broth with catabolite repression (SOC) medium, including
the ingredients of SOB with additional 10 mM magnesium chloride, 10 mM magnesium
sulfate (Merck kGaA, Germany), and 20 mM glucose (VWR, Germany) were used.
For cultivations, a terric broth (TB) medium was applied, composed of 12 g/L wheat
peptone, 24 g/L bacteriological yeast extract, 5 g/L glycerol bidistilled 99.5% (VWR,
Germany), and 89 mM potassium dihydrogen phosphate (VWR, Germany). For the se-
lection of transformed cells, antibiotics were added to a nal concentration of 100 g/mL
carbenicillin and 34 g/mL chloramphenicol (AppliChem GmbH, Germany). The TB
medium was adjusted to pH 6 or pH 7 using potassium hydroxide and for experiments
including magnesium, magnesium sulfate heptahydrate (Merck kGaA, Germany) was
added to a nal concentration of 2 mM. The induction procedure of the pTac promoter
was realized with isopropyl--D-thiogalactopyranosid (IPTG) from a 1 M stock solution
(VWR, Germany).
As a lysis buer for native protein release (compatible with the GX II system), a 20 mM
Tris buer (Merck KGaA, Germany) adjusted to pH 8 with hydrochloric acid (Merck
KGaA, Germany), including 1X SigmaFASTTM protease inhibitor and 5 mM dithiothre-
itol (DTT) (Sigma Aldrich, Germany), was used. The lysis buer for purication experi-
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ments consisted of 20 mM Tris-HCl (VWR, Germany), 1 mM EDTA disodium dihydrate
(Fluka Chemie GmbH, Switzerland), 5% (v/v) glycerol, 1X SigmaFASTTM protease in-
hibitor, and 5 mM DTT (Sigma Aldrich, Germany). Total protein extraction under
denaturing conditions was carried out using trichloroacetic acid (TCA) BioChemica (Ap-
pliChem, Germany) and acetone for liquid chromatography (Merck kGaA, Germany).
The compositions of the binding and elution buer for anion-exchange chromatography
were 20 mM Tris (pH 8), 5 mM DTT, 1 mM EDTA, and 5% (v/v) glycerol, with an
additional 1 M NaCl (Merck KGaA, Germany) in the elution buer. 20 mM Tris (pH 8),
5 mM DTT, 1 mM EDTA, 5% (v/v) glycerol, and 250 mM NaCl were used as running
buer for purication by size-exclusion chromatography. The VLP assembly buer devel-
oped by [19] was used, which consists of 0.5 M ammonium sulfate, 20 mM Tris (pH 7.4),
5% (v/v) glycerol, and 1 mM calcium chloride (VWR, Germany).
Gel electrophoresis (GX) was carried out using 20X Bolt RMES SDS running buer,
NuPAGER4X LDS sample buer, and the Novex RSharp unstained protein standard
(Life Technologies, Sweden). DTT was prepared as a 1 M stock solution. For pro-
tein staining, a 'blue silver' staining solution, consisting of 10% (v/v) phosphoric acid
of 85% purity (Roth, Germany), 100 g/L ammonium sulfate BioChemica (AppliChem,
Germany), 1.2 g/L Coomassie Brilliant Blue G-250 (Merck, Germany), and 20% (v/v)
methanol (Sigma Aldrich, Germany), was used. For capillary gel electrophoresis (GX II)
experiments, an HT protein express reagent kit was purchased from Perkin Elmer, USA.
A 1 mg/mL lysozyme solution (Hampton research, USA) served as an internal concen-
tration standard.
The transfer buer for western blotting was composed of 192 mM glycine, 20% (v/v)
methanol (Sigma Aldrich, Germany), and 25 mM Tris(hydroxymethyl)-aminomethane
(Merck KGaA, Germany) and was adjusted to pH 8.3. As further buers, Tris-buered
saline (TBS), including 500 mM chloride and 20 mM Tris adjusted to pH 7.5, and TBS-T
with additional 0.05% (v/v) of Tween 20 were applied. The solution for color devel-
opment (AP color development reagent kit) was purchased from BioRad Laboratories,
USA.
2.1.3 Instrumentation & Software
Transformations were conducted using a MicroPulserTM Electroporator (Bio-Rad Lab-
oratories, USA). High-throughput micro-scale cultivation experiments were carried out
in a BioLector RMB micro-scale fermentation system run with the BioLection RHMI &
analysis software (m2p-Labs, Germany). Shake ask cultivations were conducted in a
MaxQTM 6000 incubator (Thermo Fisher Scientic, USA). A 5810 R centrifuge (Ep-
pendorf, Germany) was used for liquid-solid separation procedures, including cell har-
vest. Release of the intracellular product was realized using a Model 120 Sonic Dismem-
brator equipped with an eight-tip horn positioner (Thermo Fisher Scientic, USA) for
high-throughput micro-scale cell disruption and with a Digital Sonier R 450 (Branson
Ultrasonic Corporation, USA) for the scale-up cell lysis procedure. Product purica-
tion experiments were carried out in an AKTATM Purier system (GE Healthcare Life
Sciences, Sweden), equipped with a pump P-900, mixer M-925, UV detector UV-900,
motor valve INV-907, pH and conductivity monitoring unit pH/C-900, and a fraction
collector Frac-950 unit. The FPLC system was controlled using Unicorn 5.2 (GE Health-
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care Life Sciences, Sweden). For pH adjustment of all buers, an HI-3220 pH meter
(Hanna Instruments, USA) was used. Gel electrophoresis was carried out in an Xcell
SureLockTM Novex RMiniCell gel chamber equipped with a PowerEaseR 500 power sup-
ply (Life Technologies, USA). Capillary gel electrophoresis (GX II) was carried out in a
Caliper LabChip RGX II run with the LabChip R GX 3.1 software (Perkin Elmer, USA).
Sample denaturation for both the GX and GX II system was realized in a MUR 13
thermo-shaker with additional lid heating (HLC BioTech, Germany). Matlab R R2011a
(MathWorks, USA) served for data processing and creation of gures. Assembled virus-
like particles were inspected by transmission electron microscopy (TEM) on a CM 200
FEG/ST electron microscope (Philips, Netherlands).
2.2 Upstream Process Development
2.2.1 Plasmid Construction & Host Strain
The plasmid pALVP1TAC [42] was generously provided by Prof. Robert Garcea (Uni-
versity of Colorado, USA) and sequenced by JenaGen GmbH, Germany. The plasmid
pTacVP1 was constructed by inserting the nucleic acid sequence of murine polyoma virus
capsid protein VP1 (sequence M34958) with optimized codon usage (Fig. 1) between the
NdeI and HindIII sites of a pTac-MAT-Tag-1 expression vector (Sigma-Aldrich, USA). A
stop codon was inserted in front of HindIII to prevent the translation of the N-terminal
metal anity tag. The plasmid was designed and synthesized by Centic Biotec, Germany.
E. coli Rosetta(DE3)pLysS cells (Merck KGaA, Germany) were prepared for electropo-
ration by the standard procedure: Growth in SOB medium (250 mL shaker asks, 37C,
180 rpm), harvest at an OD600 nm-value of 0.3 by centrifugation (4
C, 12000 rpm), fol-
lowed by several cooling and washing steps with sterile bi-distilled water. Transformation
was carried out in a MicroPulserTM Electroporator at 1.8 kV with 100 L cells and 100 ng
DNA. Transformed cells containing pTacVP1 with the ampicillin resistance gene were se-
lected on carbenicillin agar plates.
2.2.2 Micro-scale Cultivations
The pre-cultures for the micro-scale cultivations were prepared as 80 mL cultures in TB
medium using E. coli Rosetta pTacVP1 from a CryobankTM strain maintenance kit cryo
culture in the MaxQTM 6000 incubator (180 rpm - 37 C). 4 dierent pre-cultures were
employed, applying TB medium of variable composition (pH 6 - w or w/o 2 mM magne-
sium sulfate and pH 7 - w or w/o 2 mM magnesium sulfate). After 16 h (late exponential
phase), the cells were diluted to a nal OD600 nm of 0.1 AU using the dierent TB me-
dia (equally treated pre-culture for all experiments). The working volume of the 48-well
FlowerPlate Rwas set to 1 mL for all cultivation experiments. The cultivation plate was
sealed with an adhesive gas-permeable sterile membrane.
The micro-scale cultivation experiments were performed at shaking speeds of 600 rpm or
1200 rpm, covering a temperature set of 27, 32, and 37 C. Per 48-well FlowerPlateR,
each cultivation experiment was performed in triplicate, allowing for a total of 16 con-
ditions to be screened (combined with all shaking speeds and temperatures, this adds
up to 166 = 96 conditions). These 16 conditions covered 2 dierent pH values (pH 6
and pH 7), 2 dierent additive setups (w and w/o 2 mM magnesium sulfate), 2 dierent
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induction times (OD600 nm of 0.5 AU and 4 AU), as well as 2 dierent inducer concen-
trations (0.1 mM and 0.5 mM of IPTG) as a full factorial experimental design. The
respective induction times, being in scattered light units in the BioLector Rsystem, were
calculated using scattered light - OD600 nm correlation functions (600 rpm: Scattered light
= 11.69  OD600 nm + 17.59; 1200 rpm: Scattered light = 11.36  OD600 nm + 16.14). After
20 h, the cultivation procedure was stopped. 50 L of each well of the FlowerPlate Rwere
transferred to 300 L polypropylene 96-well plates with a conical bottom for TCA total
protein extraction under denaturing conditions. Additionally, 150 L of cell broth were
transferred to another 300 L polypropylene 96-well plate for native cell disruption by
sonication. All plates for protein release were centrifuged at 4000 rpm and 10 C for
30 min and the supernatant was discarded prior to freezing at -20 C.
2.2.3 High-throughput Cell Disruption
For total protein extraction under denaturing conditions using a TCA protocol, the cell
pellets were resuspended in 200 L of ultrapure water. Then, 10 L of 100% (w/v) TCA
solution were added to each well and the plate was shaken for 20 s and subsequently
stored on ice for 10 min. The plate was then centrifuged at 4000 rpm and 4 C for 10 min
and the supernatant was discarded. The pellet was washed twice with 200 L of cold
pure acetone, followed by another centrifugation cycle after each washing step. In a nal
step the supernatant was removed, the pellet was dried for 3 - 4 h and stored at -20 C
until analysis.
For HTS sonication experiments using the Model 120 Sonic Dismembrator (Fisher Scien-
tic), the cell pellets were resuspended in 150 L of lysis buer for native protein release
(compatible with the GX II system). The sonication device was operated with an ampli-
tude of 70%, applying 6 cycles of 20 s pulse duration. Between the pulses, 30 s chilling
on ice followed. After the nal sonication cycle, the plates were centrifuged twice at 4 C
and 4000 rpm for 30 min. The supernatant was transferred to another 96-well plate and
stored at -20 C until analysis in the GX II system.
2.2.4 Scale-up Culture
A scale-up culture from the 1 mL micro-scale cultivation yielding highest VP1 titers to
a 2.5 L shake ask culture was realized by keeping the oxygen transfer rate constant, as
shown by [43]. The corresponding shaking frequency for scale-up was taken from [41].
The cultivation was performed at 180 rpm shaking speed and 37 C. The TB medium at
pH 6 included 2 mM magnesium sulfate and the induction was carried out at OD600 nm of
0.5 AU with 0.5 mM IPTG. 20 h after inoculation, the cells were centrifuged at 4000 rpm
and 4 C for 30 min. The supernatant was discarded and the cell pellet was frozen
at -80 C until cell disruption. Product release under native conditions was performed
by sonication using a Digital Sonier R 450 equipped with a 1/2" extension cylindrical
sonication probe. The cell pellets from 400 mL culture were suspended in 20 mL native
lysis buer for purication experiments. The sonication procedure was carried out at an
amplitude of 70% applying 8 cycles of 15 s pulse duration (each cycle followed by 30 s
chilling on ice). The lysates were centrifuged twice at 10 C and 12000 rpm for 30 min,
followed by a 0.45 m ltration step using PES lters by Sartorius, Germany. The lysates
were stored at -20 C until the purication procedure.
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2.3 Downstream Process Development
VP1 expressed in E. coli Rosetta cells was puried by anion-exchange (AEX) membrane
chromatography and size-exclusion chromatography (SEC). A claried E. coli lysate
(1 mL) was loaded onto a 3 mL Sartobind RQ Nano Membrane Capsule (Sartorius Stedim
Biotech GmbH, Goettingen, Germany) at 3 mL/min and puried by applying a salt step
elution with NaCl. Pooled VP1 fractions of the AEX eluate were further processed on a
Superose 6 RIncrease 10/300 GL column (Ge Healthcare, Uppsala, Sweden) at a ow rate
of 0.5 mL/min. Puried VP1 was nally assembled into VLPs by dialysis into the as-
sembly buer, followed by dialysis against PBS for 16 h prior to analysis by transmission
electron microscopy (TEM).
2.4 Analytical Methods
2.4.1 SDS-PAGE & Western Blot
For gel electrophoresis, the TCA pellet from the total protein extraction protocol was
dissolved in 1X NuPAGE RLDS sample buer, including 12.5 mM DTT for gel elec-
trophoresis (OD600nm  200 L), for 2 h in an overhead shaker. For native samples in
solution, the sample preparation was performed according to the NovexRNuPAGER4 -
12% Bis-Tris protein gel manual [44]. Puried VP1 derived from the GST-tag process
developed by [19] served as reference standard. All samples were denatured at 100 C
and 300 rpm for 15 min on a plate shaker with lid heating. All following steps were
carried out as described in the user manual. For each set of samples, two distinct gels
were created, one for western blotting without staining and another stained with 'blue
silver' staining solution.
Proteins were transferred from SDS-PAGE gels to a nitrocellulose membrane at 30 kV for
1 h using the XCell IITM blot module from Life Technologies, USA. Washing, blocking
with 5% BSA, and incubation with primary and secondary antibodies were performed
according to the user manual [45]. Rabbit-derived anti-VP1 antibody was a gift of Prof.
Robert Garcea [42] and was used as primary antibody. Alkaline phosphatase anity-
puried donkey anti-rabbit IgG (Jackson ImmunoResearch Laboratories, USA) served
as secondary antibody. Product detection was carried out using alkaline phosphatase
color reagents (BioRad Laboratories, USA). All gels and membranes were analyzed in a
Bio-5000 gel scanner.
2.4.2 Capillary Gel Electrophoresis
For quantitative determination of purities and VP1 concentrations, all samples were an-
alyzed in a LabChip RGX II capillary gel electrophoresis device as duplicates with an HT
Protein Express LabChip R kit. Puried VP1 derived from the GST-VP1 process devel-
oped by [19] served as reference standard. The sample and chip preparation procedures
for liquid samples were performed as described in the manufacturer's protocol for the
HT Protein Express Assay [46]. In contrast to this, the dried samples from the TCA ex-
traction were dissolved in 100 L HT Protein Express sample buer, including 34 mM of
DTT. All further steps followed the above-mentioned protocol for liquid samples. Sample
analysis was carried out using the HT Protein Express 200 assay in the LabChip RGX 3.1
3 PUBLICATIONS & MANUSCRIPTS
86
software. Product quantication was based on peak-baseline integration of the product
peak and comparison to a lysozyme standard of 1 mg/mL.
2.4.3 Transmission Electron Microscopy
Visualization and characterization of assembled virus-like particles were carried out by
transmission electron microscopy (TEM) on a CM 200 FEG/ST electron microscope.
Sample preparation was performed as described previously by [47].
3 Results & Discussion
3.1 Codon Optimization & Product Detection
The expression of virus proteins in E. coli depends on various parameters, such as strain
and vector design, promoter, cultivation and induction conditions, as well as on codon
usage. First cultures with E. coli Rosetta(DE3)pLysS cells and the pALVP1TAC [42]
plasmid showed very poor yields below 1% of total soluble protein (TSP) (data not
shown) following cultivation protocols by [30]. [30] demonstrated the presence of sev-
eral rare codons in the pALVP1TAC-derived insert of pGexVP1. Hence, we sequenced
pALVP1TAC and looked for under-represented codons in the E. coli genome. According
to [48], [49], and [50], codons which are considered rare in E. coli are AGG, AGA, CGG,
and CGA encoding for arginine, GGA encoding for glycine, ATA encoding for isoleucine,
CTA encoding for leucine, and CCC encoding for proline. As shown in Fig. 1, seven of
these rare codons are represented in the insert of the VP1 sequence.
Aiming at a higher protein expression, the sequence was codon-optimized for E. coli by
Centic Biotec (Heidelberg, Germany), obtaining a slightly dierent insert sequence than
[30] (85% identity). Subsequently, the codon-optimized DNA sequence was inserted into
a vector with a tac promoter and transformed into E. coli Rosetta cells (see section 2.2.1).
For the proof of concept, expression of the product of interest on the shaker ask scale
was evaluated by several analytical methods: SDS-PAGE, western blot, capillary gel elec-
trophoresis, and reversed-phase ultra-high-performance liquid chromatography (data not
shown). Fig. 2 shows an overview of the dierent procedures for the detection of VP1 in
E. coli cell lysates with and without the constructed pTacVP1 plasmid. A protein ladder
and a VP1 standard are included in each of the analytical technologies. Fig. 2A illustrates
the VP1 identication using capillary gel electrophoresis, showing virtual gels (left) with
VP1 highlighted as a box and as an electropherogram (right). The VP1 standard (red
solid line) was detected at 49 kDa (aligned time of 21.7 s). Accordingly, the transformed
E. coli Rosetta pTacVP1 strain (black solid line) revealed a pronounced peak at the same
molecular weight as the VP1 standard, whereas the E. coli Rosetta wild type (blue dashed
line) shows minor uorescence at 49 kDa only. In Fig. 2B a stained SDS-PAGE gel is
shown with lane 1 representing the VP1 standard highlighted by a red box. Lanes 2 and 3
represent the TCA extracted total protein fraction, lanes 4 and 5 show the soluble protein
fraction after cell disruption. Both samples of E. coli Rosetta pTacVP1 (lanes 2 and 4)
reveal an intense band at the size of the VP1 standard, whereas the E. coli Rosetta wild
type samples (lanes 3 and 5) show minor bands in this molecular weight region (compare
capillary gel electrophoresis results). The product-specic western blot is illustrated in
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Figure 1: Codon optimization of the VP1 sequence for recombinant protein expression in E. coli. The
original DNA sequence of VP1 is illustrated above the sequence after codon optimization (VP1) with
rare codons highlighted in red. Unchanged sequences in the VP1 genetic code are indicated by lines.
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Fig. 2C with VP1 highlighted. Lanes 1 to 5 correspond to the samples shown in the
SDS-PAGE (Fig. 2B), again revealing intense bands like the VP1 standard (lane 1) for
denatured and native lysates of E. coli Rosetta pTacVP1 (lanes 2 and 4). Lanes 3 and 5
as the E. coli Rosetta wild type are insensitive to the product-specic antibody.
Dierent orthogonal analytical methodologies, namely, capillary gel electrophoresis, SDS-
PAGE, western blot, as well as reversed-phase chromatography (data not shown), indi-
cated the presence of VP1 in the codon-optimized E. coli Rosetta pTacVP1 strain. As
shown in the E. coli Rosetta wild type lysate, a minor amount of contaminants was de-
tected with the same molecular weight as VP1. The slight bands of the E. coli Rosetta
wild type lysate (Fig. 2C, lanes 3 and 5) is explained by cross reactivity of the proteins
to the primary antibody for VP1, as reported by [42].
3.2 High-throughput Cultivations
3.2.1 Growth Curves
The high-throughput cultivation experiments covered shaking speeds of 600 rpm and
1200 rpm, temperatures of 27, 32, and 37 C, two medium pH values of pH 6 and pH 7, two
additive setups (w and w/o 2 mM magnesium sulfate), two induction times of OD600 nm
= 0.5 AU and 4 AU, as well as two inducer concentrations of 0.1 mM and 0.5 mM IPTG.
The growth curves for all conditions investigated are illustrated in Fig. 3 with separated
plots for the dierent combinations of temperature and shaking speeds. In each individ-
ual plot, cultivations performed at pH 6 are marked in red and at pH 7 in blue (dark
colored conditions include 2 mM magnesium sulfate). Conditions induced at an OD600 nm
of 0.5 AU are illustrated as lines (dashed lines for induction using 0.1 mM IPTG, solid
lines for 0.5 mM IPTG), whereas inductions at OD600 nm of 4 AU are shown as markers
(asterisk for induction using 0.1 mM IPTG, circles for 0.5 mM IPTG).
The lag-phase of the E. coli Rosetta pTacVP1 cells decreases steadily from 27 C (6 to
7 h) up to 37 C (3 h), shifting the induction times (downward triangles) closer to the
time of inoculation (0 h). All other factors show almost no impact on the lag-phase,
with the medium pH being the only exception. In all setups the lag-phase of cells cul-
tivated at pH 6 is elongated compared to those grown at pH 7, with this eect being
most pronounced for the cells cultivated at 27 C. The increased time until starting the
exponential phase for cultivations at lower temperatures is intuitive due to the decrease
in metabolic activity of E. coli cells at a temperature other than the optimum of 37 C.
The negative eect of slightly acidic pH on the lag-phase is due to E. coli having its pH
optimum in the neutral region.
The shape of the exponential growth shows highest variations when comparing condi-
tions of dierent shaking speeds. All cells cultivated at 1200 rpm (right graphs, Fig. 3)
display an ideal exponential growth until the stationary phase. In contrast to this, all
cultivations performed at 600 rpm result in multiple varying slopes of the exponential
growth separated by intermediate plateaus. This eect is especially pronounced for cells
cultivated at pH 7. Such behavior was also described by Funke et al. [51] for E. coli when
accumulating acidic metabolites under fermenting conditions. Lower shaking frequencies
(600 rpm) result in poor mixing and low oxygen uptake into the medium inducing such
fermenting conditions. Cultivations performed at pH 6 are less inuenced as cells grow
under 'pseudo-fermenting' conditions starting from inoculation due to the acidic environ-
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Figure 2: Product (VP1) identication out of a crude feedstock of transformed E. coli Rosetta pTacVP1.
A: Capillary gel electrophoresis of an E. coli Rosetta pTacVP1 lysate (black curve), an E. coli Rosetta
wild type lysate (blue dashed curve), and a puried VP1 standard (red curve). VP1 is detected at 49 kDa
in the virtual gel (left) equivalent to an aligned time of 21.6 s in the electropherogram (right). B: Gel
electrophoresis of a puried VP1 standard (lane 1), total protein extracts of E. coli Rosetta pTacVP1
and the wild type (lanes 2 + 3), and the soluble protein fraction after sonication of Rosetta pTacVP1
and the wild type (lanes 4 + 5). The protein standard of known molecular weight is shown in lane 0 and
the product is highlighted in red at a molecular weight of 46 kDa. C: Western blot of lanes 1 - 5 of the
gel electrophoresis run (B) for VP1 identication. The relevant product-related bands are highlighted in
red.
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ment.
The nal plateaus of the stationary phase are elevated for all conditions at a shaking speed
of 1200 rpm compared to those at 600 rpm, yielding a maximal scattered light plateau of
285 SU at 27 C. In comparison, the maximal scattered light signal for the same temper-
ature at 600 rpm is about 40% lower (180 SU). With an increase in temperature up to
37 C, this eect becomes less pronounced. Whereas the stationary phase plateaus vary
signicantly for dierent shaker speeds and temperatures, all other cultivation factors
investigated are negligible. As discussed above, higher shaking speeds result in a better
oxygen uptake into the medium and, thus, enhance growth under aerobic conditions.
3.2.2 Soluble VP1 Fraction
The soluble protein fraction of cells after sonication and lysate clarication for all con-
ditions investigated is shown in Fig. 4 as 3D bar plots. Again, plots are separated for
dierent combinations of shaking speeds and temperatures. All VP1 concentrations cV P1
are normalized to the maximal concentration attained under all conditions cV P1;max of
1.63 mg/mL  0.13 mg/mL (37 C, 600 rpm, pH 6, including 2 mM magnesium sulfate,
induced at OD600 nm of 0.5 AU using 0.5 mM IPTG).
All cultivations performed at 1200 rpm (right) resulted in lower VP1 titers compared
to those at shaker speeds of 600 rpm (left), with the highest value 38.8%  4.5% being
reached at 27 C and 1200 rpm compared to the overall maximum cV P1;max. A decrease in
temperature is slightly benecial for the formation of soluble VP1 at 1200 rpm, shifting
cV P1/cV P1;max from up to 16.4%  1.9% at 37 C to 38.8%  4.5% at 27 C. Nevertheless,
the maximal VP1 concentration investigated at 1200 rpm was below that of most condi-
tions examined for 600 rpm shaking speed, ranging from cV P1/cV P1;max of 30.8%  4.2%
to 100%  8.2%. For experiments performed at 600 rpm, the VP1 concentration in the
soluble protein fraction follows an inverse trend towards cultivation temperature, shifting
cV P1/cV P1;max from up to 49.2%  4.9% at 27 C to 100%  8.2% at 37 C. For 32 C
and 37 C, additional pH eects become apparent, showing a positive eect for cells cul-
tivated under slightly acidic conditions at pH 6 compared to experiments performed in
a medium of pH 7. The addition of 2 mM magnesium sulfate did not show pronounced
eects in all setups investigated. Also the induction time and inducer concentration were
determined to be factors of minor importance.
These ndings of high native protein production under fermenting conditions with low
oxygen supply and increased temperature agree with the ndings of Baumann et al. [41]
for glutathione-S-transferase and Losen et al. [52] for benzoylformate decarboxylase.
However, they contradict the experiments of Chuan et al. [30], who found an optimal
production of 0.18 mg/mL VP1 at a decreased temperature of 26 C. Note that the
maximal VP1 concentration in this study of 1.63 mg/mL  0.13 mg/mL corresponds to
an increase of approximately a factor of 10 compared to Chuan et al. [30]. Finally, the
pH of the cultivation medium was found to be an important factor for enhancing native
VP1 production. The eect of increased soluble protein production under slightly acidic
conditions was also reported by Kopetzki et al. [53] for -glucosidase produced in E. coli.
As fermenting conditions with acidic by-products have a positive impact on soluble VP1
formation, the decreased pH after inoculation might have enhanced this eect. Whereas
the minor inuence of the inducer concentration on the product formation agrees with
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Figure 3: BioLector Rgrowth curves of E. coli Rosetta pTacVP1 under dierent cultivation conditions:
Temperatures of 27, 32, and 37 C and two shaking speeds of 600 and 1200 rpm were investigated. For
each setup, four distinct media compositions were examined, being two pH values of pH 6 (red curves)
and pH 7 (blue curves) with (dark colored) and without (light colored) addition of 2 mM magnesium
sulfate. As a nal factor, four dierent induction setups were investigated, being the induction times
OD600 nm of 0.5 (lines) and 4 (markers) using 0.1 mM (dashed line/ asterisk) or 0.5 mM IPTG (solid
line/ circle), respectively.
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Baumann et al. [41], the minor eect of the induction time investigated in this study is
in contradiction, as was also reported by Galloway et al. [54].
When comparing the trends of the growth curves to the soluble VP1 titers, there is a
clear correlation of increased productivity of E. coli cells under non-optimal growth con-
ditions. All experiments performed at high shaker speed (1200 rpm) resulted in unlimited
growth (Fig. 3, right) and, consequently, yielded low titers on soluble VP1 (Fig. 4, right).
Fermenting conditions at 600 rpm shaker speed, by contrast, resulted in varying slopes of
the exponential growth separated by intermediate plateaus and were found benecial for
soluble VP1 formation with product concentrations of up to 1.63 mg/mL  0.13 mg/mL
(Fig. 4, left). Note that excess stress on cell growth, as shown for fermenting conditions
(600 rpm) and low cultivation temperatures (27 C), reduced this eect, which might be
due to product degradation as a consequence of cell starvation.
3.2.3 Ratio of VP1 to Total Soluble Protein
Besides the overall product titer of soluble VP1, also the initial purity of the sample
(ratio of VP1 to total soluble protein) is an important factor for subsequent purication
processes. A comparison of soluble VP1 titers and total soluble protein (TSP) is shown
in Fig. 5A. The dierent combinations of temperature and shaker speeds are indicated as
dierent markers, whereas dierent media compositions are highlighted as colors. All data
points were tted with a linear regression function yielding a coecient of determination
R2 of 85.6%, indicating that the purity of the samples increased linearly with the amount
of produced soluble VP1. All cell lysates derived from cultivations at 1200 rpm are found
in the bottom left corner of Fig. 5A (circles, upward triangles, diamonds). 600 rpm cul-
tures, by contrast, are found at higher soluble VP1 and TSP values in Fig. 5A (asterisks,
downward triangles, hexagrams) with the overall best result found for the 37 C cultiva-
tions (hexagrams), as was discussed earlier. The linear increase of TSP with soluble VP1
indicates a product enrichment without causing additional upward regulation of impu-
rity levels. Fig. 5C illustrates this eect of shaker speed and temperature on the VP1
titer and the TSP for lysates from cultivations equivalent to the optimal system point
(1.63 mg/mL  0.13 mg/mL VP1) by capillary gel electrophoresis runs. The product
band in the virtual gel (Fig. 5C, left) at 49 kDa is highlighted (red box). Lanes 1, 3,
and 5 show cultivations performed at 600 rpm (27, 32, and 37 C) whereas lanes 2, 4,
and 6 are lysates from 1200 rpm cultivations. In Fig. 5C (right graph) the corresponding
electropherograms are shown for the same samples (600 rpm in green and 1200 rpm in
red). Both illustrations emphasize that contaminant levels are rather constant, whereas
VP1 levels vary strongly, which is most pronounced when comparing 37 C - 600 rpm as
the maximum VP1 concentration and 37 C - 1200 rpm as the condition of almost no
expressed product.
The overall optimal system point for both soluble VP1 and TSP was found for the opti-
mum identied in the 'Soluble VP1 fraction' section, resulting in a TSP of 42.6% with a
concentration of 1.63 mg/mL  0.13 mg/mL soluble VP1, as magnied in Fig. 5B (red
leftward triangle). Hence, the system point of 37 C, 600 rpm, pH 6, including 2 mM
magnesium sulfate, induced at OD600 nm of 0.5 AU using 0.5 mM IPTG was selected for
scale-up and downstream process development, as both initial purity and product levels
were optimal under the investigated upstream conditions.
93
00.2
0.4
0.6
0.8
1
c
/c
[-
]
V
P
1
V
P
1
,m
a
x
0.5
4
0.5
4
0.5
0.1
0.5
0.1
IPTG
[mM]
pH 6
+ Mg
- Mg
Ind. OD
[AU]
600 nm
pH 7 0.5
4
0.5
4
0.5
0.1
0.5
0.1
IPTG
[mM]
pH 6
+ Mg
- Mg
Ind. OD
[AU]
600 nm
pH 7
0.5
4
0.5
4
0.5
0.1
0.5
0.1
Ind. OD
[AU]
600 nm
IPTG
[mM]
pH 6
pH 7
+ Mg
- Mg
0.5
4
0.5
4
0.5
0.1
0.5
0.1
Ind. OD
[AU]
600 nm
pH 6
pH 7
+ Mg
- Mg
IPTG
[mM]
0.5
4
0.5
4
0.5
0.1
0.5
0.1
Ind. OD
[AU]
600 nm
IPTG
[mM]
pH 6
pH 7
+ Mg
- Mg
0.5
4
0.5
4
0.5
0.1
0.5
0.1
Ind. OD
[AU]
600 nm
IPTG
[mM]
pH 6
pH 7
+ Mg
- Mg
0
0.2
0.4
0.6
0.8
1
c
/c
[-
]
V
P
1
V
P
1
,m
a
x
0
0.2
0.4
0.6
0.8
1
c
/c
[-
]
V
P
1
V
P
1
,m
a
x
600 rpm 1200 rpm
2
7
 °
C
3
2
 °
C
3
7
 °
C
0
0.2
0.4
0.6
0.8
1
c
/c
[ -
]
V
P
1
V
P
1
,m
a
x
0
0.2
0.4
0.6
0.8
1
c
/c
[-
]
V
P
1
V
P
1
,m
a
x
0
0.2
0.4
0.6
0.8
1
c
/c
[-
]
V
P
1
V
P
1
,m
a
x
Figure 4: Soluble protein fraction of lysed cells shown in 3D bar plots. Separated plots are shown
for dierent combinations of shaking speeds (600 rpm and 1200 rpm) and temperatures (27, 32, and
37 C). Results for dierent media compositions (pH and magnesium sulfate concentrations), induc-
tion times, and inducer concentrations are shown for each individual sub-plot. All VP1 concentra-
tions cV P1 are normalized to the maximal concentration attained under all conditions cV P1;max being
1.63 mg/mL  0.13 mg/mL.
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Figure 5: Impurity levels of the dierent lysates investigated in the BioLector Rscreening. A: Ratio of
VP1 to total soluble protein, including a linear regression of data points. The dierent combinations
of temperature and shaker speeds are indicated as dierent markers and dierent media compositions
are highlighted as colors. B: Ratio of VP1 to total soluble protein, including a linear regression of
data points for the optimal system points (cultivation at 37 C, 600 rpm, and pH 6). The dierent
combinations of induction times and inducer concentrations are indicated as dierent markers, dierent
levels of magnesium sulfate are highlighted as colors. C: Comparison of the impact of shaker speed and
temperature on the VP1 titer and the impurity levels shown for the media conditions of the overall
optimal system point (pH 6, including 2 mM magnesium sulfate, induced at OD600 nm of 0.5 AU using
0.5 mM IPTG). The left gure shows virtual gels of these 6 combinations of temperature and shaking
speed, with lanes 1, 3, and 5 representing cultivations at 600 rpm (27, 32, and 37 C) and lanes 2, 4, and
6 for 1200 rpm (27, 32, and 37 C) and the VP1 band at 49 kDa highlighted in red. The corresponding
electropherograms are shown on the right with samples from cultivations at 600 rpm highlighted in green
and those of 1200 rpm shown in red.
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3.2.4 Ratio of Soluble to Total Expressed VP1
Apart from the soluble VP1 fraction, also the total product fraction, including insoluble
species, was determined using a TCA protocol for total protein extraction under dena-
turing conditions (Fig. 6). Fig. 7 illustrates the ratio of soluble to total expressed VP1
for each setup. For cultivations performed at 1200 rpm, the fraction of soluble VP1 is
low, ranging from 4.6% to 39.1% compared to experiments at 600 rpm, where the fraction
ranges from 20.9% to 106.1%. The optimal ratio of soluble to total VP1 was obtained
for cells grown at 600 rpm and 27 C, the range being 67.4% to 106.1%. Under these
conditions, the neutral medium condition of pH 7 was slightly benecial compared to
pH 6. The same trend was found for cultivations at 600 rpm under 32 C as well as
37 C. 32 C was found to be the condition of the lowest soluble to insoluble VP1 ratio
for cells cultivated at 600 rpm.
It was shown that a good mixing and oxygen uptake at 1200 rpm do not only result
in poorly soluble VP1 titers as discussed earlier, but also in the formation of aggre-
gates and inclusion bodies. Poor mixing at 600 rpm shaker speed, by contrast, resulted
in ratios of soluble VP1 of up to 100%, mostly for conditions of reduced temperature,
as was reported in dierent studies [55, 56, 53]. Note that a factor of 100% does not
imply optimal conditions for yielding high overall product titers (compare Fig. 4), but
conditions of non-soluble VP1 formation. For the condition of highest productivity of
1.63 mg/mL  0.13 mg/mL VP1, the ratio of soluble product was determined to be
72.8%, indicating an economic system point for scale-up, as was discussed earlier.
3.3 VP1 Purication & Assembly of Virus-like Particles
The development of an alternative production pathway for murine polyoma VLPs with-
out an anity protein tag entails the establishment of a novel downstream process. Fig. 8
summarizes the outcome of the purication procedure with chromatograms for the cap-
ture and polishing step, electropherograms of VP1 process samples, and a TEM micro-
graph of assembled murine polyoma VLPs.
Capturing of VP1 from claried E. coli cell lysate was performed by anion-exchange mem-
brane chromatography. The chromatogram of the optimized salt step elution is shown
in Fig. 8A. UV absorption (blue line), conductivity signals (dashed gray line), and VP1
concentration (green bars) are plotted against the mobile phase volume. Virtual gels for
all fractions are plotted below the chromatogram to track the elution of VP1 and HCPs.
As shown in the chromatogram of Fig. 8A, VP1 eluted mainly in the second salt step
removing weaker and stronger charged molecules in a low salt step at 0.09 M NaCl and
a high salt step at 1 M NaCl, respectively. 69  4% VP1 were recovered in the second
salt step with a protein purity of 61  0.9% in the pooled fractions. Fig. 8B shows the
chromatogram of the polishing step by size-exclusion chromatography for VP1 captured
by anion-exchange membrane chromatography. The UV signal (blue line) reveals four
major peaks. VP1 (green bars) elutes in the major peak at a retention volume of 15 mL,
separating smaller host cell impurities (10 to 40 kDa) as displayed in the virtual gels of
the FPLC fractions. The nal purity of the pooled VP1 fractions was 92  2% recovering
58  1.5% of VP1. In Fig. 8C capillary gel electrophoresis analysis of claried cell lysate
(dashed black line), captured VP1 (blue line), and polished VP1 (red line) is compared in
an electropherogram. The comparison reveals the high purity achieved at the end of the
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Figure 6: Total (soluble and insoluble) VP1 fraction shown in 3D bar plots. Separated plots are shown
for dierent combinations of shaking speeds (600 rpm and 1200 rpm) and temperatures (27, 32, and
37 C). Results for dierent media compositions (pH and magnesium sulfate concentrations), induc-
tion times and inducer concentrations are shown for each individual sub plot. All VP1 concentrations
cTCA;V P1 are normalized to the maximal concentration attained in all conditions cTCA;V P1;max.
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Figure 7: Ratio of soluble to total expressed VP1 of lysed cells shown in 3D bar plots. Separated plots
are shown for dierent combinations of shaking speeds (600 rpm and 1200 rpm) and temperatures (27,
32, and 37 C). Results for dierent media compositions (pH and magnesium sulfate concentrations),
induction times, and inducer concentrations are shown for each individual sub-plot.
3 PUBLICATIONS & MANUSCRIPTS
98
AB
69 kDa
48 kDa
29 kDa
16 kDa
0 5 10 15 20 25 30
0
200
400
600
800
U
V
 2
8
0
 n
m
 [
m
A
U
]
0
0.2
0.4
0.6
0.8
c
V
P
1
[m
g
/m
L
]
Volume [mL]
UV
VP1
69 kDa
48 kDa
29 kDa
16 kDa
0 10 20 30 40 50 60 70 80
0
1000
2000
3000
Volume [mL]
U
V
 2
8
0
 n
m
 [
m
A
U
]
0
20
40
60
80
C
o
n
d
u
c
ti
v
it
y
 [
m
S
/c
m
]
0
1.5
3
4.5
c
V
P
1
[m
g
/m
L
]UV
VP1
Cond.
16 18 20 22 24
0
1000
2000
3000
4000
5000
Aligned time [s]
F
lu
o
re
s
c
e
n
c
e
 [
F
U
]
Cell Lysate
SEC Sample
Purified VP1
C D
Figure 8: VP1 purication and VLP assembly procedure. A: Chromatogram of the AEX step for
VP1 capturing. The UV signal is illustrated as a blue line, the conductivity is shown as a dashed line,
and the VP1 concentrations are marked as green bars. The product-containing fractions are magnied
in virtual gels of the capillary gel electrophoresis procedure, with the VP1 fraction shown at 49 kDa.
B: Chromatogram of the SEC step for VP1 polishing. The UV signal is illustrated as a blue line and
the VP1 concentrations are marked as green bars. The product-containing fractions are magnied in
virtual gels of the capillary gel electrophoresis procedure with the VP1 fraction shown at 49 kDa. C:
Electropherograms of the cell lysate (blue solid line), the pooled elution fraction after AEX (black dashed
line), and the puried product after SEC polishing (red solid line). The VP1 peak is detected at 21.6 s of
aligned time. D: TEM micrographs of the generated VLP sample after VLP assembly, showing spherical
homogeneous particles (diameter of 40 - 50 nm).
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two-step downstream process with only one minor impurity left. The cell lysate obtained
from the 2.5 L shaker ask-scale fermentation showed almost the same VP1 concentration
of 1.5  0.2 mg/mL as in the 1 mL micro-scale cultivation and a similar TSP value of
42  2% .
Puried VP1 at a concentration of 0.3 mg/mL was nally assembled to VLPs, as de-
scribed earlier by Middelberg et al. [19]. Fig. 8D shows the TEM micrographs of the
generated VLP sample, revealing spherical homogeneous particles with diameters of 40 -
50 nm. The empty particles can hardly be distinguished from those murine polyoma VLPs
produced in former studies [19, 27, 57]. While the overall recovery of the downstream
process can still be optimized, the concept was proven by purifying non GST-tagged VP1
with a rapid and scalable two-step purication procedure, yielding a protein purity close
to the desired purity level for recombinant protein-based VLP vaccines of 95 - 99% [6].
Both anion-exchange chromatography and size-exclusion chromatography currently are
the methods of choice for the purication of numerous viral or VLP-based vaccines and
vaccine candidates [58, 59, 60, 61]. Thus, an industrially common downstream process
setup was developed for the processing of VP1 capsomeres.
4 Conclusions
Generating high numbers of vaccine doses in short time and at low cost remains the main
challenge for the vaccine industry, especially in the light of pandemic threats and arising
pathogens. VLPs represent promising nanocarriers for antigen epitopes of pathogens, but
still lack straightforward and easily controllable upstream and downstream procedures.
In this study, we aimed at optimizing both expression and purication methods of the
murine polyoma VLP platform by using a high-throughput screening procedure for micro-
scale upstream process development and product analysis. A novel insert and expression
system was designed and used to produce up to 1.63 mg/mL  0.13 mg/mL VP1. The
highest product titers were obtained at a high temperature (37 C), a low oxygen supply
at 600 rpm shaker speed, and a slightly acid pH of 6. To the best of our knowledge, this
exceeds all reported VLP yields achieved in shaker ask cultivations so far. In general,
the micro-scale cultivations suggested that induced stress during cell growth and product
formation (e.g. by oxygen limitation or slightly acidic pH) is benecial for high titers of
soluble product. The main parameter was identied to be the oxygen supply that needed
to be low to ensure fermenting conditions.
Following the successful scale-up from micro-titer plates to 2.5 L shaker asks, VP1
was puried by a simple two-step downstream process and nally assembled into homo-
geneous, spherical particles. The produced VLPs constitute an ideal potential carrier
platform for the presentation of antigen epitopes, packaging of small molecules, DNA
or as a model nanoparticle or viral system. The microbial murine polyoma VLP plat-
form has now been advanced further towards an industrially feasible option for tailored
vaccines.
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Systematic Purication of Salt-intolerant Proteins in
Ion-exchange Chromatography: The Example of Human
-Galactosidase A
P. Baumann1, A. Osberghaus1 and J. Hubbuch1,
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Abstract
Chromatography is an essential tool for purifying biopharmaceutical products. Many
processes are still developed based on traditional routines and empiric procedures. Prod-
uct losses are mostly due to insucient optimization of purication setups and product
sensitivity to process conditions. In order to eliminate these shortcomings, a system-
atic strategy for the setup of ion-exchange chromatography is presented, which considers
both product stability as well as operational conditions. The stages - a hybrid approach
combining high-throughput screening and analytical small-scale chromatography - are
as follows: (1) 'pH stability - short-term' ; (2) 'pH stability - long-term', followed by a
screening of additives to enhance protein stability, if required; (3) Analytical 'pH gradi-
ent chromatography' for evaluation of the operational pH window; and (4) 'salt stability -
long-term' in the operational pH window determined. Eciency and straightforwardness
of the strategy were shown in a case study on capturing the human -Galactosidase A
enzyme. Following the above procedure, the enzyme was found to be salt-unstable. The
applied strategy allowed for a quick establishment of a dedicated capture step at low salt
concentrations under stable conditions by well-chosen prior screening experiments. In
this setup a purication factor of 13.2, a concentration factor of 4 and an overall yield of
84.3% were achieved.
Keywords: Ion-exchange Chromatography, High-throughput Screening, Hybrid Ap-
proach, Salt-intolerance, -Galactosidase A
1 Introduction
Chromatographic procedures are commonly used to capture biological products from com-
plex mixtures. The critical process parameters determining purity and yield are among
others the pH, salt type and salt concentration used during binding, wash and elution
procedures. Ion-exchange chromatography has become the method of choice for capture
steps due to the rather mild process conditions and high binding capacities. However,
even moderate concentrations of salts being low in chaotropic or cosmotropic nature might
aect protein integrity as was reported in a variety of studies on therapeutically relevant
proteins. The granulocyte colony-stimulating factor was found to form aggregates in the
presence of 150 mM sodium chloride under physiological conditions in phosphate-buered
saline [1, 2]. Analog aggregation behavior was observed for the recombinant human tis-
sue factor pathway inhibitor [3]. A slight increase in sodium chloride concentration from
0.04 mM to 0.11 mM induces major insulin brillation under acidic conditions [4]. RNAse
A was found to be destabilized by moderate sodium chloride concentrations of 250 and
500 mM [5]. Lysozyme also showed a strong decrease in solubility at salt concentrations
below 0.5 M [6].
A very simple approach to enhancing separation eciency of IEX chromatography is the
initial determination of an operational pH window exploiting the charge-pH dependency
of product and contaminants. In a heuristic approach, the binding pH in ion-exchange
chromatography is chosen to be  0.5 to 1 pH units above or below the isoelectric point
(pI) of the product [7]. Those pI values from literature are either calculated in silico
based on molecular modeling or determined experimentally using isoelectric focusing.
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Figure 1: Schematic illustration of the systematic strategy for the purication of salt-intolerant proteins
in ion-exchange chromatography. A: Sequential order of screenings for an optimized IEX chromatogra-
phy process. B: pH gradient chromatography for determination of the product's elution pH. C: IEX
chromatography - pH elution mode with two dierent elution setups of a step (a) or 5 CV gradient (b).
Such values are, however, mostly not identical to the actual product elution pH on a
specic column. Charge distributions and charge clusters on protein surfaces may lead
to binding to the adsorber even at a molecular net charge of zero [8]. Another factor to
be considered is the interference with the resin backbone, where non-electrostatic forces,
such as hydrophobic interactions, come into play [9]. Especially proteins with a neutral pI
(pI 6 to 8) tend to elute experimentally at much higher pH values than expected [10, 11].
Also posttranslational modications like glycosylation patterns were shown to aect the
elution pH of proteins [12].
A deterministic approach to evaluating an operational pH window applies pH gradient
chromatography as an elegant analytical tool in IEX process development. Instead of
relying on pI values from literature, the elution pH values of products and contaminants
are determined experimentally on a specic column [10]. The salt gradient purication
can then be designed for a pH value of  0.5 apart from the experimental elution pH.
Previously, pH gradients for the determination of the pH operational window in IEX
chromatography were used in the purication of a monoclonal antibody from a cell cul-
ture supernatant on an AEX and CEX column [13]. Similar approaches were applied for
separating Nucleolin from an Sf9 insect cell extract by AEX and CEX chromatography
[14] and the anthrax-protective gene (PA) from an E. coli cell lysate by AEX chromatog-
raphy [15].
However, protein stability and use of additives under typical process conditions have not
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been considered so far. In fact, colloidal and conformational stability problems, namely,
aggregation and unfolding of proteins, will lead to product losses [16]. A pH close to the
isoelectric point of a protein might lead to aggregation due to a reduction of repulsive
intermolecular forces [17]. In contrast to this, a pH value far from the isoelectric point
leads to identical intramolecular charges [17]. This can induce an unfolding of proteins.
Another factor to be considered is the amount and type of salt, as discussed above.
So far, protein stability and additive screenings have mostly been applied for protein re-
folding and crystallization studies. Lysozyme and carbonic anhydrase were stabilized by
addition of cyclodextrins and surfactants [18]. The native state of -Lactamase was main-
tained by adding sucrose to the buer. Other examples of additives are co-factors, amino
acids (e.g. lysine, proline), several sugars, alcohols (e.g. glycerol), and other detergents
like CHAPS [19]. Reducing agents, such as DTT in low concentrations, were applied
as well [20]. Lysozyme is shown to be stabilized by low-molecular-weight polyethylene
glycols (PEGs), detergents, such as Tween 20, and dierent sugar molecules like sorbitol
and sucrose [6]. For this reason, an integral strategy for optimizing an IEX capture step
combining product stability and operational parameters over a wide pH range needs to
be considered. In the following chapters the term 'stability' refers to the conservation of
enzymatic activity.
A systematic strategy for the purication of salt-intolerant proteins in IEX chromatogra-
phy will be introduced in this paper. The strategy is illustrated in Fig. 1A and consists
of four consecutive stages, including screenings for short- and long-term pH stability, salt
tolerance, additives, and optimal pH for a pH-based IEX procedure: In a rst stage (1)
'pH stability - short-term' the general pH stability of the product/ feed stream is evalu-
ated. Conditions of instant denaturation or irreversible aggregation can be excluded in
the further process development. Product exposure times to a certain chemical environ-
ment can, however, be in the range of several minutes to hours. The identied pH region
of stage 1 is further evaluated in a second stage (2) analyzing product 'pH stability - long-
term'. If the product is found to be unstable at this point, an additive screening follows.
During this stage, the procedures of stage 2 'pH stability - long-term' are repeated with
dierent excipients to nd out whether the product can be kept in a native state for a
predened period time. In a third stage (3) the crude feedstock is analyzed by 'pH gradi-
ent chromatography' to identify the operational pH window for IEX chromatography. At
this point, the mode of IEX chromatography needs to be chosen. In order to dene the
optimal elution mode, screenings to determine (4) 'salt stability - long-term' in the oper-
ational pH window determined earlier are used to test the eect of product exposure to
dierent concentrations of salt. If the protein is found to remain in a native state during
salt exposure, traditional (5a) 'IEX chromatography - salt elution mode' can follow. For
salt-unstable products, a low-salt purication process based on product elution by pH
shift 'IEX chromatography - pH elution mode' (5b) is carried out. Such elution setups are
commonly used in anity chromatography [21, 22]. In several cases IEX chromatography
applying pH shifts for elution were used for separating protein isoforms (e.g. PEGylated
Lysozyme, human transferrin) or chemically similar variants (e.g. deaminated protein
variants) or as an intermediate purication step of D-amino-acid oxidase from Candida
guilliermondii [23, 24, 25, 26].
This case study focuses on the use of the systematic strategy proposed for ion-exchange
chromatography for capturing human -Galactosidase A from Pichia pastoris. The en-
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zyme consists of two 50 kDa subunits and is naturally located in human cellular lysosomes
[27] and is involved in the cellular detoxication mechanism by metabolizing harmful
glycolipids. The absence of -Galactosidase A inside the human body leads to an accu-
mulation of glycolipids and major cell damage (Fabry Disease).
2 Materials & Methods
2.1 Materials
Sample conditioning was performed using PD-10 desalting columns (bed volume 8.3 mL)
packed with Sephadex RG-25 Medium resin (GE Healthcare Life Sciences, Sweden). Frac-
tionations were carried out in 2 mL 96-well square deep well plates (VWR, Germany). The
enzyme assay was performed in 96-well at-bottom polypropylene microplates (Greiner
Bio-One, Germany). Absorption measurements were carried out in 96-well at-bottom
UV-Star Rmicroplates (Greiner Bio-One, Germany). For chromatography runs, Media-
Scout RMiniChrom R5-50 columns (Atoll, Germany) pre-packed with 1 mL of the fol-
lowing resins were purchased: Source 30 S, Source 30 Q (GE Healthcare Life Sciences,
Sweden).
The buer system used, allowing for the generation of highly linear pH gradients, fol-
lows a description by Kroener et al. [11]. For cation-exchange, the buer system uses
the following components: 10 mM sodium chloride, 11 mM MES, 9.9 mM formic acid
and 13 mM acetic acid (Merck, Germany), 8.7 mM MOPSO, 9.9 mM HEPPSO, 4.6 mM
TAPS, 9.4 mM CHES and 15.6 mM CAPS (AppliChem, Germany). The anion-exchange
buer system is composed of the following components: 7.7 mM hydroxylamine, 9.8 mM
methylamine, 6.99 mM 1,2-ethane-diamine, 13.47 mM 1,4-dimethylpiperazine (Merck,
Germany), 5.8 mM Bis-Tris (Molekula, UK), and 6.4 mM 1-methylpiperazine (Sigma-
Aldrich, USA). The pH of the buers was adjusted by titration using hydrochloric acid
or sodium hydroxide (Merck, Germany), respectively. For the adapted 4-nitrophenole
assay, the substrate 4-nitrophenyl -D-galactopyranoside (4-NPG) and the colorimetric
product 4-nitrophenol (4-NP) were purchased from Sigma-Aldrich, USA. As a reaction
medium, a 100 mM acetate buer at pH 5 was prepared from acetic acid (Merck, Ger-
many). For termination of the enzyme reaction, disodium carbonate (Merck, Germany)
was applied. A supernatant from a P. pastoris fermentation (strain NRRLY - 11430),
during which the enzyme human -Galactosidase A is produced extracellularly, as well
as puried human -Galactosidase A standard were obtained from BioIngenium (Spain).
2.2 Instrumentation & Software
For pH adjustment of all buers, an HI-3220 pH meter (Hanna Instruments, USA) was
used. The instrument was calibrated using high-precision standards from Hanna In-
struments (USA). For the enzyme assay, an MUR 13 thermo-shaker with additional lid
heating (HLC BioTech, Germany) was used. For absorption measurements, an Innite
M200 Reader (Tecan, Germany) was applied and operated with I-control 1.9 (Tecan,
Germany). The 'pH gradient chromatography' and 'IEX chromatography - pH elution
mode' were carried out in an AKTATM purier system operated with Unicorn 5.2 (GE
Healthcare Life Sciences, Sweden). The system was equipped with a pump P-900, mixer
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M-925, UV detector UV 900, motor valve INV-907, pH and conductivity monitoring
pH/C-900, and a fraction collector Frac-950 unit. Data processing and creation of gures
were performed in Matlab RR2011a (MathWorks, USA).
2.3 Strategic Process Development
2.3.1 Adapted 4-Nitrophenole Assay
A necessary prerequisite for the application of the proposed systematic strategy to the
case study was a pH-insensitive assay determining product concentration or activity.
I. Adapted Assay Procedure
For the determination of product titers, a 4-NPG enzyme activity assay was adapted.
The basic principles presented by Rezende et al. [28] and Marin et al. [29] were modied
and combined. The adjusted 4-NPG protocol works as follows: 200 L of 2 mM 4-NPG
in 100 mM acetate buer (pH 5) are added to 50 L sample and incubated at 37 C and
400 rpm in a plate shaker with temperature control. The enzyme reaction is stopped by
addition of 25 L of a 1 M sodium carbonate solution. The concentration of accumulated
4-NP is determined in a plate reader by 405 nm absorption measurements.
II. Assay Validation
As fractions collected throughout the pH gradient intrinsically exhibit a large variation
of the pH value, special emphasis was put on evaluating the sensitivity of the assay to pH
changes of the sample. The enzymatic activity of -Galactosidase A is optimal in the pH
range from about 4.5 to 5 [30, 31, 32]. In order to test whether the buering strength of
the receiving buering system - 200 l of 100 mM acetate buer at pH 5 - is sucient to
buer samples, the following procedure was applied in triplicate measurements: 2.5 mL
of a sample from the P. pastoris supernatant containing -Galactosidase A were condi-
tioned by buer exchange in a PD-10 desalting column into 100 mM acetate buer at
pH 5. By mixing 100 L of the conditioned sample and 100 L of 4 mM 4-NPG solution,
a nal 2 mM substrate concentration was reached. By adding 50 L of pH gradient buer
in a pH range of 3 to 11 to this basic mixture, a potentially observed decrease in activity
can be correlated directly to a strong pH uctuation in the reaction mixture.
Next to operating at the optimal pH for the enzyme reaction, care needs to be taken in
the pH-dependent readout of the colorimetric reaction. It was pointed out by Werner
2001 [33] that the absorption coecient of the cleaved colorimetric 4-NP is strongly pH-
dependent under acidic and neutral conditions. Hence, terminating the enzyme reaction
by adding 1 M sodium carbonate solution is used to shift the pH to basic conditions
where 4-NP shows no pH dependence in absorption at 405 nm. 25 L of 1 M sodium
carbonate solution were added and the absorbance was determined at 405 nm. The
405 nm signals obtained were then correlated to the eective enzyme activity by deter-
mination of released 4-NP per reaction time. For this purpose, a linear calibration of 1
to 25 g/mL 4-NP in AEX buer, pH 11, was performed, leading to a linear regression
4 NP of 0.0726 AU/(g 4-NP/mL). The molar enzyme activity Act [mol 4-NP/mL/h]
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of samples was then calculated as shown in Eq. (1):
Act =
(E405;sample   E405;blank)  5:5
t 4 NP M4 NP (1)
With E405 being the extinction of the sample/ blank measured at 405 nm [AU], 5.5
being the dilution factor of the assay, t denoting the assay duration [h], 4 NP denoting
the slope of the calibration [AU/(g 4-NP/mL)], and M4 NP being the molar mass of
4-nitrophenol (139.11 g/mol).
2.3.2 Screening Procedure
The screening methods applied as shown in Fig. 1A are described in detail in the following
chapter.
I. pH Stability - Short-term
Short-term product stability was dened to be the stability of -Galactosidase A during
a 5-minutes' period under process conditions. To analyze this stability, the following
procedure was applied in triplicate measurements: 5 L of puried -Galactosidase A
standard in water was mixed with 45 L of the respective pH gradient buer in the range
from pH 3 to pH 11 in steps of one pH unit to cover the acidic and basic pH range. Product
activity was measured with the 4-NPG assay. The reduction of enzymatic activity was
dened to be a measure of the quantity of denatured protein during 5 min exposure time.
II. pH Stability - Long-term
Long-term product stability was dened to be the stability of -Galactosidase A during
a 120-min period under process conditions. To analyze this stability, the following pro-
cedure was applied in triplicate measurements: The buer composition of the P. pastoris
supernatants was adjusted to pH 4, 5, 6, 7, and 8 with PD-10 desalting columns. From
each of these stock solutions, samples of 50 L were taken and the 4-NPG assay was
started after 0, 20, 40, and 80 min exposure time, respectively. The assay was stopped
after 120 min by adding 1 M sodium carbonate. To counteract potential pH instability
of the product, an additive screening was carried out after the pH stability screenings.
The experimental setup was identical to that of the 'pH stability - long-term' process,
with additives being added to the respective pH gradient buers. Here, 100 mM sodium
chloride and 0.02% Tween 20 were chosen.
III. pH Gradient Chromatography
pH gradient chromatography was performed in an AKTATM purier system using Media-
Scout RMiniChrom R5-50 columns (CV 1 mL) packed with Source 30 S/ Q resin. The
pH values - pHgradient;start and pHgradient;end - dening the pH gradient were determined
by the 'pH stability - long-term' experiments described above. The buer composition
of the P. pastoris supernatant was consequently adjusted to pH 8 for AEX and pH 4
for CEX chromatography in PD-10 desalting columns. A load of 500 L sample was
applied and the volumetric ow rate was set to 1 mL/min. The integrated pH electrode
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was 2-point calibrated for the start and end conditions of the pH gradient. The general
chromatographic procedure is shown in Fig. 1B. For CEX experiments, the pH gradient
was increased from pH 4 to 8. For AEX experiments, the pH was decreased from pH 8
to 4 (buer species and concentrations are described above). Initial equilibration was
performed with 5 CV of the respective binding buer. 10 CV of binding buer were ap-
plied after sample application in the wash step. Subsequently, a 20 CV pH gradient was
applied to reach the nal pH of the respective gradient. This pH was then kept constant
for another 3 CV. Finally, regeneration was performed with a 4 CV 1 M sodium chloride
step applied at the end of the chromatographic procedure. Additionally, blank runs were
conducted to calculate buer-independent UV signals. Throughout the chromatography
run, 500 L fractions were taken for product-specic analysis. 50 L of each fraction
were evaluated using the adapted 4-NPG assay.
The operational pH window for product elution was dened by a minimum of 10% en-
zyme activity found in the respective fractions when compared to the maximum enzyme
activity found (see Fig. 1B). The framing pH values are referred to as pHelution;start and
pHelution;end.
IV. Salt Stability - Long-term
The P. pastoris supernatant was adjusted to pHelution;start and the respective buer system
using PD-10 desalting columns. For the CEX setup, pH 4.3 and for the AEX setup, pH 7.5
was selected based on the criteria determined above. The conditioned samples were then
mixed (dilution factor 2) with 2-fold concentrated salt solutions of the respective buers,
leading to nal sodium chloride concentrations of 0, 50, 100, 200, 300, and 500 mM. The
4-NPG assay was started after 0, 20, 40, and 80 min exposure time and stopped after
120 min by adding 1 M sodium carbonate.
V. IEX Chromatography
As human -Galactosidase A was found to be salt-unstable, a processing mode applying
a pH shift was used. The P. pastoris samples were conditioned to pHgradient;start (compare
Fig. 1C) using the respective buer components of the analytical pH gradients. All exper-
iments were conducted in an AKTATM purier system using MediaScout RMiniChrom R5-
50 columns packed with Source 30 S/ Q resin. A load of 1000 L sample was applied
and the volumetric ow rate was set to 1 mL/min. Spectroscopic analysis was conducted
using the 280 nm signal for total protein and the 254 nm signal for nucleic acids. The
chromatographic procedure was conducted as follows (see Fig. 1C): The IEX column was
equilibrated with 5 CV of binding buer, followed by sample application and wash with
another 5 CV of binding buer. A second wash procedure for 5 CV was run by a step-
wise pH shift to pHelution;start, to elute contaminants close to the product's elution pH.
Product elution within the operational pH window was then performed in two dierent
setups for both the AEX and CEX chromatography columns: Step elution and gradient
elution over 5 CV. Elution was followed by a 5 CV pHelution;end wash and a 4 CV 1 M
NaCl high-salt regeneration step. Analogously to the pH gradient screening experiments,
blank runs were conducted to calculate the buer-independent UV signals.
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2.3.3 Analysis of Chromatographic Procedures
Throughout the 'IEX chromatography - pH elution mode' run, fractions of 1000 L were
taken for product-specic analytics.
I. Mass Balances
To investigate denaturation, protein remaining bound to the adsorber or formation of
aggregates inside the chromatography column, recovery rates were calculated. The re-
covery of total protein RTP was performed by dividing the integrated blanked 280 nm
signal from the entire chromatography run A280;run (sample injection up to the nal salt
step) by the integrated signal of a sample injected into the AKTATM system A280;sample -
Eq. (2). For this purpose, the signals have to be in a linear measurement range. The inte-
gration process was performed in Matlab R2011a (MathWorks, USA) using a trapezoidal
numerical integration.
RTP =
R
(A280;run)R
(A280;sample)
(2)
The recovery of activity RA was calculated considering the enzymatic activity of -
Galactosidase A - Eq. (3). The added activities Actfraction of all fractions (sample injection
up to the nal salt step) were divided by the total activity of the applied sample Actsample
taking the sample volumes Vfraction and Vsample into account.
RA =
P
(Actfraction  Vfraction)P
(Actsample  Vsample) (3)
II. Overall Product Yield
The product yields Y were calculated as the ratio between eluted enzyme activityActelution
and applied sample Actsample taking the sample volumes Velution and Vsample into account
- Eq. (4).
Y =
P
(Actelution  Velution)P
(Actsample  Vsample) (4)
III. Purication Factor
The product purity was calculated using specic activities as dened by Eq. (5). The
purication factor PF was dened to be the ratio between the specic activity of the
pooled elution fraction and the applied sample.
PF =
P
(Actelution)=
R
(A280;elution)P
(Actsample)=
R
(A280;sample)
(5)
IV. Qualitative Nucleic Acid Factor
As a third criterion, the qualitative nucleic acid factor NF was determined by the ratio
of the 254 nm signal and the 280 nm signal. In contrast to measurements at 260 nm,
DNA and RNA show almost equivalent absorption at these wavelengths, whereas proteins
exhibit a lower absorption at 254 nm and, hence, can be distinguished better from nucleic
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acids [34]. The factor is dened to be the ratio between the integrated 254 nm signal
A254 and the 280 nm signal A280 - Eq. (6).
NF =
R
(A254)R
(A280)
(6)
By comparing the NF values of the applied sample and the elution fractions, the quali-
tative reduction of nucleic acid levels was determined.
V. Concentration Factor
For capturing unit operations, not only the yield, purity, and nucleic acid level reduction
are important, but also the achieved product concentration. The product concentration
factor CF was determined to be the ratio between the pooled elution activity Actpool and
the applied sample Actsample - Eq. (7).
CF =
Actpool
Actsample
(7)
2.3.4 Process Simplication
I. Reduction of Buer Species
Given the optimal system parameters determined according to the procedure described
above, the complex mixture of buer substances was simplied to a two-component sys-
tem. The buer components were chosen in a buering range of the operational pH
window dened by the values of pHelution;start and pHelution;end (see Fig. 1C). For the
case study, the binding buer was set to 10 mM acetate (pKa 4.76) at pH 4.8. The
elution buer (pH 6) consisted of 10 mM MES (pKa 6.10). Sample binding occured at
pHelution;start, thus eliminating the rst pH shift depicted in Fig. 1C.
II. Product Capture at the Capacity Limit
Product capture with a simplied two-buer component system was performed at the
column capacity limit, which was determined to be a load of 20 CV at 10% of product
breakthrough. 20 mL of sample were applied and the chromatography procedure was
evaluated as described in the analysis of the chromatographic procedures section.
3 Results & Discussion
3.1 Adapted 4-nitrophenole Assay
The successful adaptation of the 4-NPG reaction towards a robust, reproducible, and
widely pH-insensitive assay for -Galactosidase A was a necessary prerequisite for the
proposed development strategy shown in Fig. 1. To validate the suitability of the chosen
assay, several aspects relating to pH insensitivity during reaction and readout as well
as reaction kinetics were evaluated. Fig. 2 illustrates the enzyme activities obtained by
assaying samples containing identical enzyme concentrations at dierent pH values. The
3 PUBLICATIONS & MANUSCRIPTS
116
3 4 5 6 7 8 9 10 110
20
40
60
80
100
pH
R
at
e
 
o
f m
a
x.
 
ac
tiv
ity
 
[%
]
 
 
CEX
AEXR
a
te
 
o
f m
ax
.
 
ac
tiv
ity
 
[%
]
CEX buffer
AEX buffer










Figure 2: Examination of the adapted 4-NPG assay's robustness at dierent pH levels. Evaluation
of the reaction buer's buering capacity for the optimal conversion pH of -Gal A. CEX and AEX
buer samples were assayed in the range from pH 3 to pH 11 with a constant concentration of enzyme.
Activities are scaled to the maximal activity determined in the test set. The error bars indicate the data
variability of the triplicate measurements.
highest 4-NPG conversion rates were measured for samples in a pH range from pH 3 to
pH 5, where the pH shift to the conditions of the reaction buer is negligible. In general,
an increase with sample pH led to a decrease of measured enzyme activity. For the AEX
buer system, an overall decrease in enzyme activity of 26.1% could be observed over the
complete pH range from pH 3 to pH 11. In the pH region of pH 3 to pH 8, in which most
of the stability and screening experiments were conducted, the decrease was about 19.3%.
The use of the CEX buer system led to a decrease in enzyme activity of 28.8% in the
overall range from pH 3 to pH 11. In the region of pH 3 to pH 8 the activity dierence
was determined to be 15.6%. In summary, the chosen reaction buer proved to be a good
compromise between sucient buer capacity and a suciently low salt concentration to
prevent salt-induced loss of enzyme activity.
The methodology can be used analogously for proteins that can be assayed specically,
including hormones, enzymes, etc. For most other proteins, antibody-based procedures
could be applied (e.g. ELISA) for product determination. Another fast method for
analyzing proteins is capillary gel electrophoresis using e.g. the Caliper Lab Chip GX
II system. Here, samples can be analyzed within approximately 30 - 40 s of processing
time.
Regardless of the subsequent analytics, all time-dependent screening steps, such as the
'pH stability - short-term' should have a similar setup: After the pre-dened exposure
time, a stabilizing buering solution (analogously to the enzyme reaction buer) should
be added to 'stop' the exposure to pH, salt, etc. The remaining soluble and active fraction
can then be analyzed.
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Figure 3: Product pH stability - short and long term in AEX and CEX buers. Short term experiments
were performed in the range from pH 3 to pH 11, long term experiments in the range from pH 4 to pH 8
with product exposure times of 0 to 80 min before stabilization by starting the 4-NPG assay. Activities
are scaled to the maximal activity determined in each test set. A: Product pH stability - short term in
AEX and CEX buers. The error bars indicate the data variability of the triplicate measurements. B:
Product pH stability - long term for the CEX buer system without additional excipients. C: Product pH
stability - long term for the AEX buer system without additional excipients. D: Product pH stability
- long term for the AEX buer system with 100 mM sodium chloride added. E: Product pH stability -
long term for the AEX buer system with 0.02% Tween 20 detergent added.
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3.2 Screening Procedure
I. pH Stability - Short-term
During the rst stage, the 'pH stability - short-term' of the given target molecule was
investigated to identify potential pH limits of instant enzyme denaturation. pH values of 3
to 11 were investigated for AEX and CEX buer systems. Following 5 min pH exposure to
puried -Galactosidase A standard, enzyme activities were determined using the assay.
Fig. 3A shows the activities Act obtained scaled to the maximal activity determined in
each test set Actmax. Both the AEX and CEX buer systems show a similar trend: The
maximal enzyme activity could be found at pH 6. A stable process window regarding
enzyme activity was found in the range from pH 4 to pH 8. In this region, maximal
variances of 12.8% (AEX buers) and 10.1% (CEX buers) were detected. Buer systems
of pH values higher than 8 led to a signicant decrease in converted 4-NPG. 59.1%
(AEX) and 64.1% (CEX) of enzyme activity were already lost at pH 3. Similar results
were observed for the pH 9 samples. Here, a loss in enzyme activity of 37.2% (AEX)
and 42.0% (CEX) was found. At pH 11 (the most basic pH investigated), a maximal
degradation of the product was detected, with decreases in activity of 82.4% (AEX) and
93.4% (CEX). Consequently, the appropriate region for all further experiments was xed
to an operational pH window ranging from pH 4 to pH 8.
II. pH Stability - Long-term
During purication processes, product streams are exposed to chemical environments
much longer than 5 min. Fig. 3B - E shows relative enzyme activities at pH levels
between pH 4 to pH 8 and exposure times of 0 to 80 min. All activities are scaled to
the activity maximum determined in the respective setup. For the CEX buer system
(Fig. 3B), a constant activity ratio of 0.965 was achieved at pH 5 to pH 7, even at
80 min exposure time. Samples exposed to pH 4 and pH 8 showed constant activity
ratios 0.871 at exposure times of up to 20 min. Even at times of up to 80 min, the
activities were constantly above 68.3%. For the AEX buer systems (Fig. 3C), enzyme
stability was achieved only at 5 min exposure time (as shown in 'pH stability - short-
term' ) and at pH 5 to pH 6. At pH 8, an exposure time of 20 min already caused a loss
of activity of 71.5%. The CEX buer systems were found to retain the enzyme activity,
while AEX buers led to a strong enzyme inactivation outside an operational pH window
from pH 5 to pH 6.
For the AEX buer system, an additive screening was carried out to stabilize human
-Galactosidase A. As a mild increase in salt concentration is reported to lead to a
stabilizing eect by salting-in for some proteins [17], a rst screening was conducted by
adding 100 mM of sodium chloride to the AEX buers (Fig. 3D). The results, however,
indicated no improvements in enzymatic stability. A second screening was performed
by adding the detergent Tween 20 to the AEX buer system. In this setup a constant
activity of more than 91.1% was reached at pH 4 to pH 7 within the period investigated
(Fig. 3E). Exposure to pH 8 revealed activities of more than 74.8% at exposure times of up
to 20 min. Up to 80 min of exposure, the activities were constantly above 63.8%. These
results obtained for the AEX buer system containing Tween 20 were then comparable
to the enzymatic stability obtained during 'pH stability - long-term' experiments for the
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Figure 4: pH gradient chromatography of the P. pastoris supernatant in duplicates. UV 280 nm signals
and pH values are plotted against column volumes. The corresponding fraction enzyme activities are
shown in a bar diagram below. A: CEX pH gradient chromatography on a Source 30 S column (pH 4 to
8) B: AEX pH gradient chromatography on a CEX Source 30 Q column (pH 8 to 4).
CEX buer system. Tween 20 prevented aggregation of active product molecules, which
must have occurred in the presence of AEX buer substances over time. Hence, the
additive screening was capable of stabilizing the enzyme and nding a suitable chemical
environment for product purication. In general, suited additives can be found when
looking at the nal formulation buer or the cultivation conditions of the investigated
product.
III. pH Gradient Chromatography
Analytical 'pH gradient chromatography' was used for comparing contaminant and prod-
uct elution proles of the complex P. pastoris feedstock. The 280 nm signals and the
enzyme activities of the assayed fractions for both the CEX and AEX (including Tween 20
as a stabilizer) pH gradient runs are shown in Fig. 4. Taking the respective fraction sizes
into account, activities are given in nmol 4-NP/h in contrast to the units of nmol 4-
NP/mL/h used above.
During the CEX 'pH gradient chromatography' (Fig. 4A), a owthrough of negatively
charged material is seen during the rst 5 CV. When determining the enzymatic ac-
tivity in fractions covering CV1 to CV10, a total -Galactosidase A activity of 51.9 
15.5 nmol 4-NP/h was found. This indicates that the dynamic binding capacity was
reached. At CV13, the pH gradient was started, leading to the elution of bound species.
The maximum elution peak with an UV 280 nm value of 9.5 mAU was found at CV19
and pH 5.3. After this peak, the 280 nm signal decreased until the end of the pH gradient
at CV35 and pH 8. Enzymatic activity was found in the region from CV16 to CV26 and
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Figure 5: Product salt stability - long-term in AEX and CEX buers in the sodium chloride concen-
tration range of 0 to 500 mM. Product exposure times of 0 to 80 min were evaluated before starting the
4-NPG assay. Activities are scaled to the maximal activity determined in each test set. A: CEX buer
system at a pH of 4.3 without additional excipients. B: AEX buer system at a pH of 7.5 with 0.02%
Tween 20 detergent added.
at pH values ranging from pH 4.6 to pH 6.7. A maximum of 39.2  2.2 nmol 4-NP/h
was reached at CV19:5 and pH 5.4. This results in an operational pH window for CEX
(declared as 10% of the activity peak maximum) from pH 4.8 to pH 6. During the 1 M
NaCl high-salt wash from CV35 to CV39, a nal 280 nm peak of 16.6 mAU was observed.
Evaluation of the salt fraction showed no major residual enzyme activity.
During the AEX 'pH gradient chromatography' (Fig. 4B), owthrough of positively char-
ged material is seen during the rst 5 CV. When determining the enzymatic activity in
fractions from CV1 to CV10, a total -Galactosidase A activity of 7.8  1.2 nmol 4-NP/h
was observed. In this setup, less enzyme was detected in the owthrough compared to the
CEX setup. Although the pH gradient started at CV13, the 280 nm signal only started
to increase at CV15 and pH 7.5. Beginning at CV15 and pH 7.5, two local maxima at
CV28 and pH 4.9 of 17.3 mAU and at CV30 and pH 4.5 of 7.0 mAU were reached. Enzy-
matic activity was found in the region from CV16 to CV30 and at pH values ranging from
pH 7.3 to pH 4.5. the maximum being 19.1  1.6 nmol 4-NP/h at CV19:5 and pH 6.7.
This results in an operational pH window for AEX (declared as 10% of the activity peak
maximum) from pH 7 to pH 4.7. During the 1 M NaCl high-salt wash from CV35 to
CV39, a nal 280 nm peak of 93.0 mAU was observed. Evaluation of the salt fraction
showed a residual summed up enzyme activity of 51.6  5.7 nmol 4-NP/h.
In summary, the operational pH window for CEX was determined from pHelution;start = 4.8
to pHelution;end = 6 and for AEX from pHelution;start = 7 to pHelution;end = 4.7. During both
chromatographic procedures using an analytical pH gradient, a broad range of product
elution pH values was obtained. This can most probably be explained by glycosylation
and charge variants, as P. pastoris tends to hyperglycosylate products. Posttranslational
modications of proteins are reported to inuence the elution pH of proteins [12].
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IV. Salt Stability - Long-term
The traditional 'IEX chromatography - salt elution mode' requires product stability in
the presence of salt at the chosen pH value. The results of the 'salt stability - long-term'
experiments with exposure times of 0 to 80 min are shown in Fig. 5. Operational pH
values of 7.5 (AEX) and 4.3 (CEX) were chosen and the salt strength was varied between
0 to 500 mM of sodium chloride. All activities are scaled to the activity maximum
determined in the respective setup. After 20 min, enzymatic activity decreased due to
enzyme denaturation. This eect increased with increasing salt strength and interaction
time. When using the CEX setup (Fig. 5A), an 80 min product exposure to 50 mM
sodium chloride already led to a loss in activity of about 32.3%. In contrast to this, the
AEX setup (Fig. 5B) was much less inuenced by lower added salt concentrations of up
to 200 mM sodium chloride over the entire time range. The maximal product inactivation
occurred at the highest salt strength of 500 mM tested and an interaction time of 80 min.
In this setup, 50.3% (CEX) and 45.2% (AEX) of the product were lost.
V. IEX Chromatography - pH Elution Mode
Based on the results of the 'salt stability - long-term' experiments, a purication scheme
using a salt gradient was no option for the purication of human -Galactosidase A. As
a consequence, a low-salt purication alternative by 'IEX chromatography - pH elution
mode' was applied. Fig. 6A - D shows the results of the pH step and pH gradient elution
in the determined operational pH windows (see above). The owthrough fractions and
the high-salt wash fractions will not be discussed any further.
In the CEX setup (Fig. 6A + B), binding of the product occured at pHgradient;start pH 4.
Following the binding step, the pH was shifted to pH 4.8 (pHelution;start). During the
stepwise pH shift, the 280 nm signal showed a well-dened peak at CV7 to CV8 with an
absorption maximum of 35 to 37 mAU. Evaluation of the fractions collected by the 4-NPG
assay revealed minor amounts of product. Thus, contaminants close to elution pH of the
product were removed. In the next step, elution of the product was performed either by
a pH shift in a step (Fig. 6A) or by a 5 CV gradient (Fig. 6B) to pH 6 (pHelution;end).
During the pH shift, the 280 nm signal increased in both setups, resulting in a peak
maximum of 33 mAU at CV11:5 for the step pH shift and a lower 10 mAU peak maximum
at CV14:5 for the 5 CV gradient pH shift. The decreased 280 nm maximum at a delayed
process time in the 5 CV gradient pH shift setup can be explained by the longer product
elution due to an extended time for pH change. The elution fractions were chosen to be
CV11 to CV14 with a total activity of 285.2 pm 31.9 nmol 4-NP/h for the step and to be
CV13 to CV18 with a total activity of 332.4 pm 20.7 nmol 4-NP/h for the 5 CV gradient.
The binding of the product in the AEX setup (Fig. 6C + D) was performed at pH 8
(pHgradient;start). A stepwise shift to pH 7 (pHelution;start) led to a 280 nm peak maximum
of 16 to 22 mAU at CV7 to CV8. No considerable amounts of product were detected by the
4-NPG assay and only close contaminants were removed. The second pH shift to pH 4.7
(pHelution;end) for product elution resulted in 280 nm double peak maxima of 47 & 50 mAU
at CV13 & CV14 for the step pH shift and lower 25 & 25 mAU peak maxima at CV17 &
CV19 for the 5 CV gradient pH shift. The lower 280 nm maxima at a delayed process
time in the gradient pH shift setup were discussed previously. The elution fractions were
chosen to be CV11 to CV14 with a total activity of 244.0 pm 13.4 nmol 4-NP/h for the
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Figure 6: IEX chromatography - pH elution mode runs for the P. pastoris supernatant on CEX Source
30 S/ Q columns in duplicates. UV 280/ 254 nm signals and pH values are plotted against column
volumes. The corresponding fraction enzyme activities are shown in a bar diagram below. A: Step pH
shift for product elution (CEX). B: 5 CV gradient pH shift for product elution (CEX). C: Step pH shift
for product elution (AEX). D: 5 CV gradient pH shift for product elution (AEX).
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Purication mode RA [%] RTP [%] Y [%] PF [-] NF [-]
CEX step 103.9  7.1 94.1  0.3 83.9  10.6 10.9  1.6 0.8  0.0
CEX gradient 107.5  7.2 89.7  1.2 89.9  5.5 12.6  1.4 0.8  0.0
AEX step 98.0  1.1 90.6  3.7 67.8  0.8 4.4  0.0 1.3  0.2
AEX gradient 100.8  0.6 6.9  4.9 65.3  1.1 4.9  0.1 1.5  0.0
Table 1: Recovery rates and quality factors for the dierent setups in the product capturing by IEX
chromatography - pH elution mode. RA and RTP denote the recovery of activity and total protein. Y
is the yield of product in the puried elution fractions. PF and NF describe the purication factor and
the qualitative nucleic acid reduction, respectively.
step and to be CV12 to CV18 with a total activity of 249.2 pm 13.5 nmol 4-NP/h for the
5 CV gradient.
3.3 Analysis of Chromatographic Procedures
I. Mass Balances
Mass balances were determined, as was described in the experimental section. The results
are shown in Table 1. For the CEX setups, the recovery of activity RA was found to be
103.9  7.1% and the recovery of total protein RTP was 94.1  0.3% for the step elution.
For the 5 CV gradient, similar results were observed with an RA of 107.5  7.2% and
RTP of 89.7  1.2%. For the AEX setup, the RA was determined to be 98.0  1.1%
and the RTP was 90.6  3.7% for the step elution. The 5 CV gradient again produced
similar results with an RA of 100.8  0.6% and RTP of 86.9  4.9%. This indicates that
for all processes, no signicant product losses were observed. However, minor amounts of
impurities remained in the chromatography column or were degraded and not detected.
II. Evaluation of the Purication Setups
For the evaluation of all purication setups, dierent factors were considered (see exper-
imental section). Yields Y , purication factors PF , and qualitative nucleic acid factors
NF are listed in Table 1. All CEX setups resulted in better yields of 83.9  10.6% for
step elution and 89.9  5.5% for 5 CV gradient elution. The AEX setups produced yields
of about 60 to 70%. A similar trend was found for the purication factors. The CEX
setup resulted in a PF of 10.9  1.6 for the step and 12.6  1.4 for the 5 CV gradient.
For the AEX setup, PF values of 4.4  0.0 and 4.9  0.1 were observed. Hence, they
were smaller by factor of 2 to 3. As regards the PF , gradient elution was found to be
superior to step elution in all experiments. This can be explained by the broadened elu-
tion peak which allows for a more precise and distinct product fractionation. Finally, the
qualitative nucleic acid factor NF was evaluated. Whereas the CEX setup was capable of
reducing nucleic acid levels by about 20%, AEX chromatography resulted in NR values
of above 1. This indicates a qualitative increase in nucleic acid levels. pH dependence
of the buer species or the inuence of Tween 20 can be excluded, as blank runs were
conducted for all experiments. The increase in NR was thus attributed to nucleic acid
fragments attached to the product or co-eluting contaminants. When comparing the pu-
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Figure 7: IEX chromatography - pH elution mode runs for the P. pastoris supernatant at the capacity
limit on a CEX Source 30 S column in duplicates. The complex CEX buer system was simplied to a
two-buer system using acetate (pKa 4.76) at pH 4.8 and MES (pKa 6.10) at pH 6. UV 280/ 254 nm
signals and pH values are plotted against column volumes. The corresponding fraction enzyme activities
are shown in a bar diagram below.
rication performances of the four purication setups investigated (Table 1), the 'IEX
chromatography - pH elution mode' on CEX resins reaches about 20% higher yields as
well as purication factors higher by a factor of 3 than the AEX setups. A qualitative
reduction of nucleic acid levels was achieved by CEX purication only. The best puri-
cation setup for process simplication was found to be the CEX 5 CV gradient elution
from pH 4.8 (pHElution;start) to pH 6 (pHElution;end).
3.4 Process Simplication
The complex mixture of buer substances was reduced to a two-component system using
acetate (pKa 4.76) at pH 4.8 for binding and MES (pKa 6.10) at pH 6 as the elution
buer. The column capacity limit of 10% product breakthrough was determined to be
20 CV of the loaded sample (data not shown). The 280/ 254 nm signals and the enzyme
activities of the assayed fractions of the CEX product capture at the capacity limit are
shown in Fig. 7.
The absorption plateau of 490 mAU from CV1 to CV21 describes the owthrough after
sample injection at pH 4.8 (pHElution;start). The evaluation of the fractions by enzymatic
assay showed a total activity of 835.3  48.8 nmol 4-NP/h. After the wash step for 8 CV
at pH 4.8, the pH was shifted to pH 6 (pHElution;end) using a 5 CV gradient. The 280 nm
signal reached a peak maximum of 350 mAU at CV30. The elution fraction was chosen
to be CV29 to CV33 (10% of the maximum enzyme activity as shown in Fig. 1B) with
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a total activity of 9284.7  421.5 nmol 4-NP/h. During the 1 M NaCl high-salt wash
from CV38 to CV46, a 280 nm peak with a maximum of 2500 mAU was observed. The
evaluation of the fractions by enzymatic assay shows a summed up -Galactosidase A
activity of 456.4  59.3 nmol 4-NP/h. The recovery of activity RA was determined to be
97.7  0.5% and the recovery of total protein RTP was 92.8  3.0%. These results agree
with the previous ndings presented in the product capture by pH shift section. A yield
of 84.3  1.2% and a purication factor of 13.2  0.3 were achieved. This agrees with the
result obtained for the complex buer mixture within the standard deviations (Table 1).
The qualitative nucleic acid factor NF was determined to be 0.9  0.0. As an additional
parameter, the concentration factor CF was calculated (see experimental section) to
be 4.12  0.08, indicating an increase in human -Galactosidase A concentration by
more than a factor of 4 compared to the applied sample. It was shown that a process
simplication is possible. The pH value is a rather on/ o binding mechanism and is
slightly dependent on the buering species only. However, it is important to keep the
total buering capacity constant.
4 Conclusions
It was demonstrated that optimizing an IEX capture step by product stability screen-
ings and deterministic process development is a powerful tool for protein purication. A
systematic strategy for the purication of salt-intolerant proteins in ion-exchange chro-
matography was evaluated in a case study using human -Galactosidase A from P. pas-
toris. The 80 min time frame for the determination of long-term stability can be varied.
The users of this systematic strategy can extend or shorten the exposure times according
to the expected process conditions.
During stages (1) and (2) 'pH stability - short-/ long-term' of the strategy proposed, pH
boundaries of human -Galactosidase A were determined. For the AEX buer system,
an 'additive screening' had to be performed to ensure long-term product stability. For
this purpose the detergent Tween 20 was used. In a deterministic IEX purication pro-
cess design the subsequent 'pH gradient chromatography' (3) resulted in the experimental
elution pH of the product. As the enzyme was found to be salt-unstable at its elution pH
even at NaCl concentrations of 0.1 M during stage (4) 'salt stability - long-term', 'IEX
chromatography - pH elution mode' (5b) was the purication method of choice. Dier-
ent operational modes for pH shift elution were compared, including dierent IEX modes
(CEX vs. AEX) and dierent setups of elution by pH shift (step vs. 5 CV gradient). The
best purication results were obtained in a CEX operational mode with 5 CV gradient
elution. Step elution should be chosen especially for proteins that are known to aggregate
if eluted at the pH value corresponding to their experimental pI. The critical pH value is
then exceeded for a short period of time only.
In a simplied two-buer component process, human -Galactosidase A was puried from
a P. pastoris supernatant based on the results of prior screening experiments. In this
setup a purication factor of 13.2 and an overall yield of 84.3% were achieved, which
agreed very well with the experimental results for the complex buer mixture. The prod-
uct was four times concentrated and the level of nucleic acid content was qualitatively
reduced. The results agreed with the experiments using the complex buer system and
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lower sample volumes. The 'IEX chromatography - pH elution mode' makes IEX pu-
rication processes accessible for salt-unstable products and, hence, for a much broader
spectrum of products.
The combination of protein stability tests and deterministic screenings should now be
extended to cover other purication modes, such as hydrophobic interaction chromatog-
raphy, anity chromatography, and aqueous two-phase systems. This will result in a
toolbox for process development. For upstream and formulation studies, such an ap-
proach may provide valuable information for enhancing the eciency of these processes.
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Abstract
Hydrophobic interaction chromatography (HIC) is one of the most frequently used pu-
rication methods in biopharmaceutical industry. A major drawback of HIC, however,
is the rather low dynamic binding capacity (DBC) obtained when compared to e.g. ion-
exchange chromatography (IEX). The typical purication procedure for HIC includes
binding at neutral pH, independently of the protein's nature and isoelectric point. Most
approaches to process intensication are based on resin and salt screenings.
In this paper a combination of protein solubility data and varying binding pH leads to a
clear enhancement of dynamic binding capacity. This is shown for three proteins of acidic,
neutral, and alkaline isoelectric points. High-throughput solubility screenings as well as
miniaturized and parallelized breakthrough curves on MediaScout RRoboColumns R(Atoll,
Germany) were conducted at pH 3 to pH 10 on a fully automated robotic workstation.
The screening results show a correlation between the DBC and the operational pH, the
protein's isoelectric point and the overall solubility. Also, an inverse relationship of DBC
in HIC and the binding kinetics was observed. By changing the operational pH, the DBC
could be increased up to 30% compared to the standard purication procedure performed
at neutral pH. As structural changes of the protein are reported during HIC processes,
the applied samples and the elution fractions were proven not to be irreversibly unfolded.
Keywords: Hydrophobic Interaction Chromatography, Dynamic Binding Capacity,
Protein Solubility, Binding Kinetics, Multi-variate Data Analysis
1 Introduction
Hydrophobic interaction chromatography (HIC) is a widely applied technique for the in-
termediate purication and polishing of biomolecules in biopharmaceutical industry. The
low dynamic binding capacity compared to e.g. ion-exchange chromatography (IEX) de-
mands for a deeper process understanding and optimization. For IEX, several strategies
for process design were reported [1, 2, 3, 4], whereas HIC process development still relies
on heuristics and rules of thumb. So far, optimization strategies mostly have been based
on the fundamentals of HIC, namely, the salting-out eect of dierent salts and the sto-
ichiometric displacement of water under entropically favored conditions during protein
binding [5, 6]. Considering those two principles, strategic studies mainly focus on screen-
ing to identify suitable resins, salt types, and ideal salt concentrations [7].
In [8, 9] the HIC binding mechanism was described in more detail, including additional
sub-processes determined by microcalorimetric studies:
a. Dehydration/ deionization of the protein and adsorber surface.
b. Van-der-Waals forces between protein and resin.
c. Structural changes of the protein.
d. Rearrangement of excluded water molecules in solution.
Especially the structural changes and rearrangements of the protein during the binding
process is an important factor to be considered. Various studies have shown, that proteins
undergo a partial unfolding during the hydrophobic binding process which can be irre-
versible especially at higher protein concentrations [10, 11]. In [12, 13], distinct elution
peaks were detected which were correlated to the same protein species but of dierent
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conformations. In [14] high protein pore concentrations, as found during the elution step,
were found to stabilize the structure of -lactalbumin. Jones et al. [15] proposed that
changes in selectivity for stable proteins can be explained by orientational rearrangement
on the adsorber surface, whereas unstable proteins like -lactalbumin exhibit structural
changes during binding to the HIC surface. Both aspects of rearrangement and structural
change open up new approaches for HIC optimization strategies. In that context, not
only the type of salt or adsorber should be considered, but also the physical state of the
protein. Related properties include the protein's compressibility, molecular weight and
the solute pH [16].
Although, the pH was identied earlier to be a parameter inuencing HIC [17, 18, 19],
to the best of our knowledge, the dynamic binding capacity as a function of pH and
solubility has never been systematically screened, as was shown for IEX [1, 2, 3]. Still,
the gold standard for HIC is using an operational pH in the neutral pH range of pH 6 to
8. Examples are the purication of the cystic brosis plasmid vector (operational pH 8),
the enrichment of proteins from Haemophilus inuenzae (pH 7), and the separation of
single-, double-stranded, and supercoiled nucleic acids (pH 8) [20, 21, 22]. For antibody
purication, varying pH values were considered, resulting in a modied retention behav-
ior. However, the studies covered a range of pH 6 to 8.5 only [18]. Kramarczyk et al. [23]
introduced a high-throughput strategy for solubility screenings in dependence of pH, salt
type as well as salt concentration and HIC binding experiments for a monoclonal anti-
body. Nevertheless, all subsequent binding experiments were conducted at the solubility
optimum at pH 7, only. A thorough investigation into pH eects as a determining factor
for protein solubility and adsorbent interactions under typical HIC conditions is needed.
In this study, a high-throughput strategy is developed correlating protein solubility and
pH to the dynamic binding capacity (DBC) in HIC. The screening methodology is shown
in Fig. 1. Salt type and concentration are kept constant to exclude inuences of salt
nature and altered isotherm binding eects. High-throughput solubility screenings are
performed at pH 3 to pH 10 for proteins of acidic, neutral, and alkaline isoelectric points.
pH values of instant protein denaturation are excluded from the following breakthrough
curves determined in miniaturized robotic chromatography column experiments. DBCs
as well as binding kinetics are subsequently correlated to the protein's pI and solubility
data. As protein binding is supposed to vary due to reversible structural changes in
the protein, the elution samples of increased DBC need to be investigated for protein
integrity. This is done by principal component analysis (PCA) of native and denatured
protein spectra of selected setups.
2 Materials & Methods
2.1 Materials
2.1.1 Chemicals & Disposables
The following buer substances were used: Citric acid monohydrate (Merck, Germany)
for pH 3 and 4, sodium acetate trihydrate (Fluka BioChemika, Switzerland) for pH 5,
MES monohydrate buer grade (AppliChem, Germany) for pH 6, sodium dihydrogen-
phosphate monohydrate (Merck, Germany) for pH 7, TAPS buer grade (AppliChem,
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Figure 1: Schematic overview of the HIC pH screening methodology. The solubility screenings deter-
mine the feasible pH conditions for the miniaturized column chromatography experiments. Determined
breakthrough curves can then be evaluated in terms of dynamic binding capacities, dened as 10% of
product breakthrough.
Germany) for pH 8, CHES (AppliChem, Germany) for pH 9, and CAPSO (SantaCruz
Biotechnology Inc, USA) for pH 10. All buers were prepared with a buer capacity of
40 mM and an additional sodium sulfate (Fluka BioChemika, Switzerland) concentration
of 1.875 M. The pH of all buers was adjusted using hydrochloric acid or sodium hy-
droxide (Merck, Germany). All buers were ltered using Supor-450 0.45 m membrane
lters (Pall Life Sciences, Mexico).
Three proteins of dierent isoelectric points (acidic, neutral, and alkaline) were inves-
tigated. All protein solutions were ltered using 0.2 m syringe lters with PTFE
membranes (VWR, Germany). Buer exchange and protein concentration steps were
carried out in VivaspinRcentrifugal concentrators (Sartorius, Germany) equipped with
PES membranes and molecular weight cutos of 5 kDa. Lysozyme from chicken egg
white (PDB 1LYZ, HR7-110) was purchased from Hampton Research (USA). A puried
single domain antibody was obtained from the industrial partner (BAC, Netherlands) at
a concentration of 17.18 mg/mL. Glutathione-S-Transferase (GST) with Cherry-TagTM
(Delphi genetics, Belgium) was produced in Escherichia coli SE1. The cultivation, cell
disruption, and purication process was performed according to [24]. Capillary gel elec-
trophoresis (CGE) was performed in a Caliper LabChip RGX II system (Perkin Elmer,
USA) using an HT Protein Express & Pico LabChip Rand an HT protein express reagent
kit (Perkin Elmer, USA). Sample preparation for the CE was conducted in skirted 96-well
twin.tec RPCR plates (Eppendorf, Germany). Lysozyme served as an internal standard of
known concentration. Protein denaturation as a negative control for protein spectra was
accomplished using trichloroacetic acid BioChemica (AppliChem, Germany) combined
with acetone for liquid chromatography (Merck, Germany) and urea (Fluka BioChemika,
Switzerland).
High-throughput robotic precipitation experiments and UV measurements were carried
out in 96-well at-bottom UV-Star Rhalf-area and full-area microplates (Greiner Bio-
One, Germany). The plates were sealed with non-sterile Platemax aluminum sealing
lms (Axygen RScientic, USA). For the high-throughput chromatography experiments,
600 L MediaScout RRoboColumns R(Atoll, Germany) lled with Toyopearl RPhenyl-
650M adsorber (Tosoh Bioscience, Germany) were used. Buers and protein solutions
for the robotic chromatography experiments were prepared in 8-row reservoir plates
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(Axygen RScientic, USA).
2.1.2 Instrumentation & Software
For pH adjustment of all buers, a ve-point calibrated HI-3220 pH meter (Hanna Instru-
ments, USA) equipped with a SenTix R62 pH electrode (Xylem Inc., USA) was used. The
instrument was calibrated using high-precision standards by Hanna Instruments (USA).
Concentration and purity measurements of the protein stock solutions were carried out by
capillary gel electrophoresis (CGE) in a Caliper LabChip RGX II (Perkin Elmer, USA).
For data processing and analysis, the LabChip RGX 3.1 software (PerkinElmer, USA) was
used. A NanoDropTM 2000c UV-Vis spectrophotometer operated with the NanoDropTM
measurement software version 1.4.2 (Thermo Fisher Scientic, USA) served as a fast tool
for the determination of protein concentrations. All isoelectric points were calculated
using GPMAW (Lighthouse Data, Denmark) for the respective amino acid sequence de-
rived from the protein data bank (PDB).
Solubility screenings and robotic chromatography experiments were conducted on a Free-
dom EVO R200 robotic platform operated with the Freedom EVOwareR2.5 software
(Tecan, Germany). The platform is equipped with a liquid handler with eight xed
pipette tips, a robotic moving arm for transportation of plates, a plate stacker module
for storage of plates, a Te-Chrom Bridge for RoboColumns R, and an orbital shaker. Cen-
trifugations were conducted in an integrated Rotanta 46 RSC centrifuge made by Hettich
(Germany). Absorption measurements were performed in an integrated innite M200 Pro
spectrophotometer operated with the software MagellanTM 7.1 from Tecan (Germany).
Principal component analysis (PCA) of protein spectra was performed in Simca (Umet-
rics, Sweden). Data processing and creation of gures was performed in Matlab RR2014a
(MathWorks, USA).
2.2 Experimental Setup
As temperature is an inuencing factor on protein solubility, pH and the binding behavior
in HIC [25, 5] all experiments were performed in a temperature-controlled laboratory
(constant temperature of 23 C). All used buers were adjusted to respective pH values
after equilibration to room temperature. Chromatography columns were stored at room
temperature over night for temperature adjustment. Thus, temperature related eects
were eliminated.
2.2.1 Protein Solubility Screenings
The protein stock solutions were applied at a concentration of 60 mg/mL in ultra-pure
water. Lysozyme was obtained as crystalline powder and was directly dissolved in ultra-
pure water. Cherry-GST and the single domain antibody (VHH), by contrast, were stored
in the elution buer from the purication procedures. Buer exchanges and concentrat-
ing procedures were performed using Vivaspin Rcentrifugal concentrators (Sartorius, Ger-
many) with a cuto of 5 kDa to the nal concentration of 60 mg/mL. With a NanoDropTM
2000c by Thermo Fisher Scientic, the protein concentration was determined exactly us-
ing absorption coecients derived from capillary gel electrophoresis (data not shown).
Theoretical isoelectric points of the investigated proteins were determined based on the
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primary protein structure in the GPMAW software. The calculations resulted in pI = 5.2
for Cherry-GST, pI = 7.4 for the VHH, and pI = 10.9 for lysozyme. Hence, the ex-
periments covered a range of acidic, neutral, and alkaline proteins. As high-salt stock
solutions, 40 mM buers of pH 3 to 10 at a sodium sulfate (NaS) concentration of 1.875 M
were prepared.
Protein solubility screenings were carried out on a liquid handling station of the type
Freedom EVO R200 (Tecan, Germany). A total volume of 300 L was pipetted into each
well of the 96-well UV-Star Rplate. Each mixture consisted of 200 L 40 mM high-salt
(1.875 M NaS) buer and 100 L of protein solution in ultra-pure water (3 times the
nal protein concentration of the screening), resulting in an eective NaS concentration
of 1.25 M. The real concentrations of the applied protein solutions were determined using
the NanoDropTM system. The microplates were sealed and incubated in an overhead
shaker for two hours. The plates were then centrifuged for 10 min at 4000 rpm for re-
moval of potential precipitate. The supernatant was transferred to a 96-well at-bottom
UV-Star Rfull-area plate, measured at 280 nm (414 nm for Cherry-GST) in an Innite
M200 Pro photometer by Tecan and the amount of protein recovery was determined.
Data processing to determine the protein phase behavior was performed in Matlab R. As
a threshold criterion for precipitation conditions, a recovery below 90% was stated. A
protein calibration curve in the range from 0 to 1 mg/mL served as a reference.
The initial screenings were performed in a protein concentration range from 0 to 20 mg/mL
in 5 mg/mL increments as duplicates. The regions of protein aggregation were subse-
quently investigated in more detail for each pH in 1 mg/mL steps. For conditions where
20 mg/mL of protein were still soluble, the initial protein concentration was further in-
creased. For those setups, the concentration of the protein stock solution was increased,
accordingly. Data points with a relative standard deviation larger than 10% were removed
from the evaluation.
2.2.2 Determination of Dynamic Binding Capacities
3 mg/mL of each protein solution were prepared in buers of the respective pH, includ-
ing 1.25 M sodium sulfate, as described above and lled into 8-row reservoir plates. The
1.25 M NaS equilibration and wash buers were applied to the deck of the robotic work-
station in the same way.
Dynamic binding capacities were determined using 600 L Toyopearl RPhenyl-650M Robo-
Columns R(Atoll, Germany) in an automated liquid handling station (Tecan, Germany).
The miniaturized columns were washed with 6 column volumes (CV) of ultra-pure water
for removal of the storage solution. Following 12 CV equilibration with 1.25 M high-salt
buer of the respective pH, protein sample loading was performed. During the sample
loading procedure, the liquid droplets from the column outlets were fractionated in 96-
well UV-Star Rplates. The fraction volume was 150 L for experiments with half-area
plates and 300 L for experiments with full-area plates. Each experiment was performed
in quadruplicate. For a better curve resolution, sample loading was performed interlaced.
Prior to the breakthrough experiment, column 2 was loaded with 0.25 CV, column 3
with 0.5 CV, and column 4 with 0.75 CV of protein solution, resulting in slightly shifted
elution pools. A schematic illustration is given in Fig. 1 (center). In total, 15 CV of
protein solution were applied to each column for experiments using half-area plates. For
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conditions of higher DBCs, a second method for applying 30 CV of protein sample was
developed using full-area plates. For both methods, the elution was carried out by ap-
plying 3 CV (6 CV for full-area plates) of ultra-pure water after a high salt wash step of
3 CV. After another wash of 6 CV of ultra-pure water, the columns were cleaned with
6 CV of ethanol for storage. As eight robotic columns were used simultaneously, two
pH setups could be investigated in one run as an interlaced quadruplicate for a higher
resolution.
Data processing and the calculation of the DBCs were performed in Matlab R. The
variances in sample volume per fractionation due to droplet collection from the Robo-
Columns Rwere corrected by 990 nm and 900 nm measurements as described in [26]. The
real concentrations of the applied protein solutions were determined in the NanoDropTM
system and were used in the Matlab Revaluation software. 10% of protein breakthrough
were dened as the DBC threshold. The respective absorption values were determined
by a protein calibration curve in the range from 0 to 1 mg/mL. Finally, the DBCs were
calculated considering the fraction volumes and column bed volume.
2.2.3 Determination of HIC Binding Kinetics
The measured 280 nm absorption signals of the breakthrough curves were tted to a
logistic function in Matlab Ras shown in Eq. (1). The tting was carried out using 'Trust
region' optimization in the internal Matlab Rcurve tting toolbox. a, b, and c are the
coecients of the respective t and V represents the fractionated volume of the droplets.
UV280nm =
a
1 + 10b(c V )
(1)
The maximum of the derivatives of these ts were calculated and used as a measure of
the binding kinetics.
2.2.4 Protein Unfolding Procedures
As HIC protein binding is supposed to be based on reversible partial unfolding, selected
samples of increased DBC were investigated for structural integrity after elution by anal-
ysis of protein spectra (section 2.2.5). The experiments were performed with lysozyme,
as it was obtained with the highest purity (98%) of all investigated proteins to exclude
deviations in the spectra due to impurities. Denatured lysozyme spectra were prepared
as negative controls. One sample was directly prepared in 6 M urea solution. A second
sample was treated with trichloroacetic acid (TCA). For this purpose, 1 mL of 0.3 mg/mL
lysozyme solution in ultra-pure water was mixed with 50 L of 100% (w/v) TCA solu-
tion and stored on ice for 10 min. After a centrifugation cycle at 4000 rpm for 5 min,
the supernatant was discarded and the pellet was washed twice with 1 mL of 100% cold
acetone. The remaining acetone in the protein pellet was evaporated under a vent for at
least 4 h. The dried pellets were then resuspended in 1 mL 6 M urea solution for 2 h at
40 C.
2.2.5 Principal Component Analysis of Protein Spectra
To obtain spectra in a linear range of the spectrophotometer, the protein samples needed
to be diluted to a concentration of 0.3 mg/mL. Setups of pH 5, pH 7, and pH 10 were
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Figure 2: Solubility screenings of three dierent proteins of acidic, neutral, and alkaline pI in a range
from pH 3 to pH 10 in full pH steps, including 1.25 M sodium sulfate. Conditions of soluble proteins are
indicated by blue diamonds, precipitated proteins are marked by red circles. A: Cherry-GST (pI = 5.2),
B: single domain antibody (VHH) (pI = 7.4), C: Lysozyme (pI = 10.9).
3 PUBLICATIONS & MANUSCRIPTS
138
01
2
3
4
A
b
s
o
rp
ti
o
n
[A
U
]
pH 5
pH 6
pH 7
pH 8
pH 9
pH 10
0 2.5 5 7.5 10
0
1
2
3
Volume [mL]
S
lo
p
e
B
T
C
[A
U
/m
L
]
pH 5
pH 6
pH 7
pH 8
pH 9
pH 10
A
B
Figure 3: Fitted breakthrough experiments for lysozyme using miniaturized chromatography columns
on a robotic workstation (A) and corresponding derivatives of the breakthrough curves (BTCs) (B). The
dash-dotted line indicates the maximum of the slope curve, which equals the inexion point of the BTC
shown as an example for pH 10.
investigated. The chosen range covered the boundary conditions of the breakthrough
experiments as well as the standard operational neutral pH condition. For each setup,
blanked protein spectra were determined in a range from 240 to 300 nm in 2 nm steps.
All determined spectra were then analyzed in SIMCA by performing a principal com-
ponent analysis (PCA). The mean centered data matrix consisted of 31 variables (wave-
lengths from 240 nm to 300 nm in 2 nm steps) and 9 objects (1 urea and 2 TCA denatured
lysozyme samples as well as 6 lysozyme samples before and after chromatography binding
at pH 5, 7, and 10). The sample clusters in the score scatter plot were used as a measure
of a change in protein integrity.
3 Results
3.1 Protein Solubility Screenings
The results of the protein solubility screenings are illustrated in Fig. 2. All precipitation
screenings were carried out in buers of pH 3 to pH 10 using full pH steps and increas-
ing protein concentrations. The buers included 1.25 M sodium sulfate. Conditions at
which the protein stays soluble are indicated by blue diamonds, whereas conditions of
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precipitation are marked by red circles.
For Cherry-GST (pI = 5.2), all reaction mixtures of pH 3 and pH 4 resulted in instant
product precipitation even at concentrations below 1 mg/mL (Fig. 2A). For all other pH
values, the protein was found to be stable even up to concentrations above 80 mg/mL.
Starting from pH 11, Cherry-GST showed a behavior analogous to that at pH 3 and pH 4
(data not shown).
The single domain antibody (VHH) (pI = 7.4) was not stable above a concentration of
5 mg/mL for all investigated setups (Fig. 2B). pH 3 resulted in an instant precipitation
of the product even at a concentration of 1 mg/mL. At pH 4, the VHH was found to be
stable up to 1.25 mg/mL. Starting from pH 5, an almost constant solubility limit in a
range from 4 to 5 mg/mL was observed. The maximal solubility was achieved for pH 6,
8, 9, and 10 (5 mg/mL), whereas a decline in solubility was determined for pH 7.
Lysozyme (Fig. 2C), as the most alkaline of the investigated proteins (pI = 10.9), was
not stable at pH 3 and pH 4 analogously to Cherry-GST. The solubility maximum was
determined to be up to 10 mg/mL for pH 6 and the protein could be kept soluble up to
6 mg/mL at pH 5. Starting from pH 7, lysozyme was found to be stable in the range
from 7 to 8 mg/mL. At pH 10, a sharp decline in solubility was observed, with a maxi-
mal soluble protein concentration of 4 mg/mL. For pH 11, lysozyme showed a behavior
analogous to that at pH 3 and pH 4 (data not shown).
Due to these results, the DBC experiments were carried out in a range from pH 5 to
pH 10 only. The protein concentration for the DBC determinations was set to 3 mg/mL
for lysozyme and Cherry-GST. Due to the comparably low solubility of the VHH, the
respective experiments were carried out using 2 mg/mL protein solutions.
3.2 Dynamic Binding Capacities (DBCs)
In Fig. 3A the breakthrough curves of lysozyme are exemplarily shown for all investigated
pH values. The DBCs were calculated at a breakthrough of 10% of the initial protein
concentration, as described above. In Fig. 4A the calculated relative dynamic binding
capacities (DBCs) of the three investigated proteins are shown at varying binding pH on
the Toyopearl RPhenyl-650M adsorber. The DBCs were normalized to the DBC at pH 7
as the standard procedure. For all investigated proteins, the DBCs show a strong pH
dependence.
For Cherry-GST (Fig. 4A - red), the minimal DBC was observed for pH 6, with the DBC
being 8.2%  0.8% smaller than under standard pH 7 binding conditions. Towards acidic
conditions (pH 5), an increased DBC of 12.8%  2.4% was observed. Towards the alkaline
pH region, higher DBCs were investigated with a maximum increase of 23.4%  1.3% at
pH 9. Overall, the lowest DBCs were found for the neutral pH conditions (pH 6 to 8),
while acidic and alkaline buers increased protein binding by up to more than 23%.
The single domain antibody (Fig. 4A - blue) revealed the highest DBC under the stan-
dard operating conditions at pH 7. The lowest DBC was observed for pH 9, the value
being 13.8%  2.4% smaller than under the standard pH 7 binding conditions. Towards
acidic as well as alkaline conditions, the DBC decreased compared to pH 7, with the
impact being more pronounced in the alkaline region.
For lysozyme from chicken egg white (Fig. 4A - green), the maximal DBC was observed
for pH 10 with an increase of 28.3%  1.0% compared to pH 7. Overall, a trend to-
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Figure 4: Relative dynamic binding capacities (DBCs) of the three investigated proteins: Cherry-GST
(pI = 5.2) is shown in red, the single domain antibody VHH (pI = 7.4) in blue and lysozyme (pI = 10.9)
in green. A: DBC scaled to the typical operational condition at pH 7. B: DBC scaled to the respective
isoelectric points.
wards increased protein binding was found under alkaline operational conditions. This
observation is claried in the chromatograms shown in Fig. 3A. Here, the curves of
latest breakthrough correspond to the experiments at pH 9 (squares) and pH 10 (down-
ward triangles). Acidic conditions, by contrast, resulted in a decrease in DBC of up
to 12.2%  4.7% at pH 6. In summary, a continuous increase of DBC was observed for
lysozyme from acidic towards alkaline binding conditions on the Toyopearl RPhenyl-650M
adsorber.
In Fig. 4B the DBCs are scaled to the values of the respective protein pI's. Except for
Cherry-GST at pH 9 and pH 10 all residual conditions yielded in negative relative DBCs.
Thus, the isoelectric point was found to be the system point of maximal DBC of almost
all investigated conditions.
Fig. 5 shows the correlation between the protein's relative solubility limit (scaled to the
solubility maximum) and the corresponding relative DBC (scaled to the maximal inves-
tigated DBC) for the single domain antibody (Fig. 5A) and lysozyme (Fig. 5B). Both
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Figure 5: Correlation of relative (scaled to the maximum) protein solubilities (dash-dotted line) and
relative (scaled to the maximum) dynamic binding capacities (solid line) of the single domain antibody
VHH (A) and lysozyme (B) in dependence of the operational pH value.
proteins show an inverse trend of relative solubility and relative DBC, most pronounced
at pH 6 and pH 10 for lysozyme (Fig. 5B). For Cherry-GST no solubility limit could be
determined making such a gure for this protein obsolete.
3.3 Determination of HIC Binding Kinetics
The derivatives of the breakthrough curves (BTCs) are shown as an example for all
lysozyme setups in Fig. 3B. The maxima of the derivatives describe the binding kinetics
and mark the inexion points of the BTCs as highlighted by the dash-dotted lines in
Fig. 3. In Table 1 the maximal slopes of the tted breakthrough curves are listed under all
investigated conditions. For Cherry-GST, the highest binding kinetics were determined
in the range from pH 6 to pH 8 up to 1.26  0.16 AU/mL. At pH 5, the slope was
 30% lower compared to those at neutral pH. At pH 9, the slowest binding kinetics of
0.53  0.04 AU/mL was observed. For pH 10, no tting to a logistic function was possible,
as the kinetics was too slow to reach a nal plateau within the dened experimental
setup.
For the single domain antibody, the dierences in the binding kinetics were negligible
between pH 5 and pH 9. In this pH region the minimal slope of 0.61  0.05 AU/mL was
obtained for pH 9 and the maximal slope of 0.79  0.06 AU/mL was calculated for pH 8.
The only signicant variation of the binding kinetics was observed for the pH 10 setup,
yielding an overall minimum of 0.43  0.06 AU/mL.
The highest slope for lysozyme of 3.12  0.32 AU/mL was calculated for pH 5 with a
continuous decrease towards alkaline conditions. The slowest kinetics was observed for
pH 10 with 1.59  0.21 AU/mL.
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pH [-] KineticsCh GST [AU/mL] KineticsVHH [AU/mL] KineticsLys [AU/mL]
5 0.85  0.06 0.76  0.12 3.12  0.32
6 1.24  0.06 0.74  0.08 2.79  0.35
7 1.17  0.24 0.66  0.09 2.46  0.26
8 1.26  0.16 0.79  0.06 2.53  0.19
9 0.53  0.04 0.61  0.05 2.29  0.19
10 n/a 0.43  0.06 1.59  0.21
Table 1: Maximal slopes of the tted breakthrough curves as a measure of binding kinetics depending on
the pH value for the three investigated proteins - Cherry-GST, single domain antibody (VHH), Lysozyme.
3.4 Investigation of Lysozyme Integrity & Recovery
To investigate samples of increased protein binding for structural integrity after elu-
tion, a principal component analysis of protein spectra was conducted. The analysis
was performed with lysozyme, as it was the protein of the highest purity (98%) of all
investigated biomolecules. Spectra of TCA and, alternatively, urea denatured lysozyme
were compared to samples before and after binding to the HIC column. The number
of principal components (PCs) describing 99.3% of the system was determined to be 2
(87.3% variance described by PC 1 and 12.0% variance described by PC 2). Creating
models of more PCs resulted in no further improvements and measurement noise was
found to be included into the model. Fig. 6A illustrates the scatter plot for the score
values. The maximal deviance in the score plot of PC 1 was determined for the TCA
denatured samples, both located in one isolated cluster. Fig. 6B shows line plots for the
loading values of PC 1 and PC 2. Looking at the loading plot for PC 1, those dierences
were mainly detected in the region from 240 to 248 nm. For PC 2, the score scatter plot
revealed a maximal deviation for the urea denatured lysozyme sample. Again, an isolated
cluster was observed. The loading plot for PC 2 revealed the wavelength range of 244 to
260 nm to be the most inuential one, with a second important region beginning from
284 nm. All remaining samples from the BTC binding experiments merged in one nal
cluster close to the coordinate origin of the score scatter plot.
In addition to protein integrity studies, lysozyme recoveries were determined in terms of
total mass balances for the above-mentioned conditions (pH 5, pH 7, and pH 10). The
mass of lysozyme in the elution fraction was divided by the total mass of bound lysozyme
until breakthrough. At pH 5 the recovery rate of lysozyme was determined to be 90.7%.
For pH 7 94.3% and for pH 10 100.2% of bound lysozyme were recovered.
4 Discussion
4.1 Protein Solubility Screenings
The protein solubility screenings were carried out to identify pH and solubility boundaries
suitable to correlate dynamic binding capacities obtained on HIC with systems expressing
dierent protein solubility (Fig. 2). At pH 3 and pH 4, an instant product loss occurred
for Cherry-GST, indicating an instability towards acidic conditions induced by protona-
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Figure 6: Principal component analysis of lysozyme spectra. Calibration experiments included urea
and TCA denatured spectra as well as spectra of samples and elution fractions of the chromatography
experiments. A: Scatter plot of the resulting score values for a system of two principal components.
B: Line plots of the loading values of the two principal components as a function of the wavelength.
tion of amino acid residues. For all other pH values investigated between pH 5 and pH 10,
the protein was stable even at concentrations of up to 60 mg/mL. These ndings agree
with the reported stabilizing eect of the fused Cherry-TagTM resulting in an increased
protein solubility [27, 28].
The single domain antibody (VHH) showed a much lower solubility over the whole in-
vestigated pH range, with a maximum solubility of 5 mg/mL in presence of 1.25 M NaS.
Acidic conditions again resulted in instant product loss, as was discussed for Cherry-GST.
The reduced protein solubility at pH 7 compared to pH 6 and pH 8 correlates with the
isoelectric point of the VHH of 7.4.
The most alkaline protein investigated, namely lysozyme, again revealed an instant prod-
uct loss at pH 3 and pH 4. The protonation of amino acid residues showed a strong
negative impact on the protein solubility for all investigated protein species. As ex-
pected, lysozyme showed a strong decrease in solubility towards alkaline pH conditions
3 PUBLICATIONS & MANUSCRIPTS
144
close to its isoelectric point of pH 10.9. The solubility maximum was found in the neutral
pH region. Here, lysozyme is stabilized towards amino acid residue protonation, as well
as towards aggregation close to the isoelectric point.
When comparing the solubility screenings of all investigated proteins, it can be sum-
marized that strongly acidic conditions (pH 3) result in instant product losses even at
protein concentrations below 1 mg/mL. Finally, for all investigated proteins a negative
impact of conditions close to the isoelectric point on the protein's solubility was observed.
4.2 Inuence of Binding pH Close to the Protein's pI on DBC
In Fig. 4B the DBCs of the dierent proteins are normalized to the values determined at
the respective pI. The acidic protein Cherry-GST (pI = 5.2) revealed an increase in HIC
binding towards acidic buer conditions compared to pH 7 (Fig. 4B - red). However,
the maximal DBC was determined for alkaline conditions at pH 9. The single domain
antibody (pI = 7.4) as a protein of neutral pI showed the maximal HIC protein binding
capacity close to the pI (Fig. 4B - blue). The same results were obtained for lysozyme
(pI = 10.9) as the most alkaline protein with a maximal DBC at pH 10 (Fig. 4B - green).
In summary, all investigated proteins showed an increase in protein binding towards their
pI as illustrated by predominantly negative relative DBCs in Fig. 4B. These ndings
are in agreement with the pI's denition: As proteins carry a net surface charge of zero
at their specied pI, electrostatic repulsions are minimized leading to a domination of
hydrophobic forces. This leads to an increased interaction of the protein with hydrophobic
ligands of HIC media. As proteins are destabilized close to their respective isoelectric
point and structural changes are thus favored, increases in protein binding are most likely
based on facilitated partial unfolding in accordance to Jungbauer et al. describing the
HIC ligands as a catalyst for partial protein unfolding [10].
4.3 Inuence of Protein Solubility on DBC
For Cherry-GST, an increase in DBC was observed under acidic as well as under alkaline
conditions. The solubility screenings revealed that Cherry-GST is not stable below pH 5
and above pH 10, indicating an increase in HIC binding towards the solubility boundaries.
Those ndings match the new insights into the HIC binding mechanism being based on
partial protein unfolding upon adsorption. Destabilization of the protein in unfavorable
buers facilitates partial unfolding during the HIC binding process.
Those ndings were substantiated by the results obtained for the VHH, which was most
stable under alkaline conditions and revealed the lowest DBCs in this pH region. The
HIC binding again increased towards conditions of decreased solubility, namely, acidic
pH values and the isoelectric point as illustrated in Fig. 5A.
For lysozyme, as a protein of alkaline pI, the maximal DBCs were determined close to
the isoelectric point and at the system point of lowest solubility (Fig. 5B) under the
investigated conditions in the miniaturized column chromatography experiments. The
lowest protein binding was obtained again at the system point of maximal solubility
(pH 6). Starting from pH 6 towards more acidic pH values, protein binding was observed
to increase again corresponding to the decline in solubility as illustrated in Fig. 5B.
The maximal DBC was not always found at the respective pI for all investigated proteins.
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Although the pI is not generally the optimal system point for HIC protein binding, it
may be a good starting point for increasing protein purication productivity. However,
there is a correlation between protein solubility and binding behavior in HIC. System
points of low protein solubility increase HIC protein binding, whereas conditions of high
solubility have the opposite eect (Fig. 5). Those ndings again indicate favored protein
binding in HIC under destabilized conditions, as was discussed above.
4.4 Correlation of Binding Kinetics and Dynamic Binding Ca-
pacities
When comparing the DBCs (Fig. 4A) to the respective binding kinetics (Table 1), a
clear inverse trend can be seen for lysozyme and Cherry-GST. Conditions of increased
binding in HIC showed a decrease in the binding kinetics. The minimal binding kinetics
were observed for the setups resulting in highest capacities and vice versa. For the single
domain antibody, those kinetic eects were not that pronounced, as the pH was not a
strongly inuencing factor in all setups investigated. It can be concluded that the inverse
correlation of DBCs and binding kinetics is due to a change of protein orientation during
the binding process induced by higher adsorber loadings. This reorientation process slows
down protein binding and, thus, decreases the binding kinetics.
4.5 Investigation of Protein Integrity & Recovery
As the determined system points of increased HIC protein binding might be accompanied
by structural changes after elution, a spectral protein analysis was conducted. The PCA
of the lysozyme spectra resulted in three dierent score clusters (Fig. 6A). The dierently
denatured samples formed two distinct score clusters, namely, the TCA cluster (mainly
described by PC 1) and the urea cluster (mainly described by PC 2). The two fundamen-
tally dierent denaturation procedures thus expanded a large area of scoring instabilities
of lysozyme. All applied samples and elution pools from the lysozyme DBC experiments
merged in one nal cluster close to the origin of the score plot, indicating no changes in
protein integrity after elution. If increased protein binding as an eect of altered pH was
due to partial unfolding of the protein, this would be a reversible process after elution
and can be neglected.
As HIC processes are reported to suer from incomplete product elution [29] the recovery
rates of the above-mentioned lysozyme samples were determined. It was shown that all
investigated setups yielded in recoveries of 90 - 100% and product losses for conditions
of increased DBCs were negligible.
5 Conclusions
The pH and protein solubility are highly inuential parameters in HIC and should be
considered for process optimization. Choosing an operational pH in the neutral region
might be a good condition to choose for some proteins but can also be the reason why HIC
can not be employed for some proteins at all until now as shown by [17] for cytochrome c.
The screening results show a correlation of the dynamic binding capacity in HIC with
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the operational pH value applied. Binding at a pH value close to the protein's isoelectric
point as well as conditions near the solubility limit resulted in increased protein binding.
These ndings indicated a structural change upon binding in HIC, which are favored un-
der destabilizing conditions. However, when comparing lysozyme spectra of the applied
samples to the elution fractions in a principal component analysis, native conformation
was veried. It can thus be assumed that the induced partial unfolding of lysozyme, if
it occurs during binding, is a reversible process under the investigated conditions. To
increase the DBCs of HIC adsorbers, choosing a pH close to the protein's pI may be a
good starting point for process development. The most inuencing factor, however, was
shown to be the solubility limit. pH conditions resulting in decreased protein solubility
have a positive eect on the binding in HIC.
As an additional factor, the protein binding kinetics were investigated and compared to
the protein binding behavior. The kinetics followed an inverse trend compared to the
DBCs. The highest DBCs were obtained for the setups of slowest kinetics. Thus, it was
concluded that a protein reorientation process took place for high adsorber loadings. This
slowed down the binding process.
In summary, dierent pH-dependent mechanisms like structural changes and protein re-
orientation upon binding help increase the DBC under varied buer conditions. As no
irreversible structural changes of the protein were investigated without signicant product
loss during elution for selected setups such an optimization strategy should be exploited
for HIC process development.
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UV Absorption-based Inverse Modeling of Protein
Chromatography
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Abstract
UV absorbance measurements play an important role in bioprocess development. Yield
and purity are often evaluated in terms of peak percentages in analytical size exclusion
chromatography or ion-exchange chromatography. Also, industrial chromatography steps
are usually controlled based on UV data with pooling decisions according to absorbance
thresholds.
Model-based process development would make elaborate screening experiments redun-
dant, once the model has been calibrated to the specic process step. So far, absorbance
measurements could not be used directly for modeling chromatography steps as the com-
monly applied models rely on mass or molar concentration. This study presents mecha-
nistic modeling of an industrially relevant chromatography setting without any knowledge
of the feed composition. The model equations were re-written to employ boundary condi-
tions in UV absorbance units, the absorption coecients were shifted into the isotherm,
and standard parameter estimation procedures could be applied. An anion-exchange
chromatography case study of a target protein expressed in Escherichia coli and eleven
lumped impurity peaks demonstrated practical applicability. The target protein con-
centration in the feed material was estimated from chromatograms. Using this method,
initially unknown feed concentrations can be determined a posteriori for ion-exchange
and multi-modal chromatography from single-component absorbance curves.
Keywords: Calibration-free, Inverse Method, Liquid Chromatography, Mechanistic
Modeling, UV Absorbance
1 Introduction
Industrial downstream processing (DSP) faces the challenge of eciently purifying a
product out of a very heterogeneous mixture. The purication sequence is commonly
based on platform processes that are only slightly adapted to new target components to
accelerate process development [1, 2]. Prior to this, high-throughput screening methods
are often used to nd promising initial conditions for platform processing [3]. Mechanistic
modeling is a favorable alternative, provided the model parameters can be determined
with less eort, allowing identication of optimal process parameters in silico.
The common models in liquid chromatography describe the mass transport in the col-
umn by so-called Convection Diusion Reaction (CDR) equations, where the reaction
term models phase transitions and, eventually, the retention of the species. With no a
priori knowledge about the components' behavior, the inverse method is a suitable op-
tion which alters parameters in a systematic fashion to achieve a match of the recorded
chromatogram and the model prediction.
The potential of mathematical modeling and numerical optimization of chromatography
has already been demonstrated in academic set-ups for mixtures of small molecules [4, 5],
model proteins [6] and antibodies [7, 8], and also for industrial process steps [9, 10]. All
applications have in common, that molar concentrations in the feed were known and
sensor calibrations existed for all components.
Cornel et al. [11] determined absorption coecients for a two-component mixture di-
rectly from the simulated concentration curves by choosing the best tting values in each
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Parameter Symbol Value Proceeding
Diameter d 7 mm From manufacturer
Length L 25 mm From manufacturer
Bead radius rp 0.045 mm From manufacturer
System dead volume Vd 0.07 mL Acetone injection without column
Ret. volume Acetone VRetAc 0.96 mL Acetone peak injection with column
Ret. volume dextran VRetDex 0.34 mL Dextran peak injection with column
Std. dev. of dextran Dex 0.029 mL AKTA
TM peak integration
Volume of HCl VHCl 1.48 mL Acid/base titration
Molarity of HCl cHCl 0.01 M Manually controlled
Flow rate u 0.2 mm
s
Manually controlled
Table 1: Measured column parameters.
iteration of the estimation procedure. No sensor calibration was necessary, but mass
concentrations in the feed were known a priori.
In the following sections, we describe a mechanistic modeling approach for an industri-
ally relevant chromatography setting that does not require prior knowledge of the feed
composition in terms of molar or mass concentrations. We re-write the model equation
for boundary conditions in UV absorbance units and aim at determining the unknown
feed concentrations a posteriori by taking advantage of the particular structure of stoi-
chiometric exchange models. Standard parameter estimation procedures can be applied
if single-component absorption curves are available.
A case study based on an anion-exchange chromatographic (AEX) process step (Q Sepha-
rose FF, GE Healthcare) demonstrates the applicability. The mixture fed into AEX is a
crude feed stock of Escherichia coli SE1, including the Cherry-tagged enzyme Glutathione-
S-Transferase as the product.
2 Materials & Methods
2.1 Column Parameter Determination
To model the mass transport in the chromatography system, the column properties listed
in Tables 1 and 2 must be determined by pulse injections of non-interacting tracer
molecules [12]. A 1 mL column (eective volume 0.962 mL), with Q Sepharose Fast
Flow Resin (GE Healthcare, Germany) was analyzed rstly with an 1% acetone (Merck,
Germany) pulse and secondly with a dextran pulse from Leuconostoc spp. MW 2,000,000
(Sigma Aldrich, Germany) using an AKTATM Purier system (GE Healthcare, UK) con-
trolled with Unicorn 5.2 (GE Healthcare, Sweden) to determine the essential system
parameters [12] presented in Table 1. Acid-base titration was carried out to determine
the total ionic capacity: the column was ushed with a 0.5 M NaOH solution (Merck,
Germany) until a constant UV and conductivity signal was achieved. Afterwards, the
column was washed with ultra pure water until a constant UV and conductivity baseline
was reached. Then, the column was titrated at a ow of 0.64 mL/min with a 0.01 M
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Parameter Symbol Value Proceeding
Volume V 0.962 mL 1
4
   d2  L
Fluid volume Vf 0.89 mL VRetAc   Vd
Interstitial volume Vint 0.27 mL VRetDex   Vd
Total column porosity "t 0.925
Vf
V
Interstitial porosity "b 0.28
Vint
V
Particle porosity "p 0.896
Vf Vint
V Vint
Interstitial ow uint 0.714
mm
s
u
"b
Axial dispersion Dax 0.1
mm2
s
1
2
 L  uint 

Dex
Vint
2
Ionic capacity  0.22 M cHClVHCl
V (1 "b)(1 "p)
Table 2: Calculated column parameters.
HCl solution (Merck, Germany) until an increase in the conductivity signal was recorded.
From the Cl  ion concentration of the titrant and the volume of the applied titrant, the
total number of exchangeable ions was calculated. All chemicals used were obtained in
highest quality.
With this set of parameters, all system-specic parameters occurring in the mathematical
model can be xed as given in Table 2.
2.2 Sample Production
The applied sample consisted of an Escherichia coli SE1 lysate, including Cherry-tagged
Glutathione-S-Transferase (GST) as a product. The Cherry-TagTM, which can be fused
to any target protein, allows for straightforward product analytics by VIS absorbance
measurements [13]. The cultivation was performed for 24 h in 800 mL standard TB
(terric broth) medium at 37 C and 180 rpm rotational speed in 2.5 l TUNAIRTM asks
(Sigma Aldrich, Germany). Cell disruption was performed by sonication of the cell pellet
in 20 mL of 50 mM Tris buer (pH 8), including 1 SigmaFASTTM protease inhibitor
(Sigma Aldrich, Germany), in a Branson Digital Sonier R 450 (70% pulse amplitude, 10
 15 s pulse duration, 30 s resting on ice between pulses). The lysate was centrifuged at
12000 rpm for 60 min at 10 C using a 5810 R centrifuge (Eppendorf, Germany) followed
by a second clarication step using 0.2 m sterile PES lters (VWR, Germany). Finally,
the permeate was 10 times diluted in 50 mM Tris buer (pH 8).
2.3 Sample Characterization
For comparison, the product concentration was determined in the Caliper LabChip RGX II
capillary gel electrophoresis system with LabChip GX 3.1 software (Perkin Elmer, USA).
The HT Protein Express and Pico LabChip Rwas run with the HT Protein Express
LabChip Rreagent kit using the HT Protein Express 200 assay. Cherry-tagged GST was
identied using the sample ladder from the reagent kit. The product was quantied by
peak-baseline integration of the uorescence signals (Fig. 1) and scaling to an external
lysozyme protein standard of 1 mg/mL (Hampton Research, USA).
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Figure 1: Capillary gel electrophoresis analysis of feed material.
2.4 Bind-elute Experiments
The component-specic isotherm parameters are determined from bind-elute experiments.
The general approach is identical to concentration-based parameter estimation [6, 7, 8].
A 50 mM Tris-HCl buer, pH 8 was employed as the mobile phase during binding and the
same buer supplemented with 1 M NaCl was used for elution. Dierent salt gradients
were generated from these two buers. After the 0.5 mL sample was injected (12.4 mL
for the breakthrough experiment), the column was washed with low-salt buer for 3 mL
of 50 mM Tris-HCl buer, before initiating linear gradient (0 to 1 M NaCl) elution over
5, 10, 15 and 20 mL. On gradient completion the columns were irrigated with 2 mL of
50 mM Tris-HCl and 1 M NaCl before re-equilibrating with 5 mL of 50 mM Tris-HCl
buer. The linear phase linear velocity employed was 0.2 mm/s throughout.
2.5 Parameter Estimation
In general, estimation of an unknown parameter set p solves the least squares optimization
problem
min
p
X
j
 
m(tj) 
X
i1
ci(L; tj; p)  ai
!2
; (1)
where m(tj) is the measured chromatogram value at time tj, typically given in milli
absorbance units [mAU]. This measurement might also contain noise, which can be ne-
glected when assuming the noise to be zero-mean Gaussian and isotropic.
ci(L; t) is the simulated mass or molar concentrations at the outlet of the column with
length L. The transformation into absorbance units is performed with a scaling factor ai.
According to Beer's law, the absorption coecient ai consists of an extinction coecient
and UV cell path length. It is unknown in this case.
2.6 Chromatography Model
The Transport Dispersive Model (TDM) [12] in Eqs. (2) and (3) is used to model the
macroscopic protein transport through the column. For simplicity, the component-specic
internal and external diusion eects are lumped in an eective mass transfer coecient.
155
The system is of Convection Diusion Reaction (CDR) type. Eq. (2) describes the rate of
change of the concentration ci(x; t) of component i in the interstitial volume of a column
with length L, which consists of convective mass transport in space with the average
interstitial velocity of the uid u. Peak broadening eects are modeled as dispersion in
axial direction with respect to a coecient Dax. The exchange between the interstitial
concentration and the particle pore concentration cp;i(x; t) depends on the porosity of the
bed "b, the radius of adsorber particles rp, and a component-specic eective mass transfer
coecient keff;i. The model is one-dimensional in space, such that the concentrations
depend on the axial position in the column and time. Eq. (3) models the accumulation of
mass in the pore volume cp;i and stationary phase qi as a function of the particle porosity
"p. The model is complemented by Danckwert's boundary conditions Eqs. (4) and (5),
including the applied inlet concentration cin;i, and an isotherm equation modeling the
stationary phase concentration qi.
@ci
@t
=  u(t)@ci
@x
+Dax
@2ci
@x2
  1  "b
"b
keff;i
3
rp
(ci   cp;i) (2)
@cp;i
@t
=  1  "p
"p
@qi
@t
+ keff;i
3
"prp
(ci   cp;i) (3)
@ci
@x
(0; t) =
u(t)
Dax
(ci (0; t)  cin;i (t)) (4)
@ci
@x
(L; t) = 0 (5)
The steric mass-action isotherm (SMA) [14] is a commonly used semi-mechanistic isotherm
in ion-exchange chromatography. It is capable of reproducing the inuence of counter ions
on the retention behavior of protein species using the proteins' characteristic charges i.
In addition, it considers adsorber properties such as the total ionic capacity  and steric
shielding eects i of the protein covering an amount of binding sites, greater than the
actual number of sites it interacts with. The kinetic SMA isotherm is given in Eq. (6) for
k proteins, with qi and cp;i being the concentration of the protein i 2 f1; : : : ; kg adsorbed
and in solution, respectively. cp;salt is the salt concentration of the solution. kads;i and
kdes;i are the constants of the adsorption and desorption rate.
@qi
@t
= kads;i
 
 
kX
j=1
(j + j)qj
!i
cp;i   kdes;icip;saltqi (6)
qsalt =  
kX
j=1
jqj (7)
The model is chosen because of its capability of simulating the whole chromatographic
process, including elution, by changing the induced salt concentration at the inlet. The
model is based on molar concentrations, such that the boundary conditions of the TDM
must be set in terms of molarities.
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2.7 Transformation
As the SMA model is based on molar concentrations [M], interstitial and pore volume
concentrations must be given in [M] as well. This also applies to the boundary conditions.
Here, the exact molar concentrations in the feed are unknown, as are the scaling factors
for UV absorbance. We will re-write the equations to directly incorporate UV absorbance
values.
First, the injected protein concentrations are transformed into absorbance values:
c0in[mAU ] = a [mAU=M ] cin[M ]. These can be determined later from the respective peak
area in the chromatogram.
The equations for the interstitial and pore volume as well as the boundary conditions are
linear in c. These can be multiplied by a to obtain
ai
@ci
@t
= ai

 u@ci
@x
+Dax
@2ci
@x2
  1  "c
"c
kf (ci   cp;i)

(8)
() @c
0
i
@t
=  u@c
0
i
@x
+Dax
@2c0i
@x2
  1  "c
"c
kf
 
c0i   c0p;i

(9)
@c0i
@x
(0; t) =
u
Dax
 
c0i (0; t)  c0in;i (t)

(10)
@c0i
@x
(L; t) = 0 (11)
We obtain equations for c0i = ai  ci that use c0p;i = ai  cp;i. This is calculated from the
scaled lumped rate model
"p
@c0p;i
@t
+ (1  "p) @q
0
i
@t
= keff;i
3
rp
 
c0i   c0p;i

: (12)
Again, we require an equation for q0i = ai  qi. Scaling the kinetic SMA formulation yields
ai
@qi
@t
= ai
"
kads;i
 
 
kX
j=1
(j + j) qj
!i
cp;i   kdes;icis qi
#
(13)
() @q
0
i
@t
= kads;i
 
 
kX
j=1
(j + j) qj
!i
c0p;i   kdes;icis q0i (14)
() @q
0
i
@t
= kads;i
 
 
kX
j=1
(j + j)
aj
aj
qj
!i
c0p;i   kdes;icis q0i (15)
() @q
0
i
@t
= kads;i
 
 
kX
j=1
j + j
aj
q0j
!i
c0p;i   kdes;icis q0i: (16)
Here, we multiplied by
aj
aj
in step Eq. (14)!Eq. (15) to transform the remaining q into q0.
Essentially, we shifted the unknown scaling factor from the least-squares problem Eq. (1)
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into the isotherm.
We are left with Eq. (7), which can be altered to include q0 as above:
qsalt =  
kX
j=1
jqj (17)
=  
kX
j=1
j
aj
aj
qj (18)
=  
kX
j=1
j
aj
q0j: (19)
The transformation procedure is also applicable to other isotherms with stoichiometric
exchange, e.g. the mixed-mode isotherm in [15].
Binding models of Langmuir type and isotherms without an additional equation for
counter-ions, e.g. for hydrophobic interaction chromatography (HIC) [9], can be treated
as above. But due to the missing second equation, a will stay hidden in other constants.
In case of the kinetic Langmuir isotherm, we obtain
@qi
@t
= kads;iqmax;i
 
1 
kX
j=1
qj
qmax;j
!
cp;i   kdes;iqi (20)
() @q
0
i
@t
= k0ads;iq
0
max;i
 
1 
kX
j=1
q0j
q0max;j
!
c0p;i   kdes;iq0i; (21)
with k0ads;i = kads;i=ai and q
0
max;i = qmax;i ai . These parameters can be used for UV-based
modeling but not for determining absorption coecients and molar concentrations.
Other convection-diusion models, such as the general rate model [12] or models of radial
ow chromatography [16], are also linear in the concentration variables and can be treated
as the TDM above.
2.8 Uniqueness
In this section, it is shown that the transformation does not aect the parameter deter-
mination.
The linear range of the isotherm is uninuenced by the transformation. For  Pk
j=1
j+j
aj
q0j, we obtain
@q0i
@t
 kads;iic0p;i   kdes;icis q0i: (22)
Consequently, all methods to determine the linear SMA parameters kads, kdes, and  can
be employed here. It has been shown that the characteristic charge  and equilibrium
coecient, dened as keq =
kads
kdes
, determine the retention time in gradient elution [17].
At least two gradients with dierent lengths and/ or slopes are necessary to uniquely
determine the two values. The kinetic parameter kdes can be identied from the peak
shape [7]. This method is also applicable to multi-component settings, as no protein-
protein interactions are assumed to happen in the linear range.
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The non-linear parameter  is typically determined by a frontal experiment or from batch
isotherms. Both methods rely on determining the saturation capacity qmax =

+
and
calculating
 =

qmax
  : (23)
If the [mAU] equivalent q0max is determined, the equation becomes
 =
  a
q0max
  : (24)
With known  and a,  can be uniquely determined. Alternatively, the steric factor can
be identied from the peak shape in non-linear chromatography [18], again with known
 and a. This method allows for including additional steric shielding eects in multi-
component settings.
To determine a, one of the original methods for identifying the characteristic charge can
be used. It relied on measuring the increase in conductivity caused by freed counter-ions
[14]. In the UV-based case, the amount of freed counter-ions can be determined from the
second isotherm Eq. (19): Z L
0
kX
j=1
j
aj
q0j dx: (25)
If  has been determined, e.g. from gradient elutions as above, a can be identied uniquely
from the increase in conductivity in single-component adsorption. In non-linear multi-
component settings, the increase of conductivity will be visible in the chromatogram.
The a-dependent locally varying counter-ion concentration in the pores due to adsorbing
proteins will lead to a dierent adsorption behavior.
Summarizing, every parameter plays a distinct role and can be determined from single-
component absorbance curves. If only the chromatogram is available in multi-component
settings, the parameters might be correlated.
2.9 Numerical Solution
The numerical simulation is performed using the in-house software package ChromX
(http://www.chromx.org). Following the method of lines, the equation system is rst
discretized in space using the Finite Element Method (FEM). A Streamline-Upwind-
Petrov-Galerkin (SUPG) ansatz was used here with linear basis and test functions. The
discretization in time is performed with the fractional step -scheme, a semi-implicit pro-
cedure providing second-order accuracy [19]. Finally, the non-linearity of the equation
system introduced by the isotherm must be treated with an iterative procedure, here,
Picard iteration. The resulting linear systems are solved by LU factorization.
A variety of algorithms is available for the solution of the optimization problem in Eq. (1).
We employed a heuristic method, the genetic algorithm implementation GAlib, and a de-
terministic Levenberg-Marquardt implementation CMinpack. Genetic algorithms prevent
local minimums by performing random jumps and, hence, explore a larger area of the
search space. The result of the genetic algorithm is then rened with the deterministic
algorithm. To support this, we divide the kinetic isotherm by kdes and use the formula-
tion with equilibrium coecient keq. Working with kads would require to always change
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Figure 2: Result of the 20 mL gradient elution: UV 280 nm (solid line), UV 536 nm (dotted line)
and conductivity (dashed line). 11 impurities were identied with peak maxima at 0.65 mL (imp. 1),
1.21 mL (imp. 2), 1.96 mL (imp. 3), 5 mL (imp. 4), 6.5 mL (imp. 5), 7.5 mL (imp. 6), 8.23 mL (imp. 7),
9.21 mL (imp. ml8), 11.28 mL (imp. 9), 15.52 mL (imp. 10), 17.11 mL (imp. 11). The target component
is clearly visible in the 536 nm signal, with the peak maximum at 11.54 mL.
kdes at the same time to keep the retention time constant. This is unsuitable for the
deterministic algorithm that only uses rst derivatives [20].
3 Results & Discussion
3.1 Bind-elute Experiments
Five experiments in bind/ elution mode were performed. Fig. 2 shows the result obtained
with a 20 mL gradient. Several impurity peaks could be resolved. The rst one is a
breakthrough at 0.65 mL. The second peak occurs slightly later at 1.21 mL, followed by
two shoulders (impurities 3 and 4) and a high peak at 6.50 mL. The signal continues
with three lower peaks (imp. 6, 7, 8), followed by a larger one at 11.28 mL that is also
visible at 536 nm. It is identied to be the target component. The fact that this peak's
maximum is reached 0.26 mL earlier at 280 nm leads to the assumption that a impurity
(imp. 9) is eluting slightly before. A small shoulder (imp. 10) and a nal peak at 17.1 mL
(imp. 11) complete the elution prole.
3.2 Protein Parameter Estimation
The components' peak areas were determined with Unicorn peak integration from the
280 nm signal of the 20 mL gradient chromatogram. The resulting areas in mAUmL
were divided by the sample volume of 0.5 mL to obtain the inlet absorbance values for
modeling c0in in mAU. Hence, the estimated absorption coecients a refer to 280 nm. The
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Figure 3: Comparison of measured and simulated chromatograms with UV signals (solid lines), con-
ductivity measurement (dashed lines), simulated Cherry-GST absorbance (dotted lines), impurity traces
(light solid lines), and sum of simulated proteins (dot-dashed lines). Plots A and B show the 10 mL
gradient elution, C and D the 20 mL gradient elution, and E and F the breakthrough experiment.
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same bounds of integration were used for the 300 nm signal. No additional simulation
was necessary, the simulated 280 nm peaks were scaled according to the ratio of 300 nm
and 280 nm peak areas. The 300 nm signal was used for modeling the breakthrough
experiment. Here, the 280 nm signal was incomplete due to sensor saturation.
As the genetic algorithm performs random jumps, admissible parameter ranges have to
be set. First estimates of  and keq were obtained from the correlation of retention
times in gradient elution as in [1] for all binding species. The resulting large equilibrium
parameter values in the order of 106 t well to the observed retention. kdes has to reside
in the natural range k 1des 2 [0; 1] and the upper limit for keff is given by 3  keff=rp = 1.
The steric factor was assumed to be in a range of  2 [0; 200] as it scales approximately
with the molecular weight [21] and we expect HCPs of 100 kDa and above. The range of
absorption coecients was chosen large, a 2 [105; 1010]. Eventually, the curve tting was
rened using the Levenberg-Marquardt algorithm.
Selected results are presented in Fig. 3. The left column shows the simulated components,
their sum, and the chromatograms at 280 nm for the 10 and 20 mL gradient as well as the
300 nm chromatogram of the breakthrough experiment. The right column shows the same
curves at 536 nm. The 15 mL gradient result looks very similar. In the 5 mL gradient
chromatogram, highly overlapping impurities lead to only three distinct peaks (data not
shown). The corresponding model parameters are given in Table 3. As the rst peak is not
retained, isotherm parameters could not be determined. The second and third impurity
are only slightly retained and the correlation from [1] cannot be used. Furthermore,
there might be other parameter combinations of keq and  that lead to the same retention
volume, and combinations of  and a with the same amount of occupied ligands. Certainty
can be increased by using dierent low-salt buer concentrations or including samples
with dierent impurity ratios. But parameter determination for components in the ow-
through is not in the focus of this study. The other linear parameters lead to good
agreement of simulation and measurement in the rst and second row of Fig. 3. As
the species do not interact, the four linear parameters can be determined well from the
four gradient experiments. The experiment with 12.4 mL sample volume shows good
agreement as well, in particular in UV 536 nm. Thanks to this visibility of Cherry-
tagged GST in UV 536 nm, a single-component adsorption curve is available that allows
for an accurate estimation of the absorption coecient.
3.3 Capillary Gel Electrophoresis
The target protein can be identied easily in the capillary gel electrophoresis result be-
cause of its high uorescence value. The determined concentration was 3:73  105M,
resulting in an absorption coecient of 7:86  107mAU=M at 280 nm. This is smaller
than the estimated value by approximately 9%. The estimate of a is very good, consid-
ering the number of interacting species.
Although capillary gel electrophoresis identied even more species, the lumped peaks
found by Unicorn peak integration were sucient to model the elution behavior of the
protein components at all investigated wavelengths.
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Component keff=10
 3 k 1des keq   a=10
8
Contaminant 1 0.010 - - - - -
Contaminant 2 2.090 1 0.004 0.066 157.1 0.600
Contaminant 3 5.006 0 3.939 1.293 102.5 0.056
Contaminant 4 5.586 0.050 22.46 0.566 6.325 0.130
Contaminant 5 15.00 0.151 32.36 0.866 1.895 41.37
Contaminant 6 13.00 0 21.54 1.890 0.001 0.150
Contaminant 7 12.08 0 32.22 1.930 1.702 13.24
Contaminant 8 7.077 0.066 75.83 4.135 0 1.967
Contaminant 9 7.100 0.070 175.8 4.289 0.022 42.91
Cherry-tagged GST 9.271 0.208 334.0 4.000 0.035 0.865
Contaminant 10 14.98 0.424 3084.3 5.350 2.241 2.396
Contaminant 11 7.131 0.235 152227 7.968 0.025 30.00
Table 3: Estimated component-specic model parameters.
4 Conclusions
This study demonstrates that mechanistic modeling can be applied to an anion-exchange
step of a crude feed stock, even if the molar concentrations of the feed components are
unknown. The model equations were re-written to dene injection with respect to the
peak areas determined from chromatograms at a chosen wavelengths. The unknown ab-
sorption coecients that scale molar concentration to absorbance units then occur in the
isotherm equation. The counter-ion balance of stoichiometric exchange models can be
used for estimating these factors using the inverse method. For the steric mass-action
model, it was shown theoretically that this additional parameter can be uniquely deter-
mined in single-component settings.
In a multi-component case study, the molar concentration of the target protein, Cherry-
tagged GST, estimated by chromatogram tting was only 9% less than the value measured
by capillary gel electrophoresis. Here, a single-component absorbance curve was available
through the absorbance of the Cherry-TagTM in UV 536 nm. For the other components,
a correlation of the steric shielding factor and the absorption coecient persists. Only
the total counter-ion concentration on the adsorber surface is measurable, but not the
exact amounts displaced per-component.
Additional reliability can be achieved by including samples with dierent impurity pro-
portions or fraction analyses that only need to provide peak percentages in one of the
observed wavelengths. In preparative chromatography process development, these frac-
tion analyses are performed on a regular basis, e.g. with size-exclusion chromatography
[7] or ion-exchange HPLC [10], such that no additional experiments are required.
References
[1] A. A. Shukla, B. Hubbard, T. Tressel, S. Guhan, D. Low, Downstream processing of
monoclonal antibodies - application of platform approaches, J Chrom B 848 (2007)
163
28{39.
[2] H. F. Liu, J. Ma, C. Winter, R. Bayer, Recovery and purication process development
for monoclonal antibody production, mAbs 2 (2010) 480{499.
[3] R. Bhambure, K. Kumar, A. S. Rathore, High-throughput process development for
biopharmaceutical drug substances, Trends Biotechnol 29 (2011) 127{135.
[4] S. Abel, G. Erdem, M. Amanullah, M. Morari, M. Mazzotti, M. Morbidelli, Opti-
mizing control of simulated moving beds - experimental implementation, J Chrom
A 1092 (2005) 2{16.
[5] P. Forssen, R. Arnell, T. Fornstedt, An improved algorithm for solving inverse prob-
lems in liquid chromatography, Comput Chem Eng 30 (2006) 1381{1391.
[6] A. Osberghaus, S. Hepbildikler, S. Nath, M. Haindl, E. von Lieres, J. Hubbuch, Opti-
mizing a chromatographic three component separation: a comparison of mechanistic
and empiric modeling approaches., J Chrom A 1237 (2012) 86{95.
[7] D. Karlsson, N. Jakobsson, A. Axelsson, B. Nilsson, Model-based optimization of
a preparative ion-exchange step for antibody purication, J Chrom A 1055 (2004)
29{39.
[8] M. Degerman, N. Jakobsson, B. Nilsson, Constrained optimization of a preparative
ion-exchange step for antibody purication., J Chrom A 1113 (2006) 92{100.
[9] J. M. Mollerup, T. B. Hansen, S. Kidal, L. Sejergaard, A. Staby, Development,
modelling, optimisation and scale-up of chromatographic purication of a therapeu-
tic protein, FFE 261 (2007) 133{139.
[10] E. J. Close, J. R. Salm, D. G. Bracewell, E. Sorensen, Modelling of industrial biophar-
maceutical multicomponent chromatography, Chem Eng Res Des 92 (2014) 1304{
1314.
[11] J. Cornel, A. Tarafder, S. Katsuo, M. Mazzotti, The direct inverse method: A novel
approach to estimate adsorption isotherm parameters, J Chrom A 1217 (2010) 1934{
1941.
[12] M. Michel, A. Epping, A. Jupke, Preparative Chromatography: Of Fine Chemicals
and Pharmaceutical Agents, Wiley-VCH, 2005, pp. 215{312.
[13] P. Baumann, N. Bluthardt, S. Renner, A. Osberhaus, J. Hubbuch, Integrated Devel-
opment of Up- and Downstream Processes Supported by the Cherry-Tag for Real-
time Tracking of Stability and Solubility of Proteins, J Biotech 200 (2015) 27{37.
[14] C. A. Brooks, S. M. Cramer, Steric mass-action ion exchange: Displacement proles
and induced salt gradients, AIChE Journal 38 (1992) 1969{1978.
[15] B. K. Nfor, M. Noverraz, S. Chilamkurthi, P. D. Verhaert, L. A. van der Wielen,
M. Ottens, High-throughput isotherm determination and thermodynamic modeling
of protein adsorption on mixed mode adsorbents, J Chrom A 1217 (2010) 6829{6850.
3 PUBLICATIONS & MANUSCRIPTS
164
[16] T. Gu, Mathematical Modeling and Scale-up of Liquid Chromatography, Springer
Berlin Heidelberg, 1995, pp. 102{110.
[17] A. A. Shukla, S. S. Bae, J. A. Moore, K. A. Barnthouse, S. M. Cramer, Synthesis and
characterization of high-anity, low molecular weight displacers for cation-exchange
chromatography, Ind Eng Chem Res 37 (1998) 4090{4098.
[18] S. R. Gallant, A. Kundu, S. M. Cramer, Modeling non-linear elution of proteins in
ion-exchange chromatography, J Chrom A 702 (1995) 125{142.
[19] R. Glowinski, Handbook of Numerical Analysis, North-Holland, 2003.
[20] T. Hahn, A. Sommer, A. Osberghaus, V. Heuveline, J. Hubbuch, Adjoint-based
estimation and optimization for column liquid chromatography models, Comput
Chem Eng 64 (2014) 41{54.
[21] D. Karlsson, N. Jakobsson, K.-J. Brink, A. Axelsson, B. Nilsson, Methodologies for
model calibration to assist the design of a preparative ion-exchange step for antibody
purication, J Chrom A 1033 (2004) 71{82.
165
3 PUBLICATIONS & MANUSCRIPTS
166
High-throughput Micro-scale Cultivations and Chromatography
Modeling: Powerful Tools for Integrated Process Development
P. Baumann1, T. Hahn1 and J. Hubbuch1,

	




	
		

	

 	
 
1 : Institute of Process Engineering in Life Sciences, Section IV: Biomolecular Separation En-
gineering, Karlsruhe Institute of Technology, Engler-Bunte-Ring 1,76131 Karlsruhe, Germany
 : Corresponding author. E-mail-address:juergen.hubbuch@kit.edu (J. Hubbuch)
167
Abstract
Upstream processes are rather complex to design and the productivity of cells under suit-
able cultivation conditions is hard to predict. The method of choice for examining the
design space is to execute high-throughput cultivation screenings in micro-scale format.
Various predictive in silico models have been developed for many downstream processes,
leading to a reduction of time and material costs. This paper presents a combined op-
timization approach based on high-throughput micro-scale cultivation experiments and
chromatography modeling. The overall optimized system must not necessarily be the one
with highest product titers, but the one resulting in an overall superior process perfor-
mance in up- and downstream.
The methodology is presented in a case study for the Cherry-tagged enzyme Glutathione-
S-Transferase from Escherichia coli SE1. The Cherry-TagTM (Delphi Genetics, Belgium)
which can be fused to any target protein allows for direct product analytics by simple
VIS absorption measurements. High-throughput cultivations were carried out in a 48-
well format in a BioLector Rmicro-scale cultivation system (m2p-Labs, Germany). The
downstream process optimization for a set of randomly picked upstream conditions pro-
ducing high yields was performed in silico using a chromatography modeling software
developed in-house (ChromX). The suggested in silico-optimized operational modes for
product capturing were validated subsequently. The overall best system was chosen based
on a combination of excellent up- and downstream performance.
Keywords: Micro-scale Cultivation, BioLector R, High-Throughput Screening, UV
Absorption Modeling, Ion-exchange Chromatography
1 Introduction
Although the complexity of the protein purication procedure is strongly dependent on
the cultivation conditions, up- and downstream processes are mostly optimized sepa-
rately. When linking those two process parts, the best cultivation must not necessarily
be the one leading to highest yields and titers, but the one resulting in an overall superior
process performance. For product formation, it is important to have tools to screen large
numbers of organisms and production conditions. The subsequent downstream screening
needs to be capable of scoring the large number of produced feedstocks in terms of their
applicability for downstream process development (DSP).
Cultivation conditions for the eective production of biopharmaceuticals are hard to pre-
dict. The chosen cultivation conditions strongly inuence product formation and can
signicantly dier from standard growth conditions. For human interferon-2, human
interferon-, and the interferon-induced murine protein Mx, it was shown that lowered
temperatures lead to an increase in soluble protein during product formation in E. coli
[1]. Similar results were shown for the production of Vitreoscilla globin under oxygen
limitations [2]. Dierent levels of benzoylformate decarboxylase were obtained using
various culture media components in E. coli [3]. These results, however, cannot be trans-
ferred directly when investigating dierent strains and products, and in silico model
implementation is limited. Thus, high-throughput process development (HTPD) is the
method of choice for screening a large pool of conditions in upstream process development
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Figure 1: Schematic overview of the integrated optimization approach for bioprocess development based
on high-throughput micro-scale cultivations and lysate characterization by chromatography modeling.
Dierent lysates from the micro-scale cultivations are investigated in low column volume chromatography
for model calibration. The created models are then used for in silico optimization of the purication
process. The overall best system is chosen based on the overall optimal performance in up- and down-
stream.
(USPD) on the micro-scale. Dierent miniaturized high-throughput cultivation systems
were described, mostly resulting in a strong decrease in accessible process information
[4]. One approach uses small-scale vessels which imitate the industrial scale fermenters
and can be run in parallel [5, 6, 7]. However, the highest capabilities for high-throughput
experiments are reached by cultivations in microtiter plates (MTPs). A major disad-
vantage is the loss of process information and process control, leading to optimization
results that might not be suited for scale up. An approach linking the advantages of
high-throughput experimentation in microtiter plates with those of continuous process
control is the BioLector Rtechnology (m2p-Labs, Germany). Cultivations are carried out
in continuously shaken 48-well plates on the sub-milliliter scale. For better mixing and
oxygen uptake, microtiter plates with baed wells (FlowerPlates R) were developed [8].
For continuous monitoring of cell growth by scattered light measurements, the plates are
equipped with an optical bottom, making sampling obsolete [9, 10].
Besides the eects on product formation, inuences of cultivation conditions on the con-
taminant levels are not considered in most cases. E.g. dissolved oxygen levels [11, 12],
temperature changes [13, 14], cultivation media [15, 16], as well as the state of the cell in
the cell cycle [17, 18] are highly inuential on e.g. host cell protein levels. Consequently
the initial purity of the product will dier largely.
The above-mentioned variations of the initial purity and concentrations of critical con-
taminants play a crucial role in downstream process development. Hence, cultivations
should not only be scored by the product titers, but also by the contaminant proles
of respective upstream conditions. Besides HTPD, a large number of predictive in silico
models have been developed for many downstream unit operations, leading to a reduction
of time and material costs. Mathematical modeling and numerical optimization of chro-
matography were applied successfully for model proteins [19], antibodies [20, 21] as well
as for industrial processes [22, 23]. All simulation procedures mentioned rely on known
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molar concentrations of the biomolecules involved. However, models can also be based
on absorption data using an inverse method [24]. The major advantage of this procedure
is that data from chromatograms can be used directly for model development. No sensor
calibration is needed, which is why this method appears to be an ideal tool for comparing
a large number of feedstocks within a short period of time.
This paper presents an integrated optimization approach based on high-throughput micro-
scale cultivations and lysate characterization by chromatography modeling using chro-
matogram tting (Fig. 1). The methodology is presented in a case study for the Cherry-
tagged enzyme Glutathione-S-Transferase from Escherichia coli SE1. The 11 kDa Cherry-
TagTM (Delphi Genetics, Belgium) is fused to the target protein and can be detected by
414 nm absorption measurements [25, 26]. The upstream screening for varying culti-
vation conditions, such as temperature and induction conditions, was performed in a
BioLector Rsystem (m2p-Labs, Germany). A set of randomly picked upstream conditions
producing high yields was then characterized and optimized in silico using a chromatogra-
phy modeling software developed in-house (ChromX). The operational modes for process
optimization suggested were validated subsequently. Instead of choosing the cultivation
leading to highest product concentrations, the ideal system was chosen based on a com-
bination of overall excellent up- and downstream performance.
2 Materials & Methods
2.1 Mathematical Methods
2.1.1 Chromatogram Fitting
In the following section, the governing equations of the simulations are presented. p
describes the solution of the least squares optimization problem given in Eq. (1):
argmin
p
X
j
 
m(tj) 
X
i1
ci(L; tj; p)  ai
!2
; (1)
with m(tj) being the absorption value derived from the chromatogram at point in time
tj, ci being the protein concentration i at the end of the column of length L, and ai
describing the absorption factor. The algorithms used for solving the above-mentioned
problem were a heuristic method based on a genetic algorithm [27] and a deterministic
method based on Levenberg-Marquardt implementation [28]. Genetic algorithms prevent
local minima by performing random jumps for exploring a larger area in the search space.
The deterministic algorithm served for result renement.
2.1.2 Steric Mass-action (SMA) Model
As an adsorption model for ion-exchange chromatography, the semi-mechanistic steric
mass-action isotherm (SMA) [29] was applied allowing for chromatography simulations
including varying salt concentrations. It covers eects of counter-ions on the retention be-
havior of proteins, including the proteins' characteristic charges i. Adsorbent properties,
such as the total ionic capacity , are also considered. Steric shielding eects caused by
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proteins covering binding sites without electrostatic interactions are included as a factor
i. The kinetic form of the SMA isotherm is shown in Eq. (2) for k proteins, with qi
and cp;i being the concentration of the protein i adsorbed and in solution inside the pore,
respectively. cp;salt describes the eective pore salt concentration. kads;i and kdes;i are the
constants of adsorption and desorption, respectively. qsalt in Eq. (3) describes the number
of salt ions still attached to the adsorbent surface and is dened as the dierence between
the total ionic capacity  and the number of areas blocked by electrostatic adsorptionPk
j=1 jqj. The areas blocked due to steric shielding still possess the counter-ions and,
hence, are not taken into account.
@qi
@t
= kads;i
 
 
kX
j=1
(j + j)qj
!i
cp;i   kdes;icip;saltqi (2)
qsalt =  
kX
j=1
jqj (3)
For small sample loadings ranging from 0 to 5% of the maximum binding capacity of
the applied adsorbent resin as in this study the ionic capacity predominates and the
occupied adsorption slots can be neglected. This results in a quasi-linear form of the
SMA isotherm, meaning that the peak shape is not inuenced by the concentration, as
shown in Eq. (4). When dividing Eq. (4) by kdes;i, Eq. (5) results in a kinetic term
1
kdes;i
and an equilibrium term keq;i which equals
kads;i
kdes;i
.
@qi
@t
 kads;iicp;i   kdes;icip;saltqi (4)
1
kdes;i
@qi
@t
 keq;iicp;i   cip;saltqi (5)
In contrast, for setups at the column capacity limit besides the 4 gradients presented in
this study a frontal experiment (breakthrough experiment) is mandatory. The estimation
procedure then includes further parameters to be determined, namely the steric shielding
factor  and the absorption factors. However, considering the limited sample volume
derived from high-throughput cultivations such frontal experiments were not possible.
Nevertheless, for the determination of critical contaminants the simplied methodology
works well for pre-selecting feasible lysates for scale up applications.
2.1.3 Transport Dispersive Model (TDM)
The Transport Dispersive Model (TDM) [30] in Eqs. (6) and (7) describes macroscopic
protein transport inside the chromatography column and considers the interstitial volume
of the mobile phase, as well as the mass transfer into the pore volume. Film and pore
diusion eects are lumped in an eective mass transfer coecient keff;i for simplication.
The system is of Convection Diusion Reaction (CDR) type. Eq. (6) describes the rate
of change of the concentration ci(x; t) of component i in the inter-particle phase of a
column with length L. The rst term of Eq. (6) refers to the convective transport which
is dominated by the inter-particle velocity of the uid u. The middle term describes
hydrodynamic dispersion in axial direction using the dispersion coecient Dax. The last
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term refers to the transition of molecules from the interstitial into the particle pore phase
ci - cp;i which depends on the porosity of the bed "b, the radius of adsorbent particles rp,
and a component-specic lumped eective mass transfer coecient keff;i.
Eq. (7) models the accumulation and distribution of mass inside the pores. It is composed
of the protein pore concentration in the liquid phase cp;i and the protein concentration
bound to the stationary phase qi. Particle porosity "p is one of the inuencing factors.
For the model, Danckwerts boundary conditions in Eqs. (8) and (9) were used describing
that the concentration at the inlet is inuenced by diusion and back mixing whereas the
concentration at the outlet is unaected by such eects. The adsorption mechanism was
described using the SMA isotherm model shown above in Eqs. (2) and (3).
@ci
@t
=  u@ci
@x
+Dax
@2ci
@x2
  1  "b
"b
keff;i
3
rp
(ci   cp;i) (6)
@cp;i
@t
= keff;i
3
rp"p
(ci   cp;i)  1  "p
"p
@qi
@t
(7)
@ci
@x
(0; t) =
u
Dax
(ci (0; t)  cin;i (t)) (8)
@ci
@x
(L; t) = 0 (9)
The model was simulated one-dimensionally in space. Consequently, the concentrations
depend on the axial position in the column, only. As a quasi-linear form of the SMA
isotherm is used, all concentration terms ci and qi in Eqs. (3) - (9) can be transformed
into absorptions using the absorption factors.
2.1.4 Pareto Optimization
Yields and purities of the elution fractions were investigated for all possible product
fractionation setups. Finding a global optimum for a multi-objective problem can be
accomplished by Pareto optimization. Single objective problems mostly result in single
solutions. For multi-objective problems, by contrast, innite Pareto optimal solutions
exist, as the single objectives interfere. The so-called Pareto front describes the feasible
system points of all possible single parameter combinations.
2.2 Materials
2.2.1 Disposables & Reaction Vessels
The nucleic acid sequence of Glutathione-S-Transferase (GST) derived from S. japonicum
was inserted into the pSCherry vector of the CherryTM Express T7 protein expression
kit (Delphi Genetics, Belgium). The storage of cells was realized in a CryobankTM strain
maintenance kit for microorganisms (Mast Diagnostica, Germany). Micro-scale culti-
vations were carried out in 48-well FlowerPlatesRcovered with adhesive sterile sealing
foil (m2p-Labs, Germany). Pre-cultures were cultivated in 1 L baed asks (Schott,
Germany). Cell harvest and removal of cell debris after disruption was carried out in
15 mL centrifugal tubes (Falcon, Germany). Absorption measurements were carried
out in 96-well at bottom UV-Star Rhalf-area micro-plates (Greiner Bio-One, Germany).
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Anion-exchange chromatography experiments were conducted in a '1 mL' HiTrapTM Q
FF column with eective volume of 0.962 mL (GE Healthcare Life Sciences, Sweden).
For ltration of samples, 0.2 m polyethersulfone sterile lters were applied (VWR, Ger-
many). Capillary gel electrophoresis (GX II) was performed in an HT Protein Express
& Pico LabChip R(Perkin Elmer, USA). Sample preparation for GX II was conducted in
skirted 96-well twin.tecRPCR plates (Eppendorf, Germany).
2.2.2 Chemicals & Buers
As a cultivation medium, standard Terric Broth (TB) medium was used, including
12 g/L wheat peptone for microbiology (Fluka, Germany), 24 g/L bacteriological yeast
extract (Amresco, USA), 5 g/L glycerol bidistilled 99.5%, 17 mM potassium dihydrogen
phosphate, and 7 mM di-potassium hydrogen phosphate (VWR, Germany). Isopropyl-
-D-thiogalactopyranosid (IPTG) from a 0.25 M stock solution (VWR, Germany) was
applied for the induction of the pSCherry's T7 promotor. As a lysis buer for cell
disruption, the 20 mM Tris-HCl AEX running buer was used (VWR, Germany) adjusted
to pH 8 with hydrochloric acid (Merck, Germany). 1X SigmaFASTTM Protease Inhibitor
(Sigma Aldrich, Germany) was added for prevention of protease degradation. The binding
buer for the 1 mL HiTrapTM Q FF column was composed of 20 mM Tris-HCl at pH 8,
as described above. The elution buer consisted of the same buer, including 1 M NaCl
(Merck, Germany). For column regeneration, a 0.1 M sodium hydroxide solution (Sigma
Aldrich, Germany) was applied. The pH adjustment of all buers was done by titration
using sodium hydroxide (Merck, Germany). A 1% acetone solution (Merck, Germany)
and a 10 g/L MW 2,000,000 dextran solution from leuconostoc spp. (Sigma Aldrich) were
applied to determine porosities and dispersion properties. The total ionic capacity was
determined by acid-base titration using 0.01 M HCl solution and 0.5 M NaOH solution
(Merck, Germany). For the capillary gel electrophoresis (GX II) experiments, an HT
protein express reagent kit (Perkin Elmer, USA) was used. 1 mg/mL Lysozyme solution
served as an internal concentration standard (Hampton research, USA).
2.2.3 Instrumentation & Software
Micro-scale cultivations were performed in a BioLector RMB micro-scale fermentation
system equipped with the BioLection RHMI & analysis software (m2p-Labs, Germany).
Lab-scale fermentations were carried out in a MaxQTM 6000 incubator (Thermo scien-
tic, USA). Cell harvest and clarication after disruption were carried out in a 5810 R
centrifuge (Eppendorf, Germany). The cells were disrupted using a Digital Sonier R 450
(Branson Ultrasonic Corporation, USA). Absorption measurements were conducted in an
Innite M200 Reader controlled with I-control 1.9 (Tecan, Germany). For the chromatog-
raphy procedures, an AKTATM Purier system (GE Healthcare Life Sciences, Sweden)
was used, which was equipped with a pump P-900, mixer M-925, UV-detector UV-900,
motor valve INV-907, pH and conductivity monitoring unit pH/C-900, and a fraction col-
lector Frac-950 unit. The FPLC system was controlled using Unicorn 5.2 (GE Healthcare
Life Sciences, Sweden). The pH of all buers was adjusted with an HI-3220 pH meter
(Hanna Instruments, USA). Random sampling, data processing, and creation of gures
were performed in Matlab R R2011a (MathWorks, USA). Simulations and modeling were
performed using the software developed in-house, called ChromX (Karlsruhe Institute of
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Technology, Germany). Capillary gel electrophoresis (GX II) was carried out in a Caliper
LabChip RGX II using the LabChip R GX 3.1 software (Perkin Elmer, USA).
2.3 Experimental Setup
2.3.1 Micro-scale Cultivations
For the micro-scale cultivations, an equally treated pre-culture was used. A 250 mL TB
medium cultivation was prepared by inoculating with an E. coli SE1 Cherry-GST cryo
culture from the CryobankTM strain maintenance kit in a 1 L baed shake ask. The
cultivation was performed in the MaxQTM 6000 incubator at 170 rpm and 37 C. After
17 h (end of the exponential growth), the cells were diluted in sterile TB medium to
a starting OD600 nm for the BioLector
Rexperiments of 0.1 AU. Each well of the 48-well
FlowerPlate Rwas then lled with 1 mL of diluted pre-culture. The micro-scale cultiva-
tion plate was subsequently sealed with an adhesive gas-permeable sterile membrane.
All cultivations were performed at a BioLector Rshaking speed of 600 rpm. As the dier-
ent cultivation processes were performed in quadruplicates, 12 dierent conditions could
be screened per plate in total. Per 48-well FlowerPlate R, three inducer concentrations
(IPTG concentrations of 0.1, 0.5, and 1 mM) and four induction times (OD600 nm of 1, 2,
4, and 8) were investigated. As the BioLector Rsystem measures scattered light signals
instead of optical densities at 600 nm OD600 nm, a correlation function was used. For
600 rpm shaking frequency, the linear correlation slope of 17.26 SU/AU was determined.
As soon as the scattered light signal exceeded the pre-dened induction threshold value,
the respective well was induced by adding IPTG. The above-mentioned procedure was
repeated for three dierent cultivation temperatures of 27, 32, and 37 C as a full factorial
experimental design. The cultivation procedure was stopped at 12 h after induction by
transferring the cell broth to a 2 mL 96-well square deep-well plate and by centrifuging at
4000 rpm and 10 C for 30 min. After discarding the supernatants, the cell pellets were
frozen at -20 C. The frozen cells from 1 mL cultivations were resuspended in 1.25 mL
of lysis buer and the quadruplicates were pooled. The cell disruption for the 5 mL sus-
pensions was performed in 15 mL centrifugal tubes in the Branson Digital Sonier R 450
using a 1/8" tapered micro-tip sonication probe at 30% maximal power output and a
total treatment time of 90 s (6 X 15 s pulse on and 30 s pulse o for prevention of heat
denaturation). The sonication probe was xed 0.5 cm above the centrifugal tube bot-
tom. Lysate clarication was accomplished by centrifugation at 12000 rpm and 10 C for
60 min in a 5810 R centrifuge. The supernatants of all cultivations were then analyzed
using the Cherry-TagTM analytics at 414 nm. 414 nm Cherry-GST signals could be cor-
related directly to concentrations via the previously determined absorption coecient of
2.213 mg/(mLAU414 nm) (data not shown).
2.3.2 Random Sampling Procedure
As a feasibility study, 5 upstream conditions were chosen randomly for ChromX lysate
characterization, instead of choosing the cultivations of highest titers. First, the 'Thresh-
old Criterion' was dened: Conditions resulting in Cherry-GST concentrations below
0.4 mg/mL were deleted for economic reasons and replaced by a concentration of 0 mg/mL.
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Parameter Symbol Value
Diameter d 7 mm
Length L 25 mm
Bead radius rp 0.045 mm
System dead volume Vd 0.07 mL
Retention volume acetone VRetAc 0.96 mL
Retention volume dextran VRetDex 0.34 mL
Standard deviation of dextran Dex 0.029 mL
Volume of HCl VHCl 1.48 mL
Molarity of HCl cHCl 0.01 M
Flow rate u 0.2 mm
s
Table 1: Column- and system-specic parameters
Parameter Symbol Value Proceeding
Volume V 0.962 mL 1
4
   d2  L
Fluid volume Vf 0.89 mL VRetAc   Vd
Interstitial volume Vint 0.27 mL VRetDex   Vd
Total column porosity "t 0.925
Vf
V
Interstitial porosity "b 0.28
Vint
V
Particle porosity "p 0.896
Vf Vint
V Vint
Interstitial ow uint 0.714
mm
s
u
"b
Axial dispersion Dax 0.1
mm2
s
1
2
 L  uint 

Dex
Vint
2
Ionic capacity  0.22 M cHClVHCl
V (1 "b)(1 "p)
Table 2: Model parameters derived from the column- and system-specic parameters
All conditions were then scaled between 0 (= 0 mg/mL) and 1 (= maximal titer investi-
gated), which is referred to as the 'Probability Criterion'. The random sampling procedure
of 5 cultivation conditions was then performed in Matlab R R2011a. The probabilities
of being chosen were based on the 'Probability Criterion'. This means that cultivations
of lower product concentrations have lower probabilities of being picked, but can still be
chosen for downstream investigation.
2.3.3 Model Parameter Determination
For the ChromX model, dierent chromatography column- and system- specic parame-
ters were determined (compare 'Mathematical Methods' section). The procedure followed
the description of [30]. The bed porosity "b and the axial dispersion Dax of the '1 mL'
HiTrapTM Q FF column were determined with a 20 L injection of 10 g/L MW 2,000,000
dextran solution from leuconostoc spp.. The large dextran molecules are excluded from
the pores and, thus, only access the interstitial area of the chromatography column. For
the particle porosity "p, a 20 L injection of 1% acetone solution was performed. In
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contrast to this, the small acetone molecules have access to all pores and are a measure
for the overall porosity of the system. The system's dead volume Vd was determined by
acetone injection without connecting the column to the FPLC system.
For the total ionic capacity , an acid-base titration of the ion-exchange column was
carried out. For this purpose, the column was ushed with a 0.5 M NaOH solution until
the UV and conductivity signal was constant and all functional groups were blocked with
OH  ions. Following a wash with ultrapure water, a titration with 0.01 M HCl solution
followed at a ow of 0.2 mm/s. The amount of acid needed until the conductivity signal
increased was recorded. From the number of Cl  ions replacing the OH  ions, the total
number of binding sites was determined. All other column properties were taken from the
manufacturer. All given and determined parameters are listed in Table 1. The calculated
model parameters and the underlying proceedings are shown in Table 2.
2.3.4 ChromX Model Calibration
For ChromX model calibration, 4 dierent gradient experiments were conducted for each
cell lysate selected in the 'Random Sampling Procedure'. The number of gradients should
ideally at least be equal to the number of estimated parameters (here: kkin, keq, keff ,
). Each sample was 4 times diluted in 20 mM Tris binding buer pH 8, with a 1 mL
injection being ensured for each gradient. After sample application, the column was
washed for 2 CVs with binding buer. The elution was conducted by increasing the NaCl
concentration up to 1 M applying 5, 10, 15, and 20 CV gradients. Including steep and
shallow slopes helps the created model better predict steps and shallow gradients during
the in silico optimization procedure. The high-salt stage was kept constant for another
2 CVs, followed by a re-equilibration step for 5 CVs. The resulting chromatograms from
Unicorn 5.2 were then exported and implemented in the ChromX model. The areas of
the contaminant peaks in each 20 CV run (the longest gradient shows the most 'visible'
peaks) were used as the 'absorption factors' in the ChromX model.
Finally, the boundary conditions of all estimated parameters were set (namely for kkin,
keq, keff , ) to accelerate the estimation process and to exclude non-logical solutions as
e.g. negative values for the equilibrium binding coecient keq. For initial simulations,
a genetic algorithm was used to prevent local minima in the search space, followed by
a deterministic Levenberg-Marquardt algorithm for result renement. To determine the
amount of protein loaded onto the chromatography column the fractions taken from the
20 CV gradients were measured in the LabChip RGX II device as duplicates using the
HT Protein Express LabChip Rkit. The sample and chip preparation procedures were
performed as described in the manufacturer's protocol for the HT Protein Express Assay
(www:bioneer:co:kr). The results were analyzed by peak baseline integration using the
HT Protein Express 200 assay in the LabChip RGX 3.1 software.
2.3.5 Pareto Optimization
The ChromX model of each cell lysate selected in the 'Random Sampling Procedure'
was used for an in silico optimization procedure. The operational setup proposed for
product purication was subsequently validated using the AKTATM Purier system for
all 5 selected samples. The best system of all was chosen based on a combination of
excellent up- and downstream performance using a Pareto optimization method. The
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Figure 2: Product titers of soluble Cherry-GST [mg/mL] in E. coli SE1 cultivated at 600 rpm shaker
frequency under dierent cultivation conditions. The investigated temperatures were 27, 32, and 37 C.
Additionally, three inducer concentrations (IPTG concentrations of 0.1, 0.5, and 1 mM) and four induc-
tion times (OD600 nm of 1, 2, 4, and 8) were investigated. The sample selection of the 'Random Sampling
Procedure' is indicated by black arrows.
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Figure 3: BioLector Rgrowth curves of E. coli SE1 cultivated at 600 rpm shaker frequency under
dierent cultivation conditions. Bacterial growth is shown for the 37 C cultivation at three inducer
concentrations (IPTG concentrations of 0.1, 0.5, and 1 mM) and four induction times (OD600 nm of 1,
2, 4, and 8).
overall recovery Reci was dened as the initial titer from the cultivation cinit;i multiplied
by the yield Yi in the downstream process of a sample cultivated under condition i, as
shown in Eq. (10). The product recoveries were determined in silico by integration of
the Cherry-GST- specic 414 nm signal. The purity Puri was based on integrating the
280 nm signals in ChromX. The 280 nm signal of a puried Cherry-GST sample served
as a 100% purity reference A280nm;Cherry GST;i and was compared to the actual 280 nm
signal of the elution fraction A280nm;Elu;i, as shown in Eq. (11).
Reci = cinit;iYi (10)
Puri =
A280nm;Cherry GST;i
A280nm;Elu;i
(11)
An in silico fractionation was performed to scan all product fractionation possibilities.
The resulting pooled recoveries and purities were then plotted in a Pareto optimization
diagram, resulting in a Pareto front of optimal operational conditions for each upstream
setup. The comparison of those fronts results in a global Pareto front of all selected
cultivation conditions.
3 Results & Discussion
3.1 Micro-scale Cultivations & Random Sampling
All cultivations were performed at a BioLector Rshaking speed of 600 rpm. Incubation
temperatures of 27, 32, and 37 C were investigated. On each 48-well FlowerPlateR,
four dierent induction times at cell densities of OD600 nm 1, 2, 4, and 8 AU and three
inducer concentrations of 0.1, 0.5, and 1 mM IPTG were investigated as quadruplicates.
The product titers were determined after cell disruption by absorption measurements of
the cleared lysates at 414 nm. Those data were converted into concentrations using the
Cherry-GST extinction coecient. The results of the micro-scale cultivation screening is
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shown in Fig. 2.
The maximal Cherry-GST titer of 0.85 mg/mL was determined for the 37 C setup apply-
ing a late induction at OD600 nm of 8 with 0.1 mg/mL of IPTG. Generally, a pronounced
trend of increased soluble product formation towards late induction was observed for the
setups of 32 and 37 C. Here, cells induced at OD600 nm of 1 resulted in product titers of
only 0.09 to 0.27 mg/mL. In contrast to this, product titers during induction at OD600 nm
of 8 were much higher, ranging from 0.77 to 0.85 mg/mL. Total protein extraction under
denaturing conditions revealed that early induced cells resulted in inclusion bodies (data
not shown). This implies that an early induction of the E. coli SE1 T7-promoter leads to
an overproduction of Cherry-GST and, thus, to high amounts of insoluble and incorrectly
folded proteins at 32 and 37 C. The 27 C setups showed a dierent trend. Here, almost
constant Cherry-GST levels were obtained for all dierent induction setups in the range
from 0.32 to 0.54 mg/mL. As E. coli is a mesophilic organism, lowered temperatures
result in a downward regulation of the metabolism and, thus, in slowly and correctly
folded Cherry-GST. However, the expression levels are far below those determined at
higher cultivation temperatures. For all investigated setups, the IPTG concentration
did not show any major inuence on soluble Cherry-GST formation (Fig. 2). Also the
growth curves of dierent inducer concentrations at 37C (Fig. 3) do not deviate largely.
In contrast to this, growth curves for dierent induction times and cultivation temper-
atures (data not shown) diered signicantly, indicating large variances in contaminant
levels of the respective cell lysates. Those variations in contaminant concentrations can
be related to adaption of E. coli to changes in temperature, cell cycle and metabolism.
Changes in cultivation temperature induce e.g. the formation of heat or cold shock
proteins, temperature-adapted enzymes, and alternative transport mechanism proteins
[13, 14, 31, 32, 33]. Additionally, dierent induction conditions resulted in a change of
the cell cycle and overburden metabolism [17, 18]. It was therefore suggested that the
overall system optimized for up- and downstream processing must not necessarily be the
one with highest product titers. As a feasibility study, 5 upstream conditions were chosen
randomly in Matlab Raccording to the description of the 'Random Sampling Procedure'
in the experimental section. The selected setups (Fig. 2 - arrows) included:
 27 C - OD600 nm of 1 AU - 0.1 mM IPTG
 27 C - OD600 nm of 8 AU - 0.1 mM IPTG
 32 C - OD600 nm of 4 AU - 0.5 mM IPTG
 32 C - OD600 nm of 8 AU - 0.1 mM IPTG
 37 C - OD600 nm of 8 AU - 0.1 mM IPTG
3.2 ChromX Model Calibration
For the selected lysates from the micro-scale cultivations 5, 10, 15, and 20 CV gradients
were performed in the '1 mL' HiTrapTM Q FF column for ChromX model calibration.
To evaluate whether the assumption of low sample loading is valid in the presented setup
the collected fractions derived from the 20 CV gradients of all setups were analyzed using
quantitative capillary gel electrophoresis. It was shown that the amount of protein bound
to the '1 mL' HiTrapTM Q FF column ranged from 0.2 to 1% of the nominal maximum
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Figure 4: Chromatograms of the ChromX model calibration experiments. The UV280 nm signals are
shown as blue lines. Product peaks are indicated as red areas below. The salt concentrations are
illustrated as black lines. A: 5, 10, 15, and 20 CV gradients of the lysate derived from the 32 C
cultivation, induced at OD600 nm = 8 with 0.1 mM IPTG. B: Magnication of the product elution
window for the 20 CV gradient for all selected cultivation conditions. C: Magnication of the 280 nm
signal of the product elution window for the 20 CV gradient for all selected cultivation conditions after
subtraction of the product-related 280 nm signal.
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27 C
OD600 nm 1
27 C
OD600 nm 8
32 C
OD600 nm 4
32 C
OD600 nm 8
37 C
OD600 nm 8
Peak area
[mAU mL]
Peak area
[mAU mL]
Peak area
[mAU mL]
Peak area
[mAU mL]
Peak area
[mAU mL]
Peak 1 1369 711 1455 1049 441
Peak 2 1149 1569 1041 1374 2071
Peak 3 178 210 150 183 309
Peak 4 1661 1651 1042 1374 1594
Peak 5 278 309 189 230 274
Peak 6 198 240 166 205 373
Peak 7 211 256 204 287 376
Peak 8 890 1047 935 1425 1798
Peak 9 574 768 480 688 918
Peak 10 399 548 373 486 653
Peak414 nm 259 260 199 356 459
Table 3: Areas of all 'visible' peaks of the 20 CV gradients determined by zero baseline integration in
Unicorn. The 414 nm peak was used for product-specic analysis.
binding capacity (120 mg HSA per mL chromatography resin - Product information sheet
www:sigmaaldrich:com). Thus, the simplication of the SMA model was justied.
As an example, the chromatograms of the calibration experiments are shown for the
32 C cultivation induced at OD600 nm = 8 with 0.1 mM IPTG in Fig. 4A. Flowthrough
of non-binding and weakly binding contaminants can be observed during the rst 3 CVs.
The number of detectable peaks during the salt gradient elution starting after 5 CVs
increases with the length of the gradient. Also the elution of Cherry-GST, which is shown
as a red area, is shifted to higher column volumes and results in an increased product
peak broadening. The 20 CV gradient served as a measure of the number of modeled
contaminant peaks, which was identied to be 10 for all setups. The zero baseline peak
integration in Unicorn resulted in the peak areas shown in Table 3. Those areas were
used as scaling factors for the ChromX model. Obviously, there is no systematic trend
of one cultivation condition towards higher or lower peak areas. This means that the
previously determined dierences in the growth curves due to altered metabolism were
conrmed by ion-exchange chromatograms.
A magnication of the product elution window of the 20 CV gradient for all selected
cultivation conditions is shown in Fig. 4B. Note that for comparison, the signals are
scaled to an equal product peak area. The UV280 nm peak maximum after 11.3 CVs is
not equivalent to the Cherry-GST VIS414 nm peak maximum after 11.7 CVs, indicating a
closely eluting contaminant. The levels of this critical contaminant (CC) strongly dier
within the 5 investigated lysates as shown in Fig. 4C illustrating the overall 280 nm
signal subtracted by the 280 nm signal of Cherry-GST. The 27 C cultivation induced at
OD600 nm = 1 with 0.1 mM IPTG reveals the lowest CC levels, resulting in an UV280 nm
peak maximum of 0.45 AU. In contrast to this, the 32 C cultivation induced at OD600 nm
= 4 with 0.5 mM IPTG reveals the highest CC levels with an UV280 nm peak maximum
of 0.72 AU. The quantitative variances in CC levels can also be seen in the areas of peak
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Component keff kkin keq 
Contaminant 1 0.00049 0.000 0.0 0.000
Contaminant 2 0.00559 0.000 22.5 0.566
Contaminant 3 0.01200 0.000 24.7 1.156
Contaminant 4 0.01300 0.001 21.5 1.890
Contaminant 5 0.01208 0.050 26.2 3.930
Contaminant 6 0.01208 0.020 70.2 4.300
Contaminant 7 0.00808 0.090 243.2 5.670
Contaminant 8 0.00153 0.100 1623.4 6.159
Target 0.00128 0.000 757.1 6.589
Contaminant 9 0.01548 0.125 152227.0 8.968
Contaminant 10 0.00053 0.700 94223.4 7.259
Table 4: Converging SMA parameters of the target and the 10 contaminants for the 5 selected lysates.
8 in Table 3.
The chromatograms were exported from Unicorn 5.2 and implemented in the ChromX
simulation. Including the scaling factors and the model parameters (Table 2), the model
parameter estimates were obtained using rst a heuristic and then a deterministic solver
as described in the experimental section. The experimental and simulated data for the
32 C cultivation induced at OD600 nm = 8 with 0.1 mM IPTG are shown for the 10 CV
and 20 CV gradients in Fig. 5. The chromatogram derived from Unicorn (blue dashed line)
agrees very well with the UV280 nm sum signal in ChromX for all cultivation setups and
gradients. Hence, the calibration was successful and the models could be used for in silico
optimization studies. The single contaminant peaks 1 to 10 (grey lines) were resolved
decoupled from the UV280 nm sum signal, and single SMA parameters were estimated. All
USP setups consisted of the identical number of 10 contaminant peaks, as was discussed
before. As the contaminant levels of all investigated setups diered strongly, regions of
overlapping peaks resulted in shifted peak maxima when comparing dierent cell lysates.
For that reason it was rst assumed that those shifted peaks incorporated highly distinct
protein species and separate models were created for all 5 cell lysates, incorporating the
4 calibration gradients each. However, the SMA parameter sets of all dierent lysates
converged towards similar values as shown in Table 4.
Thus, ChromX revealed that all USP setups consisted of 10 resemblant contaminant
peaks which diered in their concentration levels only. To investigate this assumption,
the same modeling experiments were carried out in one batch for all lysates, forcing the
model to result in identical parameters for all characterized feed stocks. This simulation
was found to have a performance equivalent to that of the above-mentioned setup to
model all 5 setups in a decoupled way in a much shorter time frame. This even makes
an investigation all conditions of micro-scale cultivations feasible as a full factorial design
instead of performing a random sampling as shown in this study. For the selected cell
systems and cultivation setups, however, it might also be possible to investigate new
or dierent contaminant peaks. Then, the decoupled simulation methodology must be
chosen.
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Figure 5: 10 CV and 20 CV gradients of the experimental (blue dashed lines) and ChromX-simulated
(purple solid line) chromatograms are shown for the 32 C cultivation induced at OD600 nm = 8 with
0.1 mM IPTG. The single contaminant peaks (gray lines) and the product peak (red line) are indicated
below the UV280 nm sum signal.
3.3 ChromX Optimization
Using the created models for the 5 lysates, an in silico optimization was performed with
the help of the ChromX software. The emphasis of the optimization function was laid
on yield and purity, resulting in identical purication setups for all samples investigated:
After sample application, a 1 CV low-salt wash and a step gradient to 0.21 M NaCl
followed, which was kept constant for 5 CVs. Afterwards, the salt concentration was
shifted in a step to 0.37 M, followed by a 5 CV gradient to 0.47 M NaCl. In a nal high-
salt wash and re-equilibration step, the column was prepared for the next chromatography
run.
The proposed optimal purication setups were subsequently validated as shown in Fig. 6
for the experimental and simulated data of the 32 C cultivation, induced at OD600 nm =
8 with 0.1 mM IPTG. Again, the chromatogram derived from Unicorn (blue dashed line)
agrees very well with the the UV280 nm sum signal in ChromX for all cultivation setups.
Thus, the chromatogram was correctly predicted by performing 4 dierent shallow and
steep calibration gradients only.
3.4 Integrated Up- & Downstream Performance
The integrated up- and downstream performance was investigated using a Pareto opti-
mization method. The single contaminant peaks 1 to 10 (gray lines) and the product
peak (red line) from the optimized purication model were used to calculate the purities
Puri and recoveries Reci for all possible peak fractionation setups, as was described in
the experimental section. The product recoveries and purities strongly diered depending
on the fractionation boundaries. The in silico procedure of scanning all product fraction-
ation possibilities resulted in the Pareto fronts for the 5 lysates shown in Fig. 7. The
overlaps of those optimal system points resulted in a global Pareto front of all lysates,
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Figure 6: Optimized purication setup of the experimental (blue dashed lines) and ChromX-simulated
(purple solid line) chromatograms shown for the 32 C cultivation induced at OD600 nm = 8 with 0.1 mM
IPTG. The single contaminant peaks (gray lines) and the product peak (red line) are indicated below
the UV280 nm sum signal.
which describes the feasible conditions. The optimum recovery was found for the culti-
vation at 37 C induced at OD600 nm = 8 with 0.1 mM IPTG (green triangles in Fig. 7).
This result is quite intuitive, as most parts of the product peak are fractionated for this
setup and the cultivation of highest initial upstream product titers performs best. How-
ever, the optimum purity was found for the cultivation at 27 C induced at OD600 nm
= 1 with 0.1 mM IPTG resulting in a purity of up to 65% (dark blue circles in Fig. 7).
For all other cultivation setups, a purity above 58% could not be reached. The lowest
process performance was identied for the cultivation at 32 C induced at OD600 nm =
4 with 0.5 mM IPTG (dark red stars in Fig. 7). As discussed, the global Pareto front
describes a set of optimal system points which have to be selected based on the value of
the product.
It becomes obvious that the cultivation conditions are of crucial importance to down-
stream processing and the overall process performance due to dierent contaminant levels
and species. The critical contaminants (CCs) which elute close to the product are the
factors having the highest inuence.
4 Conclusions
The optimization approach based on high-throughput micro-scale cultivation experi-
ments, chromatography modeling, and Pareto optimization was found to be an elegant
tool for integrated up- and downstream process optimization. Micro-scale cultivations in
the BioLector Rsystem helped nd feasible cultivation conditions. Besides variations of
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Figure 7: Pareto optimization based on dierent fractionation setups based on the purities and recov-
eries of the 5 selected lysates in the pooled elution fractions. The Pareto fronts of the 27 C setups are
shown as blue circles, the 32 C setups as red and orange stars, and the 37 C setup as a green triangle.
product titers, large dierences in the growth curves were observed, indicating distinct
contaminant levels. Instead of selecting cultivations of highest Cherry-GST titers, a fea-
sibility study applying random sampling was conducted. Two criteria were specied: To
eliminate all conditions of marginal product concentrations, a 'Threshold Criterion' was
given. Sampling from the resulting conditions was then performed randomly, with the
selection probability being based on the product titers ('Probability Criterion' ). For the
5 chosen lysates, chromatography models were successfully created using 4 calibration
gradients in an AEX chromatography column. ChromX revealed that all investigated
USP setups consisted of 10 contaminant peaks at dierent concentration levels only. One
coupled model with scaled contaminant levels and identical SMA parameter sets for all
investigated lysates was found to perform similarly to decoupled models allowing for
distinct SMA parameters sets for the ve selected lysates. This even allows for an inves-
tigation of all conditions of the micro-scale cultivations as a full factorial design instead
of performing a random sampling as shown in this study. However, for cell systems where
new contaminant peaks are investigated, induced by dierent cultivation conditions, the
decoupled simulation methodology is the method of choice. An in silico optimization of
the AEX purication process based on the created models was performed and successfully
validated. It was shown that the shallow and steep gradients from the calibration runs
could correctly predict steps as well as gradients. As a nal step, the integrated up- and
downstream performance was determined by a Pareto optimization based on product re-
covery (initial titer  yield) and purity. The Pareto fronts of the selected lysates resulted
in a global set of optimal system points which need to be set based on the value of the
product.
In summary, the integrated approach showed large potential for concerted up- and down-
stream optimization and the upstream conditions were found to result in strong variations
in the levels of critical contaminants (CC). The procedure now needs to be tested for fur-
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ther systems, e.g. for eucaryotic organims like P. pastoris.
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4 Conclusion & Outlook
This PhD thesis contributes to solving issues that arise in the biopharmaceutical industry
during process development and characterization. One main focus was to develop strate-
gies complying with the 'Quality by Design' and 'Time to Market' guidelines in terms of
a fast design of robust and well characterized processes. Another challenge was to loosen
the strict separation between up- and downstream process development ('over the wall'
workow) and to facilitate concerted up- and downstream optimization strategies. In
that context the following topics were covered:
 Advanced analytical technologies for HTS and modeling applications
 Systematic HTS strategies for downstream intensication
 Mechanistic chromatography modeling based on process UV data
 Integrated up- and downstream process development
In the rst section dierent approaches for HTS compatible analytical technologies were
evaluated and applied. The Cherry-TagTM as a protein fusion tag of special optical
properties proved to be a highly sophisticated tool for real-time and in-line tracking of
target molecules. The tag even allowed for a distinction between the soluble and active
state of the protein and the insoluble or denatured state in dierent applications of up-
and downstream process development. This property was exploited during screenings
on feasible cultivation conditions to prevent the formation of misfolded inclusion bodies
and the results were directly transferable to a production process of the untagged pro-
tein species. Also the native state of the product can be assured during downstream
applications so that critical process steps can be changed or replaced to result in an ef-
fective overall process. Despite changing the protein structure, additional straight-to-use
analytical technologies were investigated. Multi-variate data analysis (MVDA) of pro-
tein spectra was used as a fast and non-invasive method which was implemented into
the HTS workow of a robotic workstation and helped preventing analytical bottlenecks
created during HTS experiments. Such empirical partial least squares - projection to
latent structures (PLS) models were successfully used for deconvolution of HTS multi-
component isotherm data and resulted in modeling quality data. Additionally, MVDA
facilitated the fast and straightforward distinction of native and denatured protein species
during optimization studies on hydrophobic interaction chromatography. As a nal HTS
compatible analytical tool, high-throughput capillary gel electrophoresis (HT-GCE) was
evaluated. In contrast to traditional analytical methods being based on e.g. chromatog-
raphy (processing time per sample of several minutes even in optimized setups), HT-CGE
(processing time per sample approximately 40 s) was found to be highly eective for large
data sets. In HT upstream applications HT-CGE was used for the characterization of
the soluble and insoluble protein fractions of crude feed stocks and for providing a rank-
ing on the performance of dierent cultivation conditions. In addition, a high-resolution
characterization of the subsequent downstream process was possible as a large number
of collected fractions could be analyzed by HT-CGE. Thus, three very fast, reliable and
straightforward analytical tools for HTS and modeling applications were investigated and
ready-to-use for diverse applications.
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The second section of this PhD thesis proposed systematic HTS strategies for downstream
intensication (deterministic experimental approach). For ion-exchange chromatography
a methodology was introduced being suited for both salt-stable and salt-intolerant pro-
teins. An optimized product capturing step under stabilized conditions was ensured
by a combination of stability and additive screenings in high-throughput as well as a
deterministic chromatofocusing strategy for nding optimal operational conditions. For
salt-intolerant proteins a straightforward pH shift purication protocol was introduced as
an alternative to the traditional salt elution mode. A similar deterministic experimental
approach was developed for hydrophobic interaction chromatography (HIC). HTS solu-
bility screenings and miniaturized robotic column chromatography experiments resulted
in dierent correlations of the protein's isoelectric point, overall solubility and the HIC
binding behavior. Conditions of decreased solubility as e.g. close to the isoelectric point
enhanced protein binding without aecting the protein's structural integrity. Eective
protein capture steps were again designed based on well-chosen prior screening exper-
iments. Such systematic strategies should now be extended to other downstream unit
operations like aqueous two-phase systems (ATPS) for resulting in a global toolbox for
process design.
The third section of the thesis focused on mechanistic models for chromatography using
process UV data. The idea was to move away from modeling based on known concentra-
tions and molar fractions to standard industrial process UV data. Changes in the down-
stream workow can be detected directly, which opens up new possibilities for real-time
intervention and increased eectivity of processes. The UV-based approach for mechanis-
tic modeling of a complex feed stock was realized by re-writing all model equations from
molar concentrations to absorption based units by introducing absorption coecients. As
a result standard parameter estimating procedures using chromatogram tting (inverse
modeling) were applicable for standard process UV data.
Finally, high-throughput technologies and the straightforward modeling toolbox were
merged to an integrated up- and downstream process optimization strategy. The pre-
selection for suited upstream conditions was based on HT cultivation screenings, exclud-
ing settings of unfeasible product levels. However, the subsequent lysate characterization
using the above-mentioned procedure of mechanistic UV-based inverse modeling of chro-
matography data was not only performed for the systems of highest product titers as in
industry but also on conditions of moderate productivity. The created highly predictive
ion-exchange chromatography models for each investigated lysate were then optimized in
silico for a dedicated product capturing step and analyzed by in silico sampling of all pos-
sible elution pooling setups. A multi-objective optimization nally resulted in a global set
of optimal system points of the integrated process which suggested dierent cultivation
strategies depending on the value of the product. In contradiction to the general practice
in industry, this study emphasized that the downstream process is highly inuenced by
the cultivation conditions and therefore provided a basis for analysis of dierent other
cell systems, vectors and products. With the basic tools given for such investigations
xed conditions for upstream processes in industry (e.g. antibody processes) should be
questioned and re-evaluated on the basis of such new insights.
In summary, this PhD thesis covers diverse strategies in process development and char-
acterization as demanded by the biopharmaceutical industry. It resulted in a toolbox of
HTS compatible analytical technologies for up- and downstream applications preventing
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a bottleneck for large sets of samples. The proposed deterministic experimental strategies
might become a routine in process development as an alternative to current practice like
heuristic approaches. Finally, the UV-based inverse modeling method helps identifying
process inconsistencies and, moreover, realizing sophisticated approaches of concerted up-
and downstream optimization.
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5 Abbreviations
Abbreviation Denition
4-NP 4-nitrophenole
4-NPG 4-nitrophenyl--D-galactopyranoside
AEX Anion-exchange
ambr Advanced micro-scale bioreactor
AmpR Ampicillin resistance
araBAD Arabinose metabolic operon
ATPS Aqueous two-phase system
BET BrunauerEmmettTeller
BIS-TRIS 2,2-Bis(hydroxymethyl)-2,2',2"-nitrilotriethanol
BSA Bovine serum albumine
BTC Breakthrough curve
cAMP Cyclic adenosine monophosphate
CAPS 3-(Cyclohexylamino)-1-propanesulfonic acid
CAPSO 3-(Cyclohexylamino)-2-hydroxy-1-propanesulfonic acid
CC Critical contaminant
ccdA Bacterial antidote
ccdB Bacterial toxin
cDNA Complementary deoxyribonucleic acid
CDR Convection diusion reaction
CEX Cation-exchange
CHAPS 3-[(3-Cholamidopropyl)dimethylammonio]-1-propanesulfonate
CHES 2-(Cyclohexylamino)ethanesulfonic acid
CHO Chinese hamster ovary cell
CIP Cleaning in place
CV Column volume
Cyt c Cytochrome c
DBC Dynamic binding capacity
DIOS Desorption/ ionization on silicone
DNA Deoxyribonucleic acid
DoE Design of experiments
DSP Downstream process
DTT Dithiothreitol
EcFbFP Fluorescent protein
EDTA Ethylenediaminetetraacetic acid
EGFP Enhanced green uorescent protein
ELISA Enzyme-linked immuno sorbent assay
EMA European medicines agency
ESI-MS Electrospray ionization mass spectrometry
Fc Crystallisable fragment
Fab Fragment antigen binding
FEM Finite element method
FPLC Fast protein liquid chromatography
G-CSF Granulocyte colony-stimulating factor
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5 ABBREVIATIONS
GA Genetic algorithm
GFP Green uorescent protein
GST Glutathione-S-Transferase
GX Gel electrophoresis
HCl Hydrochloric acid
HCP Host cell protein
HEPPSO N-(2-Hydroxyethyl)piperazine-N'-(2-hydroxypropanesulfonic acid)
HIC Hydrophobic interaction chromatography
His Histidine
HPLC High-performance liquid chromatography
HSA Human serum albumine
HT High-throughput
HT-CGE High-throughput capillary gel electrophoresis
HTE High-throughput experiment
HTPD High-throughput process development
HTS High-throughput screening
IB Inclusion body
IEX Ion-exchange
IgG Immunoglobuline G
IPTG Isopropyl--D-1-thiogalactopyranoside
KanR Kanamycin resistance
kb kilo base pare
kDa kilo Dalton
lac lactose-operon
LB Lysogeny broth
LDS Lauryl dodecyl sulfate
LHS Liquid handling system
LU Lower upper
LV Latent variable
Lys Lysine/ Lysozyme
mAB Monoclonal antibody
MALDI-MS Matrix-assisted laser desorption ionization mass spectrometry
MAT Metal anity tag
MCS Multiple cloning site
MD Molecular dynamics
MES 2-(N-morpholino)ethanesulfonic acid
MOPSO 3-Morpholino-2-hydroxypropanesulfonic acid
mRNA Messenger ribonucleic acid
MS Mass spectrometry
MTP Microtiter plate
MVDA Multi-variate data analysis
MW Molecular weight
MWCO Molecular weight cuto
NaCl Sodium chloride
NaOH Sodium hydroxide
NaS Sodium sulfate
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OD Optical density
OED Optimal experimental design
ori Origin of replication
OTR Oxygen transfer rate
PA anthrax-protective gene
PapMV Papaya mosaic virus
pBR322 Prokaryotic expression vector (Plasmid)
PBS Phosphate buered saline
PC Principal component
PCA Principal component analysis
PCR Polymerase chain reaction
PDB Protein data bank
PEG Polyethylene glycol
PES Polyether sulfone
pH Pondus Hydrogenii
pI Isoelectric point
pka Acid dissociation constant
pL/ pR Bacteriophage  promoter
PLS Partial least squares/ projection to latent structures
PTFE Polytetrauoroethylene
pUC Prokaryotic expression vector (Plasmid)
Q Quaternary ammonium
QbD Quality by Design
QSAR Quantitative structure-activity relationship
QSPR Quantitative structure-property relationship
RAMOS Respiration activity monitoring system
RNA Ribonucleic acid
rPTH Recombinant parathyroid hormone
S Sulte
scFv Single chain variable fragment
SDR Short-chain dehydrogenase/ reductase
SDS Sodium dodecyl sulfate
SDS PAGE Sodium dodecyl sulfate polyacrylamide gel electrophoresis
SEC Size exclusion chromatography
Sf9 Spodoptera frugiperda cell line
SOB Super optimal broth
SOC Super optimal broth with catabolite repression
SP FF Sulfopropyl fast ow
SMA Steric mass-action
SUPG Streamline-Upwind-Petrov-Galerkin
tac Hybrid of lactose- and tryptophane-operon
TAPS N-Tris(hydroxymethyl)methyl-3-aminopropanesulfonic acid
TB Terric broth
TBS(T) Tris buered saline (including Tween 20)
TCA Trichloro acetic acid
TDM Transport dispersive model
195
5 ABBREVIATIONS
TEM Transmission electron microscopy
Tris Tris(hydroxymethyl)-aminomethan
tRNA Transfer ribonucleic acid
trp tryptophane-operon
TSP Total soluble protein
USP Upstream process
USPD Upstream process development
UV Ultraviolet
VLP Virus-like particle
VHH Single domain antibody
VIS Visible
VP1 Murine polyomavirus capsid protein
WHcAg Woodchuck hepadnavirus core protein
YFP Yellow uorescent protein
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